package cleanurl

import "testing"

func Test_apex_oracle_com(t *testing.T) {
	urls := map[string]string{
		"https://apex.oracle.com/pls/apex/f?p=59578%3A10%3A2080928903990328%3A%3A%3A%3A%3A": "https://apex.oracle.com/pls/apex/f?p=59578%3A10%3A2080928903990328%3A%3A%3A%3A%3A",
	}
	testURLs(t, urls)
}
func Test_www_aviationweek_com(t *testing.T) {
	urls := map[string]string{
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p04-619431-01.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p04-619431-01.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p08-618705-04.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p08-618705-04.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p13-621121-07.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p13-621121-07.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p32-620286.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p32-620286.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p53-619400.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p53-619400.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p14-621246.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p14-621246.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p17-619219.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p17-619219.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p28-620154.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p28-620154.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p44-618765.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p44-618765.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p13-621038.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p13-621038.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p21-621204-02.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p21-621204-02.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p54-619695.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p54-619695.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p19-619538.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p19-619538.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p48-618684.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p48-618684.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-05.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-05.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-09.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-09.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p36-620268.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p36-620268.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p38-617773.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p38-617773.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-06.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-06.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p24-620364.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p24-620364.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p38-618031.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p38-618031.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p13-621121-03.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p13-621121-03.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p21-621204-01.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p21-621204-01.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p34-620358.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p34-620358.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p53-619404.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p53-619404.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p08-618705-03.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p08-618705-03.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p20-619773.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p20-619773.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p40-619758.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p40-619758.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p43-619275.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p43-619275.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-10.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-10.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-11.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-11.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p13-621109.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p13-621109.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p13-621121-01.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p13-621121-01.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p13-621121-02.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p13-621121-02.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p18-619908-01.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p18-619908-01.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p22-620995.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p22-620995.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p18-619908-02.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p18-619908-02.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p50-619648.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p50-619648.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-02.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-02.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-08.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-08.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p32-620295.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p32-620295.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p49-619115.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p49-619115.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p08-618705-02.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p08-618705-02.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p08-618705-06.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p08-618705-06.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p31-620451.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p31-620451.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p33-620445.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p33-620445.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p35-620316.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p35-620316.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p44-618785.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p44-618785.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p08-618705-05.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p08-618705-05.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-03.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-03.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-07.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-07.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p13-621121-05.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p13-621121-05.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p13-621121-06.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p13-621121-06.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p29-620388.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p29-620388.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-01.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-01.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-04.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p10-619026-04.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p16-619720.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p16-619720.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p21-621204-03.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p21-621204-03.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p26-620301.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p26-620301.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p08-618705-01.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p08-618705-01.xml",
		"https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p13-621121-04.xml": "https://www.aviationweek.com/awin/AWINLogin/tabid/1083/Default.aspx?returnurl=%2Fawin%2FArticlesStory.aspx%3Fid%3D%2Farticle-xml%2FAW_09_30_2013_p13-621121-04.xml",
	}
	testURLs(t, urls)
}
func Test_app_certain_com(t *testing.T) {
	urls := map[string]string{
		"https://app.certain.com/profile/web/index.cfm?PKWebId=0x46447531ec": "https://app.certain.com/profile/web/index.cfm?PKWebId=0x46447531ec",
		"https://app.certain.com/profile/web/index.cfm?PKwebID=0x4644753e90&varPage=home": "https://app.certain.com/profile/web/index.cfm?PKwebID=0x4644753e90&varPage=home",
	}
	testURLs(t, urls)
}
func Test_asktom_oracle_com(t *testing.T) {
	urls := map[string]string{
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A22782921394611": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A22782921394611",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A4248554900346593542": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A4248554900346593542",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A61313086268493": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A61313086268493",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7032414607769": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7032414607769",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7080001600346428865": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7080001600346428865",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7080200100346671825": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7080200100346671825",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7188836800346805118": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7188836800346805118",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A839412906735": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A839412906735",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A1202030800346981447": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A1202030800346981447",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A286816015990": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A286816015990",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A6837554200346456875": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A6837554200346456875",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7084198300346796840": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7084198300346796840",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A575623107841": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A575623107841",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7095288486502": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7095288486502",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7185307800346182830": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7185307800346182830",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A32812348052": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A32812348052",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A6633782199868": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A6633782199868",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7080171800346634518": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7080171800346634518",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7188934700346950692": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7188934700346950692",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7189681400346130590": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7189681400346130590",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A12864646978683": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A12864646978683",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A2068765100346589007": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A2068765100346589007",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A6837946100346203445": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A6837946100346203445",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A766825833740": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A766825833740",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A1264000472584": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A1264000472584",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A29518831139714": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A29518831139714",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A3932525800346405986": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A3932525800346405986",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A5090005200346616978": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A5090005200346616978",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7188966200346061482": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7188966200346061482",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3ANO%3A%3AP11_QUESTION_ID%3A367980988799": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3ANO%3A%3AP11_QUESTION_ID%3A367980988799",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3ANO%3A%3AP11_QUESTION_ID%3A43440209618042": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3ANO%3A%3AP11_QUESTION_ID%3A43440209618042",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A3021213500346960197": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A3021213500346960197",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A4972732303253": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A4972732303253",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A6137572100346136458": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A6137572100346136458",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7083192900346699217": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7083192900346699217",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3ANO%3A%3AP11_QUESTION_ID%3A16370675423662": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3ANO%3A%3AP11_QUESTION_ID%3A16370675423662",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A1281333344593": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A1281333344593",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A151682500346585057": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A151682500346585057",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A15321803936685": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A15321803936685",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A4254158186083": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A4254158186083",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A48704116042682": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A48704116042682",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A516302500346470287": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A516302500346470287",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A68212348056": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A68212348056",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7189691200346144429": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7189691200346144429",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A2654838638693": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A2654838638693",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A393018841461": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A393018841461",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A4444273995237": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A4444273995237",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A5560484386129": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A5560484386129",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A6836903900346905170": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A6836903900346905170",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A735625536552": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A735625536552",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3ANO%3A%3AP11_QUESTION_ID%3A2196162600402": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3ANO%3A%3AP11_QUESTION_ID%3A2196162600402",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A1925376100346175343": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A1925376100346175343",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A3193365100346233806": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A3193365100346233806",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A5318183934935": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A5318183934935",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3ANO%3A%3AP11_QUESTION_ID%3A15695764787749": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3ANO%3A%3AP11_QUESTION_ID%3A15695764787749",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A1155066278457": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A1155066278457",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A15151874723724": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A15151874723724",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A2259517028934": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A2259517028934",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A25323841260334": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A25323841260334",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A6840793000346893913": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A6840793000346893913",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7080614700346172368": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7080614700346172368",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7082182300346634611": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7082182300346634611",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3ANO%3A%3AP11_QUESTION_ID%3A10128287191505": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3ANO%3A%3AP11_QUESTION_ID%3A10128287191505",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A30908256823200": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A30908256823200",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7080663600346317072": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7080663600346317072",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7084058600346593982": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7084058600346593982",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3ANO%3A%3AP11_QUESTION_ID%3A442029737684": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3ANO%3A%3AP11_QUESTION_ID%3A442029737684",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A16370675423662": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A16370675423662",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A51189646104104": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A51189646104104",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A637156098168": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A637156098168",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A6841372900346319251": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A6841372900346319251",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7084058800346594698": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7084058800346594698",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7187368900346992590": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7187368900346992590",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A8764517459743": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A8764517459743",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A3396797633001": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A3396797633001",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A416718680907": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A416718680907",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A4536286321836": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A4536286321836",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A4977262687416": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A4977262687416",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A5320945700346034393": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A5320945700346034393",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A6838894800346281410": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A6838894800346281410",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7186067300346196296": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7186067300346196296",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A8912264456901": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A8912264456901",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3ANO%3A%3AP11_QUESTION_ID%3A431775600346873836": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3ANO%3A%3AP11_QUESTION_ID%3A431775600346873836",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A1853075500346799932": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A1853075500346799932",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A4844411400346525471": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A4844411400346525471",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3ANO%3A%3AP11_QUESTION_ID%3A45033135081903": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3ANO%3A%3AP11_QUESTION_ID%3A45033135081903",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A1050832240957": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A1050832240957",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A1063759517155": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A1063759517155",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A110612348061": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A110612348061",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A419593546543": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A419593546543",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7083335200346927162": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7083335200346927162",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7083459600346016743": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3A%3A%3AP11_QUESTION_ID%3A7083459600346016743",
		"http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3ANO%3A%3AP11_QUESTION_ID%3A2985886242221": "http://asktom.oracle.com/pls/asktom/f?p=100%3A11%3A0%3A%3ANO%3A%3AP11_QUESTION_ID%3A2985886242221",
	}
	testURLs(t, urls)
}
func Test_www_appliedclinicaltrialsonline_com(t *testing.T) {
	urls := map[string]string{
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/PSI-Announces-Expansion-to-India/ArticleStandard/Article/detail/820828?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/PSI-Announces-Expansion-to-India/ArticleStandard/Article/detail/820828",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Boehringer-Ingelheim-to-Present-New-Pradaxa-dabiga/ArticleNewsFeed/Article/detail/821095?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Boehringer-Ingelheim-to-Present-New-Pradaxa-dabiga/ArticleNewsFeed/Article/detail/821095",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Dipexium-Provides-Locilex-Manufacturing-Update/ArticleNewsFeed/Article/detail/822499?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Dipexium-Provides-Locilex-Manufacturing-Update/ArticleNewsFeed/Article/detail/822499",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/John-Theurer-Cancer-Center-Announces-Positive-Resu/ArticleNewsFeed/Article/detail/824072?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/John-Theurer-Cancer-Center-Announces-Positive-Resu/ArticleNewsFeed/Article/detail/824072",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MiMedx-Plantar-Fasciitis-Study-Published-In-The-Fo/ArticleNewsFeed/Article/detail/820805?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MiMedx-Plantar-Fasciitis-Study-Published-In-The-Fo/ArticleNewsFeed/Article/detail/820805",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Regeneron-and-Bayer-Report-Positive-One-Year-Resul/ArticleNewsFeed/Article/detail/819783?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Regeneron-and-Bayer-Report-Positive-One-Year-Resul/ArticleNewsFeed/Article/detail/819783",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Study-Published-in-Epilepsia-Demonstrated-Improved/ArticleNewsFeed/Article/detail/820361?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Study-Published-in-Epilepsia-Demonstrated-Improved/ArticleNewsFeed/Article/detail/820361",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Clinical-Study-Failures-Vary-Widely-by-Phase-of-St/ArticleStandard/Article/detail/822751?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Clinical-Study-Failures-Vary-Widely-by-Phase-of-St/ArticleStandard/Article/detail/822751",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Alan-Copa-PharmD-Joins-Novum-as-Vice-President-to-/ArticleNewsFeed/Article/detail/819691?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Alan-Copa-PharmD-Joins-Novum-as-Vice-President-to-/ArticleNewsFeed/Article/detail/819691",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Combinability-of-CRLX101-and-Avastin-Established-i/ArticleNewsFeed/Article/detail/824037?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Combinability-of-CRLX101-and-Avastin-Established-i/ArticleNewsFeed/Article/detail/824037",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Georgia-Reproductive-Specialists-Participates-In-T/ArticleNewsFeed/Article/detail/822860?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Georgia-Reproductive-Specialists-Participates-In-T/ArticleNewsFeed/Article/detail/822860",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Huntingtons-Disease-Could-Hold-Key-to-Alzheimers-T/ArticleNewsFeed/Article/detail/818575?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Huntingtons-Disease-Could-Hold-Key-to-Alzheimers-T/ArticleNewsFeed/Article/detail/818575",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oncolytics-Biotech-Inc-Announces-Positive-Final-Tu/ArticleNewsFeed/Article/detail/822371?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oncolytics-Biotech-Inc-Announces-Positive-Final-Tu/ArticleNewsFeed/Article/detail/822371",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Jules-Mitchels-Thoughts-on-Risk-Based-Monitoring/ArticleStandard/Article/detail/819366?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Jules-Mitchels-Thoughts-on-Risk-Based-Monitoring/ArticleStandard/Article/detail/819366",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ABRAXANE-Approved-By-The-US-Food-And-Drug-Administ/ArticleNewsFeed/Article/detail/822323?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ABRAXANE-Approved-By-The-US-Food-And-Drug-Administ/ArticleNewsFeed/Article/detail/822323",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/EYLEA-aflibercept-Injection-Approved-in-Europe-for/ArticleNewsFeed/Article/detail/821548?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/EYLEA-aflibercept-Injection-Approved-in-Europe-for/ArticleNewsFeed/Article/detail/821548",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Prolong-Pharmaceuticals-Presents-Novel-Multi-Prong/ArticleNewsFeed/Article/detail/824103?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Prolong-Pharmaceuticals-Presents-Novel-Multi-Prong/ArticleNewsFeed/Article/detail/824103",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/The-28th-Annual-Great-Sports-Legends-Dinner-To-Hon/ArticleNewsFeed/Article/detail/819206?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/The-28th-Annual-Great-Sports-Legends-Dinner-To-Hon/ArticleNewsFeed/Article/detail/819206",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Trial+Design+News/Paperless-Clinical-Trial-OptimizationmdashThinking/ArticleStandard/Article/detail/820670?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Trial+Design+News/Paperless-Clinical-Trial-OptimizationmdashThinking/ArticleStandard/Article/detail/820670",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/CancerTumor-Profiling-Market-worth-3503-Billion-by/ArticleNewsFeed/Article/detail/824007?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/CancerTumor-Profiling-Market-worth-3503-Billion-by/ArticleNewsFeed/Article/detail/824007",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/JDRF-Applauds-Launch-of-New-Low-Glucose-Suspend-Te/ArticleNewsFeed/Article/detail/824249?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/JDRF-Applauds-Launch-of-New-Low-Glucose-Suspend-Te/ArticleNewsFeed/Article/detail/824249",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Knowing-Your-Familys-Heart-Disease-History-Could-H/ArticleNewsFeed/Article/detail/825147?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Knowing-Your-Familys-Heart-Disease-History-Could-H/ArticleNewsFeed/Article/detail/825147",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Mechanism-for-Cardiac-Effects-of-Trevena-Angiotens/ArticleNewsFeed/Article/detail/819166?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Mechanism-for-Cardiac-Effects-of-Trevena-Angiotens/ArticleNewsFeed/Article/detail/819166",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Syneron-Receives-Korean-MFDS-Approval-for-elure-Ad/ArticleNewsFeed/Article/detail/819981?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Syneron-Receives-Korean-MFDS-Approval-for-elure-Ad/ArticleNewsFeed/Article/detail/819981",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/TVM-Life-Science-Ventures-VII-Announces-Investment/ArticleNewsFeed/Article/detail/819797?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/TVM-Life-Science-Ventures-VII-Announces-Investment/ArticleNewsFeed/Article/detail/819797",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Updated-St-Gallen-International-Breast-Cancer-Guid/ArticleNewsFeed/Article/detail/820973?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Updated-St-Gallen-International-Breast-Cancer-Guid/ArticleNewsFeed/Article/detail/820973",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Cardiac+Safety/Certara-Launches-Cardiac-Safety-Simulator-to-Deter/ArticleStandard/Article/detail/819406?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Cardiac+Safety/Certara-Launches-Cardiac-Safety-Simulator-to-Deter/ArticleStandard/Article/detail/819406",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/VirtualScopics-Completes-6-week-Analysis-of-Phase-/ArticleStandard/Article/detail/818463?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/VirtualScopics-Completes-6-week-Analysis-of-Phase-/ArticleStandard/Article/detail/818463",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cerevast-Therapeutics-Initiates-Phase-3-Clotbust-E/ArticleNewsFeed/Article/detail/819480?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cerevast-Therapeutics-Initiates-Phase-3-Clotbust-E/ArticleNewsFeed/Article/detail/819480",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lumena-Pharmaceuticals-Launches-Global-Clinical-Pr/ArticleNewsFeed/Article/detail/824023?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lumena-Pharmaceuticals-Launches-Global-Clinical-Pr/ArticleNewsFeed/Article/detail/824023",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/PDI-Inc-Enters-into-Collaboration-Agreement-to-Com/ArticleNewsFeed/Article/detail/820780?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/PDI-Inc-Enters-into-Collaboration-Agreement-to-Com/ArticleNewsFeed/Article/detail/820780",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/OncoGenex-Announces-that-the-Spruce-Clinical-Trial/ArticleNewsFeed/Article/detail/819442?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/OncoGenex-Announces-that-the-Spruce-Clinical-Trial/ArticleNewsFeed/Article/detail/819442",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Positive-Results-for-D-Pharms-Investigational-Drug/ArticleNewsFeed/Article/detail/820720?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Positive-Results-for-D-Pharms-Investigational-Drug/ArticleNewsFeed/Article/detail/820720",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Relmada-Therapeutics-Announces-Positive-Results-of/ArticleNewsFeed/Article/detail/822487?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Relmada-Therapeutics-Announces-Positive-Results-of/ArticleNewsFeed/Article/detail/822487",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/The-Top-Three-Strategies-the-Pharmaceutical-Indust/ArticleStandard/Article/detail/824612?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/The-Top-Three-Strategies-the-Pharmaceutical-Indust/ArticleStandard/Article/detail/824612",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cellular-Biomedicine-Group-Announces-Completion-of/ArticleNewsFeed/Article/detail/820998?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cellular-Biomedicine-Group-Announces-Completion-of/ArticleNewsFeed/Article/detail/820998",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Health-Canada-Approves-ThromboGenics-JETREA-for-th/ArticleNewsFeed/Article/detail/820626?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Health-Canada-Approves-ThromboGenics-JETREA-for-th/ArticleNewsFeed/Article/detail/820626",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/Contract-Development-and-Manufacturing-Costs-Durin/ArticleStandard/Article/detail/819754?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/Contract-Development-and-Manufacturing-Costs-Durin/ArticleStandard/Article/detail/819754",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Catabasis-Initiates-Phase-2-Trial-of-CAT-2003-in-P/ArticleNewsFeed/Article/detail/820876?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Catabasis-Initiates-Phase-2-Trial-of-CAT-2003-in-P/ArticleNewsFeed/Article/detail/820876",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MiMedx-Scientific-Study-To-Be-Published-In-The-Int/ArticleNewsFeed/Article/detail/819353?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MiMedx-Scientific-Study-To-Be-Published-In-The-Int/ArticleNewsFeed/Article/detail/819353",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/UPDATE-Multimedia-Assets-Now-Available-ViiV-Health/ArticleNewsFeed/Article/detail/820332?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/UPDATE-Multimedia-Assets-Now-Available-ViiV-Health/ArticleNewsFeed/Article/detail/820332",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/RBM-You-Cant-Get-There-from-Here/ArticleStandard/Article/detail/821191?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/RBM-You-Cant-Get-There-from-Here/ArticleStandard/Article/detail/821191",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/CROMSOURCE-Expands-in-France---Opens-New-Office/ArticleStandard/Article/detail/824606?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/CROMSOURCE-Expands-in-France---Opens-New-Office/ArticleStandard/Article/detail/824606",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Affinium-Pharmaceuticals-Announces-the-Initiation-/ArticleNewsFeed/Article/detail/822113?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Affinium-Pharmaceuticals-Announces-the-Initiation-/ArticleNewsFeed/Article/detail/822113",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Elsevier-Announces-the-Launch-of-the-Journal-of-Hi/ArticleNewsFeed/Article/detail/825320?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Elsevier-Announces-the-Launch-of-the-Journal-of-Hi/ArticleNewsFeed/Article/detail/825320",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lakewood-Amedex-Announces-Its-Novel-Bisphosphocin-/ArticleNewsFeed/Article/detail/819387?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lakewood-Amedex-Announces-Its-Novel-Bisphosphocin-/ArticleNewsFeed/Article/detail/819387",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Worlds-First-Thought-Controlled-Bionic-Leg-Unveile/ArticleNewsFeed/Article/detail/823988?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Worlds-First-Thought-Controlled-Bionic-Leg-Unveile/ArticleNewsFeed/Article/detail/823988",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioDelivery-Sciences-Announces-Submission-of-NDA-f/ArticleNewsFeed/Article/detail/819446?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioDelivery-Sciences-Announces-Submission-of-NDA-f/ArticleNewsFeed/Article/detail/819446",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/What-is-Different-Now-About-Risk-Based-Monitoring/ArticleStandard/Article/detail/819365?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/What-is-Different-Now-About-Risk-Based-Monitoring/ArticleStandard/Article/detail/819365",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/What-is-Next-for-Risk-Based-Monitoring/ArticleStandard/Article/detail/819371?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/What-is-Next-for-Risk-Based-Monitoring/ArticleStandard/Article/detail/819371",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/MedNet-Solutions-Partners-with-Heart-Imaging-Techn/ArticleStandard/Article/detail/820051?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/MedNet-Solutions-Partners-with-Heart-Imaging-Techn/ArticleStandard/Article/detail/820051",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/2-Million-Awarded-to-Sutter-Health-IBM-and-Geising/ArticleNewsFeed/Article/detail/825262?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/2-Million-Awarded-to-Sutter-Health-IBM-and-Geising/ArticleNewsFeed/Article/detail/825262",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Adaptive-Biotechnologies-Study-Reveals-Homogeneous/ArticleNewsFeed/Article/detail/825174?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Adaptive-Biotechnologies-Study-Reveals-Homogeneous/ArticleNewsFeed/Article/detail/825174",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/FDA-Approves-Stem-Cell-Clinical-Trial-For-Multiple/ArticleNewsFeed/Article/detail/820432?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/FDA-Approves-Stem-Cell-Clinical-Trial-For-Multiple/ArticleNewsFeed/Article/detail/820432",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/How-RBM-Impacts-the-Way-Sanofi-Handles-Monitoring/ArticleStandard/Article/detail/819516?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/How-RBM-Impacts-the-Way-Sanofi-Handles-Monitoring/ArticleStandard/Article/detail/819516",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Novella---Global-Oncology-Trials-Planning-for-Succ/ArticleStandard/Article/detail/820486?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Novella---Global-Oncology-Trials-Planning-for-Succ/ArticleStandard/Article/detail/820486",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Aeterna-Zentaris-First-Patient-Dosed-for-Phase-3-R/ArticleNewsFeed/Article/detail/819336?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Aeterna-Zentaris-First-Patient-Dosed-for-Phase-3-R/ArticleNewsFeed/Article/detail/819336",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Boston-Scientific-Begins-Clinical-Trial-Of-Innova-/ArticleNewsFeed/Article/detail/825313?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Boston-Scientific-Begins-Clinical-Trial-Of-Innova-/ArticleNewsFeed/Article/detail/825313",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Clitoraid-surgeon-to-speak-about-clitoral-restorat/ArticleNewsFeed/Article/detail/822207?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Clitoraid-surgeon-to-speak-about-clitoral-restorat/ArticleNewsFeed/Article/detail/822207",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Research-Suggests-Glaucoma-Screenings-for-Slee/ArticleNewsFeed/Article/detail/819971?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Research-Suggests-Glaucoma-Screenings-for-Slee/ArticleNewsFeed/Article/detail/819971",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Andrew-R-Colin-MD-Joins-AITs-Scientific-Advisory-B/ArticleNewsFeed/Article/detail/819978?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Andrew-R-Colin-MD-Joins-AITs-Scientific-Advisory-B/ArticleNewsFeed/Article/detail/819978",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioLineRx-Appoints-B-J-Bormann-to-Board-of-Directo/ArticleNewsFeed/Article/detail/820690?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioLineRx-Appoints-B-J-Bormann-to-Board-of-Directo/ArticleNewsFeed/Article/detail/820690",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioSpecifics-Technologies-Corp-Announces-Data-from/ArticleNewsFeed/Article/detail/825102?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioSpecifics-Technologies-Corp-Announces-Data-from/ArticleNewsFeed/Article/detail/825102",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Center-Of-Reproductive-Medicine-Participates-In-Th/ArticleNewsFeed/Article/detail/824026?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Center-Of-Reproductive-Medicine-Participates-In-Th/ArticleNewsFeed/Article/detail/824026",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Fattah-Champions-Neuroscience-Advancements-With-Sc/ArticleNewsFeed/Article/detail/819275?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Fattah-Champions-Neuroscience-Advancements-With-Sc/ArticleNewsFeed/Article/detail/819275",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oncobiologics-and-inVentiv-Health-Form-Strategic-P/ArticleNewsFeed/Article/detail/819849?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oncobiologics-and-inVentiv-Health-Form-Strategic-P/ArticleNewsFeed/Article/detail/819849",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oncothyreon-Announces-Initiation-of-Phase-1-Trial-/ArticleNewsFeed/Article/detail/821891?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oncothyreon-Announces-Initiation-of-Phase-1-Trial-/ArticleNewsFeed/Article/detail/821891",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Amgen-Presents-Pooled-Analysis-Showing-AMG-145-Sig/ArticleNewsFeed/Article/detail/821839?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Amgen-Presents-Pooled-Analysis-Showing-AMG-145-Sig/ArticleNewsFeed/Article/detail/821839",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioLineRx-To-Present-At-15th-Annual-Rodman-amp-Ren/ArticleNewsFeed/Article/detail/821893?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioLineRx-To-Present-At-15th-Annual-Rodman-amp-Ren/ArticleNewsFeed/Article/detail/821893",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Elsevier-Announces-the-Launch-of-a-New-Journal-Ene/ArticleNewsFeed/Article/detail/824299?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Elsevier-Announces-the-Launch-of-a-New-Journal-Ene/ArticleNewsFeed/Article/detail/824299",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Micell-Technologies-Announces-DESSOLVE-I-Manuscrip/ArticleNewsFeed/Article/detail/824300?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Micell-Technologies-Announces-DESSOLVE-I-Manuscrip/ArticleNewsFeed/Article/detail/824300",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/IT+News/Litera-Expands-Collaboration-Suite-with-Acquisitio/ArticleStandard/Article/detail/820711?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/IT+News/Litera-Expands-Collaboration-Suite-with-Acquisitio/ArticleStandard/Article/detail/820711",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioLineRx-Announces-Issuance-of-United-States-Pate/ArticleNewsFeed/Article/detail/821880?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioLineRx-Announces-Issuance-of-United-States-Pate/ArticleNewsFeed/Article/detail/821880",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/DelMar-Pharmaceuticals-Inc-to-Webcast-Live-at-Reta/ArticleNewsFeed/Article/detail/822389?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/DelMar-Pharmaceuticals-Inc-to-Webcast-Live-at-Reta/ArticleNewsFeed/Article/detail/822389",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Identification-of-a-Tau-Oligomer-Structure-That-is/ArticleNewsFeed/Article/detail/822037?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Identification-of-a-Tau-Oligomer-Structure-That-is/ArticleNewsFeed/Article/detail/822037",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oncothyreon-Announces-Merck-Serono-Decision-to-Con/ArticleNewsFeed/Article/detail/823885?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oncothyreon-Announces-Merck-Serono-Decision-to-Con/ArticleNewsFeed/Article/detail/823885",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Survey-Reveals-Technology-Gap-in-Managing-Clinical/ArticleNewsFeed/Article/detail/825248?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Survey-Reveals-Technology-Gap-in-Managing-Clinical/ArticleNewsFeed/Article/detail/825248",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/Comparing-the-Five-Methods-to-Collect-Patient-Driv/ArticleStandard/Article/detail/824021?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/Comparing-the-Five-Methods-to-Collect-Patient-Driv/ArticleStandard/Article/detail/824021",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MedNet-Solutions-To-Sponsor-The-SCDM-Annual-Confer/ArticleNewsFeed/Article/detail/822038?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MedNet-Solutions-To-Sponsor-The-SCDM-Annual-Confer/ArticleNewsFeed/Article/detail/822038",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Takeda-EXAMINE-Cardiovascular-Safety-Outcomes-Tria/ArticleNewsFeed/Article/detail/821842?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Takeda-EXAMINE-Cardiovascular-Safety-Outcomes-Tria/ArticleNewsFeed/Article/detail/821842",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/First-Patient-Treated-In-Phase-II-Of-Neuralstem-AL/ArticleNewsFeed/Article/detail/822540?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/First-Patient-Treated-In-Phase-II-Of-Neuralstem-AL/ArticleNewsFeed/Article/detail/822540",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Non-Clinical-Data-Confirm-SparVax-Anthrax-Vacc/ArticleNewsFeed/Article/detail/822987?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Non-Clinical-Data-Confirm-SparVax-Anthrax-Vacc/ArticleNewsFeed/Article/detail/822987",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Novel-Therapeutic-Opportunity-in-Narcolepsy/ArticleNewsFeed/Article/detail/825293?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Novel-Therapeutic-Opportunity-in-Narcolepsy/ArticleNewsFeed/Article/detail/825293",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Centralized-Statistical-Monitoring-Techniques-from/ArticleStandard/Article/detail/820427?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Centralized-Statistical-Monitoring-Techniques-from/ArticleStandard/Article/detail/820427",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Ximedica-joins-Theorem-Clinical-Research-Strategic/ArticleStandard/Article/detail/822156?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Ximedica-joins-Theorem-Clinical-Research-Strategic/ArticleStandard/Article/detail/822156",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/At-Six-Months-Post-Launch-the-User-Base-of-Pfizers/ArticleNewsFeed/Article/detail/818883?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/At-Six-Months-Post-Launch-the-User-Base-of-Pfizers/ArticleNewsFeed/Article/detail/818883",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MultiCell-Technologies-Expands-Scope-of-Research-A/ArticleNewsFeed/Article/detail/824617?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MultiCell-Technologies-Expands-Scope-of-Research-A/ArticleNewsFeed/Article/detail/824617",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Pivotal-Phase-3-Data-from-Boehringer-Ingelheim-Hep/ArticleNewsFeed/Article/detail/824484?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Pivotal-Phase-3-Data-from-Boehringer-Ingelheim-Hep/ArticleNewsFeed/Article/detail/824484",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Rare-inherited-mutation-leaves-children-susceptibl/ArticleNewsFeed/Article/detail/822466?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Rare-inherited-mutation-leaves-children-susceptibl/ArticleNewsFeed/Article/detail/822466",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Determining-Suitable-Overhead-Rates-to-Use-for-Stu/ArticleStandard/Article/detail/820675?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Determining-Suitable-Overhead-Rates-to-Use-for-Stu/ArticleStandard/Article/detail/820675",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/arGEN-X-Identifies-Potent-Antibody-Antagonists-aga/ArticleNewsFeed/Article/detail/822824?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/arGEN-X-Identifies-Potent-Antibody-Antagonists-aga/ArticleNewsFeed/Article/detail/822824",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Redefining-Cancer-May-Change-the-Orphan-Status-of-/ArticleStandard/Article/detail/820740?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Redefining-Cancer-May-Change-the-Orphan-Status-of-/ArticleStandard/Article/detail/820740",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Quintiles-Advances-New-Approach-to-Speed-Biomarker/ArticleStandard/Article/detail/823831?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Quintiles-Advances-New-Approach-to-Speed-Biomarker/ArticleStandard/Article/detail/823831",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Ampio-Pharmaceuticals-subsidiary-Luoxis-Diagnostic/ArticleNewsFeed/Article/detail/824449?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Ampio-Pharmaceuticals-subsidiary-Luoxis-Diagnostic/ArticleNewsFeed/Article/detail/824449",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/GW-Pharmaceuticals-plc-Opens-an-Investigational-Ne/ArticleNewsFeed/Article/detail/820414?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/GW-Pharmaceuticals-plc-Opens-an-Investigational-Ne/ArticleNewsFeed/Article/detail/820414",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Study-Shows-Unique-Dietary-Supplement-With-Ome/ArticleNewsFeed/Article/detail/818842?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Study-Shows-Unique-Dietary-Supplement-With-Ome/ArticleNewsFeed/Article/detail/818842",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Treatment-of-Diffuse-Systemic-Sclerosis-with-AIMSP/ArticleNewsFeed/Article/detail/825018?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Treatment-of-Diffuse-Systemic-Sclerosis-with-AIMSP/ArticleNewsFeed/Article/detail/825018",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Regulatory+Articles/SOPs-in-Clinical-Research/ArticleStandard/Article/detail/820674?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Regulatory+Articles/SOPs-in-Clinical-Research/ArticleStandard/Article/detail/820674",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Medidata-Minute-Video-Series/ArticleStandard/Article/detail/819025?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Medidata-Minute-Video-Series/ArticleStandard/Article/detail/819025",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Morphotek-Inc-Announces-Initiation-Of-A-New-MORAb-/ArticleNewsFeed/Article/detail/825260?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Morphotek-Inc-Announces-Initiation-Of-A-New-MORAb-/ArticleNewsFeed/Article/detail/825260",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Neurocrine-Announces-Phase-IIb-Results-Of-VMAT2-In/ArticleNewsFeed/Article/detail/822459?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Neurocrine-Announces-Phase-IIb-Results-Of-VMAT2-In/ArticleNewsFeed/Article/detail/822459",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Neurocrine-Biosciences-Announces-the-Start-of-Seco/ArticleNewsFeed/Article/detail/821577?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Neurocrine-Biosciences-Announces-the-Start-of-Seco/ArticleNewsFeed/Article/detail/821577",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/PuraMed-BioScience-Inc-Launches-LipiGesic-M-Sampli/ArticleNewsFeed/Article/detail/823970?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/PuraMed-BioScience-Inc-Launches-LipiGesic-M-Sampli/ArticleNewsFeed/Article/detail/823970",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Sparta-Systems-and-Veeva-Systems-to-Deliver-End-to/ArticleStandard/Article/detail/824608?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Sparta-Systems-and-Veeva-Systems-to-Deliver-End-to/ArticleStandard/Article/detail/824608",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BTG-Announces-Positive-Results-from-VANISH-2-Study/ArticleNewsFeed/Article/detail/818908?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BTG-Announces-Positive-Results-from-VANISH-2-Study/ArticleNewsFeed/Article/detail/818908",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cancer-Experts-Detail-New-Approaches-to-Liver-Canc/ArticleNewsFeed/Article/detail/821889?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cancer-Experts-Detail-New-Approaches-to-Liver-Canc/ArticleNewsFeed/Article/detail/821889",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Halozyme-Provides-Update-on-ViroPharma-Phase-2-Tri/ArticleNewsFeed/Article/detail/819445?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Halozyme-Provides-Update-on-ViroPharma-Phase-2-Tri/ArticleNewsFeed/Article/detail/819445",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/PTSD-after-traumatic-events-Which-teens-are-at-ris/ArticleNewsFeed/Article/detail/819099?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/PTSD-after-traumatic-events-Which-teens-are-at-ris/ArticleNewsFeed/Article/detail/819099",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/The-Killer-Instinct-Attacking-Cancer-Before-It-Dev/ArticleNewsFeed/Article/detail/824450?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/The-Killer-Instinct-Attacking-Cancer-Before-It-Dev/ArticleNewsFeed/Article/detail/824450",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/ICON-Launches-New-Patient-Safety-Service-for-Real-/ArticleStandard/Article/detail/825255?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/ICON-Launches-New-Patient-Safety-Service-for-Real-/ArticleStandard/Article/detail/825255",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Additional-Results-of-Global-Primary-Biliary-Cirrh/ArticleNewsFeed/Article/detail/824565?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Additional-Results-of-Global-Primary-Biliary-Cirrh/ArticleNewsFeed/Article/detail/824565",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/FDA-Accepts-Tasimelteon-New-Drug-Application-For-P/ArticleNewsFeed/Article/detail/819141?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/FDA-Accepts-Tasimelteon-New-Drug-Application-For-P/ArticleNewsFeed/Article/detail/819141",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/CRO/Sponsor/Medidata-Minute-Video-Series/ArticleStandard/Article/detail/819025?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/CRO/Sponsor/Medidata-Minute-Video-Series/ArticleStandard/Article/detail/819025",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Data+Analysis/CROs-Relied-Upon-for-Larger-Studies-Results-From-K/ArticleStandard/Article/detail/818911?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Data+Analysis/CROs-Relied-Upon-for-Larger-Studies-Results-From-K/ArticleStandard/Article/detail/818911",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Alliquas-SILVERSEAL-Wound-Outcome-Data-Presented-a/ArticleNewsFeed/Article/detail/824453?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Alliquas-SILVERSEAL-Wound-Outcome-Data-Presented-a/ArticleNewsFeed/Article/detail/824453",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioLineRx-Announces-Regulatory-Submission-for-Phas/ArticleNewsFeed/Article/detail/823770?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioLineRx-Announces-Regulatory-Submission-for-Phas/ArticleNewsFeed/Article/detail/823770",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Boehringer-Ingelheim-Announces-Plans-to-Expand-Bod/ArticleNewsFeed/Article/detail/821890?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Boehringer-Ingelheim-Announces-Plans-to-Expand-Bod/ArticleNewsFeed/Article/detail/821890",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Elsevier-Contributes-Scopus-Data-to-Development-of/ArticleNewsFeed/Article/detail/825317?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Elsevier-Contributes-Scopus-Data-to-Development-of/ArticleNewsFeed/Article/detail/825317",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Generex-Confirms-Conference-Call-with-Members-of-t/ArticleNewsFeed/Article/detail/818599?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Generex-Confirms-Conference-Call-with-Members-of-t/ArticleNewsFeed/Article/detail/818599",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Karmanos-Cancer-Institute-releases-Cancer-Clinical/ArticleNewsFeed/Article/detail/820691?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Karmanos-Cancer-Institute-releases-Cancer-Clinical/ArticleNewsFeed/Article/detail/820691",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Kidney-Care-Partners-to-Host-Webinar-to-Discuss-th/ArticleNewsFeed/Article/detail/824965?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Kidney-Care-Partners-to-Host-Webinar-to-Discuss-th/ArticleNewsFeed/Article/detail/824965",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Data-Utilizing-the-Eeva-Technology-to-be-prese/ArticleNewsFeed/Article/detail/825332?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Data-Utilizing-the-Eeva-Technology-to-be-prese/ArticleNewsFeed/Article/detail/825332",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oramed-to-Participate-in-Barclays-Israel-Biotech-C/ArticleNewsFeed/Article/detail/823916?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oramed-to-Participate-in-Barclays-Israel-Biotech-C/ArticleNewsFeed/Article/detail/823916",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Syndaxs-Entinostat-Receives-Breakthrough-Therapy-D/ArticleNewsFeed/Article/detail/822681?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Syndaxs-Entinostat-Receives-Breakthrough-Therapy-D/ArticleNewsFeed/Article/detail/822681",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Data-for-Investigational-Tiotropium-Show-Improved-/ArticleNewsFeed/Article/detail/822584?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Data-for-Investigational-Tiotropium-Show-Improved-/ArticleNewsFeed/Article/detail/822584",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Pooled-Analysis-Reports-Pradaxa-dabigatran-ete/ArticleNewsFeed/Article/detail/824633?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Pooled-Analysis-Reports-Pradaxa-dabigatran-ete/ArticleNewsFeed/Article/detail/824633",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Preventice-Inc-Receives-CE-Mark-for-BodyGuardian-R/ArticleNewsFeed/Article/detail/825271?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Preventice-Inc-Receives-CE-Mark-for-BodyGuardian-R/ArticleNewsFeed/Article/detail/825271",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Study-Shows-That-People-Who-Undergo-Cataract-Surge/ArticleNewsFeed/Article/detail/822017?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Study-Shows-That-People-Who-Undergo-Cataract-Surge/ArticleNewsFeed/Article/detail/822017",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Verumde-Exhibits-at-Outsourcing-in-Clinical-Trials/ArticleNewsFeed/Article/detail/821598?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Verumde-Exhibits-at-Outsourcing-in-Clinical-Trials/ArticleNewsFeed/Article/detail/821598",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Almac-Launches-SupplyTraQ-Technology-Solution-to-S/ArticleStandard/Article/detail/823796?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Almac-Launches-SupplyTraQ-Technology-Solution-to-S/ArticleStandard/Article/detail/823796",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Almac-Offering-TruSight-Tumor-Profiling-Next-Gener/ArticleStandard/Article/detail/822495?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Almac-Offering-TruSight-Tumor-Profiling-Next-Gener/ArticleStandard/Article/detail/822495",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/KemPharms-KP201-Demonstrates-Complete-Metabolic-Cl/ArticleNewsFeed/Article/detail/821185?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/KemPharms-KP201-Demonstrates-Complete-Metabolic-Cl/ArticleNewsFeed/Article/detail/821185",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MultiCell-Technologies-and-Genisphere-Evaluate-Tar/ArticleNewsFeed/Article/detail/819816?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MultiCell-Technologies-and-Genisphere-Evaluate-Tar/ArticleNewsFeed/Article/detail/819816",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Nuvo-Research-to-Receive-US20-Million/ArticleNewsFeed/Article/detail/825321?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Nuvo-Research-to-Receive-US20-Million/ArticleNewsFeed/Article/detail/825321",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Red-River-Announces-Extended-Vistas-Of-Healthcare-/ArticleNewsFeed/Article/detail/822539?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Red-River-Announces-Extended-Vistas-Of-Healthcare-/ArticleNewsFeed/Article/detail/822539",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Takeda-and-Zinfandel-Pharmaceuticals-Initiate-Phas/ArticleNewsFeed/Article/detail/821202?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Takeda-and-Zinfandel-Pharmaceuticals-Initiate-Phas/ArticleNewsFeed/Article/detail/821202",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/The-Cancer-Resource-Foundation-Hosts-The-2013-Dres/ArticleNewsFeed/Article/detail/825055?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/The-Cancer-Resource-Foundation-Hosts-The-2013-Dres/ArticleNewsFeed/Article/detail/825055",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Come-in-Oscar-Bravo/ArticleStandard/Article/detail/823795?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Come-in-Oscar-Bravo/ArticleStandard/Article/detail/823795",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/The-HIPAAHITECH-Omnibus-Final-Rule-Implications-fo/ArticleStandard/Article/detail/818998?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/The-HIPAAHITECH-Omnibus-Final-Rule-Implications-fo/ArticleStandard/Article/detail/818998",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Berg-Partners-With-Department-of-Defense-Research-/ArticleNewsFeed/Article/detail/820208?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Berg-Partners-With-Department-of-Defense-Research-/ArticleNewsFeed/Article/detail/820208",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioLineRx-Announces-Publication-of-Positive-Pre-Cl/ArticleNewsFeed/Article/detail/819688?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioLineRx-Announces-Publication-of-Positive-Pre-Cl/ArticleNewsFeed/Article/detail/819688",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cirrus--Kemwell-Receives-FDA-Grant-to-Evaluate-For/ArticleNewsFeed/Article/detail/825333?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cirrus--Kemwell-Receives-FDA-Grant-to-Evaluate-For/ArticleNewsFeed/Article/detail/825333",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Debiopharm-Group-Initiates-Phase-I-Dose-Escalation/ArticleNewsFeed/Article/detail/821843?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Debiopharm-Group-Initiates-Phase-I-Dose-Escalation/ArticleNewsFeed/Article/detail/821843",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Highland-Therapeutics-Announces-Positive-Interim-R/ArticleNewsFeed/Article/detail/824843?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Highland-Therapeutics-Announces-Positive-Interim-R/ArticleNewsFeed/Article/detail/824843",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oramed-Granted-Patent-in-China-for-its-Platform-Te/ArticleNewsFeed/Article/detail/822500?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oramed-Granted-Patent-in-China-for-its-Platform-Te/ArticleNewsFeed/Article/detail/822500",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Boston-Scientific-Completes-Enrollment-In-SuperNOV/ArticleNewsFeed/Article/detail/820766?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Boston-Scientific-Completes-Enrollment-In-SuperNOV/ArticleNewsFeed/Article/detail/820766",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Catabasis-CAT-2003-Demonstrates-Significant-Reduct/ArticleNewsFeed/Article/detail/819190?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Catabasis-CAT-2003-Demonstrates-Significant-Reduct/ArticleNewsFeed/Article/detail/819190",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Dr-Lindsay-McNair-Named-Chief-Clinical-Research-Of/ArticleNewsFeed/Article/detail/825128?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Dr-Lindsay-McNair-Named-Chief-Clinical-Research-Of/ArticleNewsFeed/Article/detail/825128",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Rhythm-Awarded-135-Million-from-The-Michael-J-Fox-/ArticleNewsFeed/Article/detail/822482?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Rhythm-Awarded-135-Million-from-The-Michael-J-Fox-/ArticleNewsFeed/Article/detail/822482",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Takedas-New-Investigational-Drug-Vedolizumab-is-Gr/ArticleNewsFeed/Article/detail/822063?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Takedas-New-Investigational-Drug-Vedolizumab-is-Gr/ArticleNewsFeed/Article/detail/822063",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/The-Michael-J-Fox-Foundation-Unites-Industry-Group/ArticleNewsFeed/Article/detail/822980?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/The-Michael-J-Fox-Foundation-Unites-Industry-Group/ArticleNewsFeed/Article/detail/822980",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/The-Evolution-of-TransCelerate/ArticleStandard/Article/detail/819514?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/The-Evolution-of-TransCelerate/ArticleStandard/Article/detail/819514",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/INC-Research-Becomes-First-Global-CRO-to-Offer-Cli/ArticleStandard/Article/detail/822456?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/INC-Research-Becomes-First-Global-CRO-to-Offer-Cli/ArticleStandard/Article/detail/822456",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Advanced-Biologics-presenting-new-OsteoAMP-data-an/ArticleNewsFeed/Article/detail/825355?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Advanced-Biologics-presenting-new-OsteoAMP-data-an/ArticleNewsFeed/Article/detail/825355",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Elusys-Releases-New-Data-On-Anthrax-Anti-Toxin-Adm/ArticleNewsFeed/Article/detail/819386?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Elusys-Releases-New-Data-On-Anthrax-Anti-Toxin-Adm/ArticleNewsFeed/Article/detail/819386",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Increasing-Public-Health-Awareness-Intensifies-Glo/ArticleNewsFeed/Article/detail/824010?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Increasing-Public-Health-Awareness-Intensifies-Glo/ArticleNewsFeed/Article/detail/824010",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Jubilant-Biosys-Announces-Successful-Filing-of-Inv/ArticleNewsFeed/Article/detail/820033?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Jubilant-Biosys-Announces-Successful-Filing-of-Inv/ArticleNewsFeed/Article/detail/820033",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Mazor-Robotics-to-Highlight-Two-Year-Clinical-Expe/ArticleNewsFeed/Article/detail/825117?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Mazor-Robotics-to-Highlight-Two-Year-Clinical-Expe/ArticleNewsFeed/Article/detail/825117",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/PharmAthene-Reports-Second-Quarter-2013-Financial-/ArticleNewsFeed/Article/detail/820061?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/PharmAthene-Reports-Second-Quarter-2013-Financial-/ArticleNewsFeed/Article/detail/820061",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Public-Responsibility-in-Medicine-and-Research-PRI/ArticleNewsFeed/Article/detail/822783?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Public-Responsibility-in-Medicine-and-Research-PRI/ArticleNewsFeed/Article/detail/822783",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Quest-Diagnostics-Introduces-Comprehensive-Opioid-/ArticleNewsFeed/Article/detail/820140?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Quest-Diagnostics-Introduces-Comprehensive-Opioid-/ArticleNewsFeed/Article/detail/820140",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Simeprevir-Data-from-COSMOS-Study-in-Hepatitis-C-P/ArticleNewsFeed/Article/detail/825028?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Simeprevir-Data-from-COSMOS-Study-in-Hepatitis-C-P/ArticleNewsFeed/Article/detail/825028",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/How-Transcelerate-Helps-the-Industry/ArticleStandard/Article/detail/819382?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/How-Transcelerate-Helps-the-Industry/ArticleStandard/Article/detail/819382",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/EFPIA-and-PhRMA-Release-Joint-Principles-for-Respo/ArticleStandard/Article/detail/818755?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/EFPIA-and-PhRMA-Release-Joint-Principles-for-Respo/ArticleStandard/Article/detail/818755",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/AbbVie-Presents-Phase-II-Data-Evaluating-the-Effic/ArticleNewsFeed/Article/detail/824705?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/AbbVie-Presents-Phase-II-Data-Evaluating-the-Effic/ArticleNewsFeed/Article/detail/824705",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/NYU-Poly-Nano-Scientists-Reach-the-Holy-Grail-in-L/ArticleNewsFeed/Article/detail/818786?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/NYU-Poly-Nano-Scientists-Reach-the-Holy-Grail-in-L/ArticleNewsFeed/Article/detail/818786",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oncopeptides-Initiates-Phase-II-Clinical-Study-wit/ArticleNewsFeed/Article/detail/820807?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oncopeptides-Initiates-Phase-II-Clinical-Study-wit/ArticleNewsFeed/Article/detail/820807",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lightlake-Therapeutics-Commences-Two-Week-Patient-/ArticleNewsFeed/Article/detail/823803?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lightlake-Therapeutics-Commences-Two-Week-Patient-/ArticleNewsFeed/Article/detail/823803",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Wake-Up-Narcolepsy-Funds-Research-at-Stanford-Harv/ArticleNewsFeed/Article/detail/821195?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Wake-Up-Narcolepsy-Funds-Research-at-Stanford-Harv/ArticleNewsFeed/Article/detail/821195",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/First-Patient-Treated-with-Civacir-after-Hepatitis/ArticleNewsFeed/Article/detail/820021?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/First-Patient-Treated-with-Civacir-after-Hepatitis/ArticleNewsFeed/Article/detail/820021",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Keystone-Hearts-TriGuard-Cerebral-Protection-Devic/ArticleNewsFeed/Article/detail/822362?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Keystone-Hearts-TriGuard-Cerebral-Protection-Devic/ArticleNewsFeed/Article/detail/822362",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/ACT-Insert-Cover/ArticleStandard/Article/detail/820666?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/ACT-Insert-Cover/ArticleStandard/Article/detail/820666",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Is-Your-RBM-Strategy-Missing-a-Critical-Link/ArticleStandard/Article/detail/825052?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Is-Your-RBM-Strategy-Missing-a-Critical-Link/ArticleStandard/Article/detail/825052",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Amgen-And-Cytokinetics-Announce-The-First-Presenta/ArticleNewsFeed/Article/detail/821860?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Amgen-And-Cytokinetics-Announce-The-First-Presenta/ArticleNewsFeed/Article/detail/821860",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BHR-Pharma-Announces-SyNAPSe-Trial-Completes-Patie/ArticleNewsFeed/Article/detail/821910?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BHR-Pharma-Announces-SyNAPSe-Trial-Completes-Patie/ArticleNewsFeed/Article/detail/821910",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/eClinicalHealth-Launches-Clinpal-a-New-Cloud-Platf/ArticleNewsFeed/Article/detail/824869?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/eClinicalHealth-Launches-Clinpal-a-New-Cloud-Platf/ArticleNewsFeed/Article/detail/824869",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Heat-Waves-Increase-Incidence-of-Infectious-Gastro/ArticleNewsFeed/Article/detail/820354?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Heat-Waves-Increase-Incidence-of-Infectious-Gastro/ArticleNewsFeed/Article/detail/820354",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Made-in-IBM-Labs-Scientists-Turn-Data-into-Disease/ArticleNewsFeed/Article/detail/824273?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Made-in-IBM-Labs-Scientists-Turn-Data-into-Disease/ArticleNewsFeed/Article/detail/824273",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/NovaRx-Announces-Results-of-Lucanix-Phase-III-Ther/ArticleNewsFeed/Article/detail/824024?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/NovaRx-Announces-Results-of-Lucanix-Phase-III-Ther/ArticleNewsFeed/Article/detail/824024",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Society-for-Clinical-Research-Sites-Ensures-All-Si/ArticleNewsFeed/Article/detail/819302?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Society-for-Clinical-Research-Sites-Ensures-All-Si/ArticleNewsFeed/Article/detail/819302",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/St-Jude-Childrens-Research-Hospital-scientists-ide/ArticleNewsFeed/Article/detail/821496?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/St-Jude-Childrens-Research-Hospital-scientists-ide/ArticleNewsFeed/Article/detail/821496",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Xencors-XmAb5871-Enters-Phase-2a-Study-for-Autoimm/ArticleNewsFeed/Article/detail/824564?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Xencors-XmAb5871-Enters-Phase-2a-Study-for-Autoimm/ArticleNewsFeed/Article/detail/824564",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/CTI-Clinical-Trial-and-Consulting-Services-Announc/ArticleStandard/Article/detail/822496?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/CTI-Clinical-Trial-and-Consulting-Services-Announc/ArticleStandard/Article/detail/822496",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/FDAs-Voice-of-the-Patient-Report-on-Chronic-Fatigu/ArticleNewsFeed/Article/detail/824895?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/FDAs-Voice-of-the-Patient-Report-on-Chronic-Fatigu/ArticleNewsFeed/Article/detail/824895",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Hitachi-Aloka-Medical-Presents-the-F31---a-Compact/ArticleNewsFeed/Article/detail/825410?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Hitachi-Aloka-Medical-Presents-the-F31---a-Compact/ArticleNewsFeed/Article/detail/825410",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Kiadis-Pharma-Secures-Manufacturing-Services-Agree/ArticleNewsFeed/Article/detail/825014?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Kiadis-Pharma-Secures-Manufacturing-Services-Agree/ArticleNewsFeed/Article/detail/825014",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/One-Year-Data-From-Global-Atrial-Fibrillation-AF-R/ArticleNewsFeed/Article/detail/821923?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/One-Year-Data-From-Global-Atrial-Fibrillation-AF-R/ArticleNewsFeed/Article/detail/821923",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/UKs-NICE-Final-Appraisal-Determination-FAD-Confirm/ArticleNewsFeed/Article/detail/821858?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/UKs-NICE-Final-Appraisal-Determination-FAD-Confirm/ArticleNewsFeed/Article/detail/821858",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Trust-Bites-the-Dust---Again/ArticleStandard/Article/detail/818572?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Trust-Bites-the-Dust---Again/ArticleStandard/Article/detail/818572",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/CRF-Health-Improves-Patient-and-Site-eCOA-Experien/ArticleStandard/Article/detail/819108?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/CRF-Health-Improves-Patient-and-Site-eCOA-Experien/ArticleStandard/Article/detail/819108",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Published-Data-Proves-Effectiveness-of-Patient-Rep/ArticleStandard/Article/detail/824326?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Published-Data-Proves-Effectiveness-of-Patient-Rep/ArticleStandard/Article/detail/824326",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Celtaxsys-Initiates-First-Clinical-Trial-of-Oral-C/ArticleNewsFeed/Article/detail/825388?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Celtaxsys-Initiates-First-Clinical-Trial-of-Oral-C/ArticleNewsFeed/Article/detail/825388",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/JDRF-Honors-Researchers-Whose-Insights-on-Early-Ty/ArticleNewsFeed/Article/detail/823886?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/JDRF-Honors-Researchers-Whose-Insights-on-Early-Ty/ArticleNewsFeed/Article/detail/823886",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Neuronetics-Inc-Announces-First-Patients-Enrolled-/ArticleNewsFeed/Article/detail/819189?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Neuronetics-Inc-Announces-First-Patients-Enrolled-/ArticleNewsFeed/Article/detail/819189",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Linagliptin-Demonstrated-Significant-HbA1c-Reducti/ArticleNewsFeed/Article/detail/820559?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Linagliptin-Demonstrated-Significant-HbA1c-Reducti/ArticleNewsFeed/Article/detail/820559",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/LUNGevity-Announces-2013-Lung-Cancer-Early-Detecti/ArticleNewsFeed/Article/detail/822913?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/LUNGevity-Announces-2013-Lung-Cancer-Early-Detecti/ArticleNewsFeed/Article/detail/822913",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Trial+Design+Articles/The-Practical-Implementation-of-Risk-Based-Monitor/ArticleStandard/Article/detail/820665?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Trial+Design+Articles/The-Practical-Implementation-of-Risk-Based-Monitor/ArticleStandard/Article/detail/820665",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Helping-Parkinsons-Patients-Rescue-Themselves-from/ArticleNewsFeed/Article/detail/820353?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Helping-Parkinsons-Patients-Rescue-Themselves-from/ArticleNewsFeed/Article/detail/820353",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Pharmalink-Raises-SEK96-Million-to-Undertake-Pivot/ArticleNewsFeed/Article/detail/824924?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Pharmalink-Raises-SEK96-Million-to-Undertake-Pivot/ArticleNewsFeed/Article/detail/824924",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ViaCyte-To-Present-Update-On-VC-01-Combination-Pro/ArticleNewsFeed/Article/detail/825387?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ViaCyte-To-Present-Update-On-VC-01-Combination-Pro/ArticleNewsFeed/Article/detail/825387",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Medidata---IRT-and-EDC-The-Unified-Experience/ArticleStandard/Article/detail/824836?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Medidata---IRT-and-EDC-The-Unified-Experience/ArticleStandard/Article/detail/824836",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/DURECT-Announces-Selection-with-Orient-PHARMA-of-L/ArticleNewsFeed/Article/detail/819447?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/DURECT-Announces-Selection-with-Orient-PHARMA-of-L/ArticleNewsFeed/Article/detail/819447",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Global-Genomics-Group-G3-and-Illumina-to-Partner-o/ArticleNewsFeed/Article/detail/823917?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Global-Genomics-Group-G3-and-Illumina-to-Partner-o/ArticleNewsFeed/Article/detail/823917",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Intrinsic-Therapeutics-Announces-the-Enrollment-of/ArticleNewsFeed/Article/detail/819441?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Intrinsic-Therapeutics-Announces-the-Enrollment-of/ArticleNewsFeed/Article/detail/819441",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Risk-Based-Monitoring-Registration/ArticleStandard/Article/detail/819478?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Risk-Based-Monitoring-Registration/ArticleStandard/Article/detail/819478",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioSpecifics-Technologies-Corp-Reports-Second-Quar/ArticleNewsFeed/Article/detail/820081?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioSpecifics-Technologies-Corp-Reports-Second-Quar/ArticleNewsFeed/Article/detail/820081",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Girls-Who-Regularly-Eat-Peanut-Butter-and-Peanuts-/ArticleNewsFeed/Article/detail/824420?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Girls-Who-Regularly-Eat-Peanut-Butter-and-Peanuts-/ArticleNewsFeed/Article/detail/824420",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Kiadis-Pharma-Completes-Five-year-Follow-up-of-its/ArticleNewsFeed/Article/detail/822643?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Kiadis-Pharma-Completes-Five-year-Follow-up-of-its/ArticleNewsFeed/Article/detail/822643",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Study-Published-in-Blood-Highlights-Axl-Inhibition/ArticleNewsFeed/Article/detail/824435?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Study-Published-in-Blood-Highlights-Axl-Inhibition/ArticleNewsFeed/Article/detail/824435",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Surgery-to-move-both-jaws-forward-noticeably-impro/ArticleNewsFeed/Article/detail/819548?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Surgery-to-move-both-jaws-forward-noticeably-impro/ArticleNewsFeed/Article/detail/819548",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Type-2-Diabetes-Market-Size-Share-Forecast-and-Ana/ArticleNewsFeed/Article/detail/823918?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Type-2-Diabetes-Market-Size-Share-Forecast-and-Ana/ArticleNewsFeed/Article/detail/823918",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Patient-Engagement-in-PD-Research-and-Why-It-Matte/ArticleStandard/Article/detail/820743?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Patient-Engagement-in-PD-Research-and-Why-It-Matte/ArticleStandard/Article/detail/820743",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Charleston-Laboratories-Inc-Announces-Successful-C/ArticleNewsFeed/Article/detail/818577?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Charleston-Laboratories-Inc-Announces-Successful-C/ArticleNewsFeed/Article/detail/818577",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/IceCure-Enters-a-New-High-Potential-Market-The-com/ArticleNewsFeed/Article/detail/824475?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/IceCure-Enters-a-New-High-Potential-Market-The-com/ArticleNewsFeed/Article/detail/824475",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Acellis---Risk-Based-Monitoring-In-Clinical-Studie/ArticleStandard/Article/detail/818932?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Acellis---Risk-Based-Monitoring-In-Clinical-Studie/ArticleStandard/Article/detail/818932",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/AnaptysBio-Expands-Immunotherapy-Portfolio-With-An/ArticleNewsFeed/Article/detail/821563?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/AnaptysBio-Expands-Immunotherapy-Portfolio-With-An/ArticleNewsFeed/Article/detail/821563",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Boy-Interrupted-Y-chromosome-Mutations-Reveal-Prec/ArticleNewsFeed/Article/detail/821859?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Boy-Interrupted-Y-chromosome-Mutations-Reveal-Prec/ArticleNewsFeed/Article/detail/821859",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Roche-and-Inovio-Pharmaceuticals-partner-on-Inovio/ArticleNewsFeed/Article/detail/822475?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Roche-and-Inovio-Pharmaceuticals-partner-on-Inovio/ArticleNewsFeed/Article/detail/822475",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Clinical-Conductor-CTMS-Collaborates-with-SCRS-to-/ArticleStandard/Article/detail/824892?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Clinical-Conductor-CTMS-Collaborates-with-SCRS-to-/ArticleStandard/Article/detail/824892",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/HealthCarePoint-and-ViS-Research-Streamline-Sharin/ArticleStandard/Article/detail/819251?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/HealthCarePoint-and-ViS-Research-Streamline-Sharin/ArticleStandard/Article/detail/819251",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Alliqua-Initiates-Proof-of-Principle-Study-of-Tran/ArticleNewsFeed/Article/detail/818559?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Alliqua-Initiates-Proof-of-Principle-Study-of-Tran/ArticleNewsFeed/Article/detail/818559",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Galectin-Therapeutics-Announces-First-Patient-Dose/ArticleNewsFeed/Article/detail/818731?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Galectin-Therapeutics-Announces-First-Patient-Dose/ArticleNewsFeed/Article/detail/818731",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Large-Scale-Global-Registry-to-Examine-Treatment-P/ArticleNewsFeed/Article/detail/821909?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Large-Scale-Global-Registry-to-Examine-Treatment-P/ArticleNewsFeed/Article/detail/821909",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Prometheus-Laboratories-Inc-Announces-Inclusion-of/ArticleNewsFeed/Article/detail/825346?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Prometheus-Laboratories-Inc-Announces-Inclusion-of/ArticleNewsFeed/Article/detail/825346",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Promising-Mayo-Clinic-Study-Shows-Wisconsin-Ginsen/ArticleNewsFeed/Article/detail/820731?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Promising-Mayo-Clinic-Study-Shows-Wisconsin-Ginsen/ArticleNewsFeed/Article/detail/820731",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Study-Finds-Brain-Training-Enhances-Brain-Health-o/ArticleNewsFeed/Article/detail/822550?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Study-Finds-Brain-Training-Enhances-Brain-Health-o/ArticleNewsFeed/Article/detail/822550",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Study-finds-that-microbes-influence-B-cell-develop/ArticleNewsFeed/Article/detail/820912?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Study-finds-that-microbes-influence-B-cell-develop/ArticleNewsFeed/Article/detail/820912",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/FDA-Updates-Current-Thinking-on-Risk-Based-Monitor/ArticleStandard/Article/detail/820007?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/FDA-Updates-Current-Thinking-on-Risk-Based-Monitor/ArticleStandard/Article/detail/820007",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Ariosa-Diagnostics-CHU-de-Quebec-and-Genome-Canada/ArticleNewsFeed/Article/detail/820289?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Ariosa-Diagnostics-CHU-de-Quebec-and-Genome-Canada/ArticleNewsFeed/Article/detail/820289",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Clinical-Laboratory-Services-Market-is-Expected-to/ArticleNewsFeed/Article/detail/824828?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Clinical-Laboratory-Services-Market-is-Expected-to/ArticleNewsFeed/Article/detail/824828",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/How-A-Little-Girl-With-Brain-Cancer-Inspired-Citiz/ArticleNewsFeed/Article/detail/820485?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/How-A-Little-Girl-With-Brain-Cancer-Inspired-Citiz/ArticleNewsFeed/Article/detail/820485",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MedNet-Solutions-Proudly-Welcomes-Accelovance-To-T/ArticleNewsFeed/Article/detail/824044?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MedNet-Solutions-Proudly-Welcomes-Accelovance-To-T/ArticleNewsFeed/Article/detail/824044",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/National-MS-Society-and-GE-Healthcare-Join-Forces-/ArticleNewsFeed/Article/detail/824451?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/National-MS-Society-and-GE-Healthcare-Join-Forces-/ArticleNewsFeed/Article/detail/824451",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Over-2000-XPED-Expanding-Pedicle-Screws-Were-Impla/ArticleNewsFeed/Article/detail/825334?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Over-2000-XPED-Expanding-Pedicle-Screws-Were-Impla/ArticleNewsFeed/Article/detail/825334",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Selexys-Pharmaceuticals-Initiates-SUSTAIN-Phase-2-/ArticleNewsFeed/Article/detail/820697?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Selexys-Pharmaceuticals-Initiates-SUSTAIN-Phase-2-/ArticleNewsFeed/Article/detail/820697",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Utility-Of-Rubicon-Genomics-ThruPLEX-FD-Kit-Valida/ArticleNewsFeed/Article/detail/824288?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Utility-Of-Rubicon-Genomics-ThruPLEX-FD-Kit-Valida/ArticleNewsFeed/Article/detail/824288",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Trial+Design+News/Business-and-People/ArticleStandard/Article/detail/820676?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Trial+Design+News/Business-and-People/ArticleStandard/Article/detail/820676",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioSpecifics-Technologies-Corp-Announces-Data-from/ArticleNewsFeed/Article/detail/818574?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioSpecifics-Technologies-Corp-Announces-Data-from/ArticleNewsFeed/Article/detail/818574",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/IMPACT-CARD-Trial-Data-Presented-at-the-2013-Europ/ArticleNewsFeed/Article/detail/821894?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/IMPACT-CARD-Trial-Data-Presented-at-the-2013-Europ/ArticleNewsFeed/Article/detail/821894",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/InspireMD-to-Report-Fiscal-Year-2013-Results-on-Se/ArticleNewsFeed/Article/detail/822405?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/InspireMD-to-Report-Fiscal-Year-2013-Results-on-Se/ArticleNewsFeed/Article/detail/822405",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oncothyreon-Announces-Presentation-of-Final-Result/ArticleNewsFeed/Article/detail/825029?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oncothyreon-Announces-Presentation-of-Final-Result/ArticleNewsFeed/Article/detail/825029",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oramed-Initiates-Patient-Recruitment-for-a-New-Cli/ArticleNewsFeed/Article/detail/820878?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oramed-Initiates-Patient-Recruitment-for-a-New-Cli/ArticleNewsFeed/Article/detail/820878",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/CHD-Bioscience-Developing-New-Class-of-Antimicrobi/ArticleNewsFeed/Article/detail/825261?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/CHD-Bioscience-Developing-New-Class-of-Antimicrobi/ArticleNewsFeed/Article/detail/825261",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/First-Injection-of-Dotarem-gadoterate-meglumine-in/ArticleNewsFeed/Article/detail/818909?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/First-Injection-of-Dotarem-gadoterate-meglumine-in/ArticleNewsFeed/Article/detail/818909",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/First-Patient-Treated-for-Essential-Tremor-in-Phas/ArticleNewsFeed/Article/detail/822538?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/First-Patient-Treated-for-Essential-Tremor-in-Phas/ArticleNewsFeed/Article/detail/822538",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Frances-Transparency-Commission-Issues-Positive-Op/ArticleNewsFeed/Article/detail/818722?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Frances-Transparency-Commission-Issues-Positive-Op/ArticleNewsFeed/Article/detail/818722",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Isis-Pharmaceuticals-Earns-2-Million-from-GSK-for-/ArticleNewsFeed/Article/detail/819162?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Isis-Pharmaceuticals-Earns-2-Million-from-GSK-for-/ArticleNewsFeed/Article/detail/819162",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/NICE-Recommends-Genomic-Healths-Oncotype-DX-Test-T/ArticleNewsFeed/Article/detail/823883?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/NICE-Recommends-Genomic-Healths-Oncotype-DX-Test-T/ArticleNewsFeed/Article/detail/823883",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Sangamo-BioSciences-announces-presentation-of-clin/ArticleNewsFeed/Article/detail/822957?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Sangamo-BioSciences-announces-presentation-of-clin/ArticleNewsFeed/Article/detail/822957",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Articles/Lifting-Up-a-Fragmented-Study-Conduct-Landscape/ArticleStandard/Article/detail/820680?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Articles/Lifting-Up-a-Fragmented-Study-Conduct-Landscape/ArticleStandard/Article/detail/820680",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Data+Analysis/Realistic-Recruitment-Expectations-Require-Disease/ArticleStandard/Article/detail/823798?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Data+Analysis/Realistic-Recruitment-Expectations-Require-Disease/ArticleStandard/Article/detail/823798",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/The-HIPAAHITECH-Omnibus-Final-Rule-Implications-fo/ArticleStandard/Article/detail/818999?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/The-HIPAAHITECH-Omnibus-Final-Rule-Implications-fo/ArticleStandard/Article/detail/818999",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Enigma-Diagnostics-Announces-Successful-Completion/ArticleNewsFeed/Article/detail/819053?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Enigma-Diagnostics-Announces-Successful-Completion/ArticleNewsFeed/Article/detail/819053",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Sickle-Cells-Loaded-with-Cancer-Fighting-Agents-am/ArticleNewsFeed/Article/detail/825118?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Sickle-Cells-Loaded-with-Cancer-Fighting-Agents-am/ArticleNewsFeed/Article/detail/825118",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Regulatory+News/Guidance-and-Strategies-for-Spurring-Development-o/ArticleStandard/Article/detail/820672?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Regulatory+News/Guidance-and-Strategies-for-Spurring-Development-o/ArticleStandard/Article/detail/820672",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/What-a-New-Proof-of-Concept-Might-Mean-for-Clinica/ArticleStandard/Article/detail/822985?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/What-a-New-Proof-of-Concept-Might-Mean-for-Clinica/ArticleStandard/Article/detail/822985",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Array-Biopharma-To-Report-Top-line-Results-From-AR/ArticleNewsFeed/Article/detail/818541?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Array-Biopharma-To-Report-Top-line-Results-From-AR/ArticleNewsFeed/Article/detail/818541",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Berg-Receives-Frost-amp-Sullivan-2013-Drug-Discove/ArticleNewsFeed/Article/detail/822757?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Berg-Receives-Frost-amp-Sullivan-2013-Drug-Discove/ArticleNewsFeed/Article/detail/822757",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ExAblate-Receives-Approval-of-Chinese-Food-and-Dru/ArticleNewsFeed/Article/detail/819052?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ExAblate-Receives-Approval-of-Chinese-Food-and-Dru/ArticleNewsFeed/Article/detail/819052",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Researchers-Prevent-and-Reverse-Fibrosis-in-a-Mous/ArticleNewsFeed/Article/detail/825294?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Researchers-Prevent-and-Reverse-Fibrosis-in-a-Mous/ArticleNewsFeed/Article/detail/825294",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/European-Medicines-Agency-launches-a-new-version-o/ArticleStandard/Article/detail/825448?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/European-Medicines-Agency-launches-a-new-version-o/ArticleStandard/Article/detail/825448",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Annual-CT-Scans-Finally-Proposed-for-those-at-High/ArticleNewsFeed/Article/detail/819136?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Annual-CT-Scans-Finally-Proposed-for-those-at-High/ArticleNewsFeed/Article/detail/819136",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/ClinTech+News/Clinical-Conductor-Site-CTMS-Releases-Third-Major-/ArticleStandard/Article/detail/825146?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/ClinTech+News/Clinical-Conductor-Site-CTMS-Releases-Third-Major-/ArticleStandard/Article/detail/825146",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Researching-Ways-to-Help-Parkinsons-Patients-Incre/ArticleNewsFeed/Article/detail/825037?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Researching-Ways-to-Help-Parkinsons-Patients-Incre/ArticleNewsFeed/Article/detail/825037",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/CRO/Sponsor+News/INC-Research-Strengthens-AsiaPacific-Capabilities-/ArticleStandard/Article/detail/819252?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/CRO/Sponsor+News/INC-Research-Strengthens-AsiaPacific-Capabilities-/ArticleStandard/Article/detail/819252",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cardiothoracic-and-Vascular-Surgeons-in-Collaborat/ArticleNewsFeed/Article/detail/824854?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cardiothoracic-and-Vascular-Surgeons-in-Collaborat/ArticleNewsFeed/Article/detail/824854",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lexicon-Completes-Pilot-Study-Of-Telotristat-Etipr/ArticleNewsFeed/Article/detail/825231?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lexicon-Completes-Pilot-Study-Of-Telotristat-Etipr/ArticleNewsFeed/Article/detail/825231",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lumena-Pharmaceuticals-Receives-Orphan-Drug-Design/ArticleNewsFeed/Article/detail/824025?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lumena-Pharmaceuticals-Receives-Orphan-Drug-Design/ArticleNewsFeed/Article/detail/824025",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/PneumRx-Incs-RePneu-Coil-Becoming-Therapy-of-Choic/ArticleNewsFeed/Article/detail/824006?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/PneumRx-Incs-RePneu-Coil-Becoming-Therapy-of-Choic/ArticleNewsFeed/Article/detail/824006",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/IRB-Services-Selects-Intralinks-VIA-for-Secure-Hig/ArticleStandard/Article/detail/822679?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/IRB-Services-Selects-Intralinks-VIA-for-Secure-Hig/ArticleStandard/Article/detail/822679",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/AlterG-Announces-Launch-of-Bionic-Leg/ArticleNewsFeed/Article/detail/820698?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/AlterG-Announces-Launch-of-Bionic-Leg/ArticleNewsFeed/Article/detail/820698",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Celsion-Corporation-Announces-Combined-Clinical-Da/ArticleNewsFeed/Article/detail/822387?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Celsion-Corporation-Announces-Combined-Clinical-Da/ArticleNewsFeed/Article/detail/822387",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Florida-Fertility-Institute-Participates-In-The-Th/ArticleNewsFeed/Article/detail/820808?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Florida-Fertility-Institute-Participates-In-The-Th/ArticleNewsFeed/Article/detail/820808",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Data-Demonstrate-Cognigram-as-a-Sensitive-Asse/ArticleNewsFeed/Article/detail/825030?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Data-Demonstrate-Cognigram-as-a-Sensitive-Asse/ArticleNewsFeed/Article/detail/825030",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Researchers-unveil-method-for-creating-re-specifie/ArticleNewsFeed/Article/detail/824868?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Researchers-unveil-method-for-creating-re-specifie/ArticleNewsFeed/Article/detail/824868",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Closing+Thought/Comprehensive-Evidence-Development-Progress-and-Op/ArticleStandard/Article/detail/820678?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Closing+Thought/Comprehensive-Evidence-Development-Progress-and-Op/ArticleStandard/Article/detail/820678",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Evidence-Guided-Molecular-Profiling-Offers-New-Hop/ArticleNewsFeed/Article/detail/824266?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Evidence-Guided-Molecular-Profiling-Offers-New-Hop/ArticleNewsFeed/Article/detail/824266",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/First-Patient-Enrolled-in-New-Cardiovascular-and-R/ArticleNewsFeed/Article/detail/819352?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/First-Patient-Enrolled-in-New-Cardiovascular-and-R/ArticleNewsFeed/Article/detail/819352",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Houston-Fertility-Institute-Participates-In-The-Th/ArticleNewsFeed/Article/detail/824022?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Houston-Fertility-Institute-Participates-In-The-Th/ArticleNewsFeed/Article/detail/824022",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Joint-Assurex-Health-and-Mayo-Clinic-Study-Demonst/ArticleNewsFeed/Article/detail/822488?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Joint-Assurex-Health-and-Mayo-Clinic-Study-Demonst/ArticleNewsFeed/Article/detail/822488",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Powerful-HBO-Documentary-Moves-New-England-Patriot/ArticleNewsFeed/Article/detail/825402?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Powerful-HBO-Documentary-Moves-New-England-Patriot/ArticleNewsFeed/Article/detail/825402",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Ruggles-Family-Foundation-and-Mr-and-Mrs-Rudy-L-Ru/ArticleNewsFeed/Article/detail/821464?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Ruggles-Family-Foundation-and-Mr-and-Mrs-Rudy-L-Ru/ArticleNewsFeed/Article/detail/821464",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Celladon-Corporation-Announces-Publication-of-Long/ArticleNewsFeed/Article/detail/824057?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Celladon-Corporation-Announces-Publication-of-Long/ArticleNewsFeed/Article/detail/824057",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/First-German-Patient-enrolled-pushes-ROX-Medical-P/ArticleNewsFeed/Article/detail/820752?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/First-German-Patient-enrolled-pushes-ROX-Medical-P/ArticleNewsFeed/Article/detail/820752",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-HAE-Drug-Candidate-from-Dyax-Produced-by-Laure/ArticleNewsFeed/Article/detail/821194?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-HAE-Drug-Candidate-from-Dyax-Produced-by-Laure/ArticleNewsFeed/Article/detail/821194",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Washington-University-Hospital-enrolls-first-patie/ArticleNewsFeed/Article/detail/823827?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Washington-University-Hospital-enrolls-first-patie/ArticleNewsFeed/Article/detail/823827",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Weill-Cornell-Medical-College-Receives-100-Million/ArticleNewsFeed/Article/detail/822486?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Weill-Cornell-Medical-College-Receives-100-Million/ArticleNewsFeed/Article/detail/822486",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/FDA-Grants-Orphan-Drug-Designation-to-Omeros-OMS82/ArticleNewsFeed/Article/detail/824291?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/FDA-Grants-Orphan-Drug-Designation-to-Omeros-OMS82/ArticleNewsFeed/Article/detail/824291",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Nektar-Announces-Preliminary-Topline-Results-from-/ArticleNewsFeed/Article/detail/824092?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Nektar-Announces-Preliminary-Topline-Results-from-/ArticleNewsFeed/Article/detail/824092",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/TransCelerate-Methodology/ArticleStandard/Article/detail/819513?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/TransCelerate-Methodology/ArticleStandard/Article/detail/819513",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Bullet-Bio-Provides-Update-On-Recent-Financing-And/ArticleNewsFeed/Article/detail/822951?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Bullet-Bio-Provides-Update-On-Recent-Financing-And/ArticleNewsFeed/Article/detail/822951",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Improving-IVF-Safety-without-Hampering-Success-Rep/ArticleNewsFeed/Article/detail/825249?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Improving-IVF-Safety-without-Hampering-Success-Rep/ArticleNewsFeed/Article/detail/825249",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Inovio-Pharmaceuticals-Potent-hTERT-DNA-Cancer-Vac/ArticleNewsFeed/Article/detail/818696?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Inovio-Pharmaceuticals-Potent-hTERT-DNA-Cancer-Vac/ArticleNewsFeed/Article/detail/818696",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/KemPharm-Continues-to-Expand-its-Pain-Therapy-Pipe/ArticleNewsFeed/Article/detail/822005?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/KemPharm-Continues-to-Expand-its-Pain-Therapy-Pipe/ArticleNewsFeed/Article/detail/822005",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Northwestern-Medicine-Enrolls-First-Participant-in/ArticleNewsFeed/Article/detail/820505?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Northwestern-Medicine-Enrolls-First-Participant-in/ArticleNewsFeed/Article/detail/820505",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/S1-Biopharma-Doses-First-Patients-in-Phase-2a-Clin/ArticleNewsFeed/Article/detail/819060?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/S1-Biopharma-Doses-First-Patients-in-Phase-2a-Clin/ArticleNewsFeed/Article/detail/819060",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/TransCelerate-BioPharma-Inc-Establishes-Clinical-T/ArticleNewsFeed/Article/detail/819839?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/TransCelerate-BioPharma-Inc-Establishes-Clinical-T/ArticleNewsFeed/Article/detail/819839",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Blog-The-HIPAAHITECH-Omnibus-Final-Rule-Compliance/ArticleStandard/Article/detail/823018?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Blog-The-HIPAAHITECH-Omnibus-Final-Rule-Compliance/ArticleStandard/Article/detail/823018",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Neuralstem-Cells-Reverse-Cognitive-Defect-In-Brain/ArticleNewsFeed/Article/detail/819460?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Neuralstem-Cells-Reverse-Cognitive-Defect-In-Brain/ArticleNewsFeed/Article/detail/819460",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-modular-vaccine-design-combines-best-of-existi/ArticleNewsFeed/Article/detail/819121?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-modular-vaccine-design-combines-best-of-existi/ArticleNewsFeed/Article/detail/819121",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Cracking-the-Code-on-Study-Start-Up/ArticleStandard/Article/detail/819719?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Cracking-the-Code-on-Study-Start-Up/ArticleStandard/Article/detail/819719",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/First-Patients-Enrolled-in-REMEDEE-Registry-to-Eva/ArticleNewsFeed/Article/detail/819838?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/First-Patients-Enrolled-in-REMEDEE-Registry-to-Eva/ArticleNewsFeed/Article/detail/819838",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Fungal-infections-can-trigger-and-exacerbate-asthm/ArticleNewsFeed/Article/detail/821840?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Fungal-infections-can-trigger-and-exacerbate-asthm/ArticleNewsFeed/Article/detail/821840",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Further-Analysis-of-the-ASSURE-Data-Finds-a-Respon/ArticleNewsFeed/Article/detail/821886?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Further-Analysis-of-the-ASSURE-Data-Finds-a-Respon/ArticleNewsFeed/Article/detail/821886",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/LX4211-Achieves-Positive-Results-in-Type-2-Diabete/ArticleNewsFeed/Article/detail/824432?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/LX4211-Achieves-Positive-Results-in-Type-2-Diabete/ArticleNewsFeed/Article/detail/824432",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/NeoGenomics-Introduces-Comprehensive-Myelodysplast/ArticleNewsFeed/Article/detail/818843?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/NeoGenomics-Introduces-Comprehensive-Myelodysplast/ArticleNewsFeed/Article/detail/818843",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/ClinTech/IRT-amp-EDC-Achieving-a-Unified-Experience/ArticleStandard/Article/detail/825142?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/ClinTech/IRT-amp-EDC-Achieving-a-Unified-Experience/ArticleStandard/Article/detail/825142",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ClinicalRM-Awarded-NIH-Contract-to-Support-the-STI/ArticleNewsFeed/Article/detail/822752?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ClinicalRM-Awarded-NIH-Contract-to-Support-the-STI/ArticleNewsFeed/Article/detail/822752",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/The-X-Change-Corporation-Sees-More-Evidence-of-Tre/ArticleNewsFeed/Article/detail/820053?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/The-X-Change-Corporation-Sees-More-Evidence-of-Tre/ArticleNewsFeed/Article/detail/820053",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/RBM-for-CRAs-and-Site-Monitors/ArticleStandard/Article/detail/819515?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/RBM-for-CRAs-and-Site-Monitors/ArticleStandard/Article/detail/819515",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Curemark-Awarded-New-Patent-For-Treatment-Of-Drug-/ArticleNewsFeed/Article/detail/820209?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Curemark-Awarded-New-Patent-For-Treatment-Of-Drug-/ArticleNewsFeed/Article/detail/820209",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/EntreMed-Initiates-Crossover-Bioavailability-And-F/ArticleNewsFeed/Article/detail/819061?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/EntreMed-Initiates-Crossover-Bioavailability-And-F/ArticleNewsFeed/Article/detail/819061",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Precision-StemCell-Reports-Encouraging-Early-Resul/ArticleNewsFeed/Article/detail/821562?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Precision-StemCell-Reports-Encouraging-Early-Resul/ArticleNewsFeed/Article/detail/821562",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Frost-amp-Sullivan-Molecular-Farming-Fits-Need-for/ArticleNewsFeed/Article/detail/818723?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Frost-amp-Sullivan-Molecular-Farming-Fits-Need-for/ArticleNewsFeed/Article/detail/818723",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Researchers-Discover-a-New-Pathway-in-Blood-Vessel/ArticleNewsFeed/Article/detail/822064?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Researchers-Discover-a-New-Pathway-in-Blood-Vessel/ArticleNewsFeed/Article/detail/822064",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Trial-Results-Prove-Potential-Benefit-From-Treatin/ArticleNewsFeed/Article/detail/819541?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Trial-Results-Prove-Potential-Benefit-From-Treatin/ArticleNewsFeed/Article/detail/819541",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Future-Clinical-Trials-How-Pharmacies-will-Transfo/ArticleStandard/Article/detail/824972?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Future-Clinical-Trials-How-Pharmacies-will-Transfo/ArticleStandard/Article/detail/824972",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Theorem-Clinical-Research-Charles-River-Form-Strat/ArticleStandard/Article/detail/822855?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Theorem-Clinical-Research-Charles-River-Form-Strat/ArticleStandard/Article/detail/822855",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Analysis-Published-In-New-England-Journal-of-Medic/ArticleNewsFeed/Article/detail/822820?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Analysis-Published-In-New-England-Journal-of-Medic/ArticleNewsFeed/Article/detail/822820",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Astellas-reports-positive-topline-phase-3-results-/ArticleNewsFeed/Article/detail/824304?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Astellas-reports-positive-topline-phase-3-results-/ArticleNewsFeed/Article/detail/824304",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/DATATRAK-International-Inc-Reports-Second-Quarter-/ArticleNewsFeed/Article/detail/820071?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/DATATRAK-International-Inc-Reports-Second-Quarter-/ArticleNewsFeed/Article/detail/820071",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lupin-Launches-Generic-ZYMAXID-Ophthalmic-Solution/ArticleNewsFeed/Article/detail/824842?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lupin-Launches-Generic-ZYMAXID-Ophthalmic-Solution/ArticleNewsFeed/Article/detail/824842",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Mast-Therapeutics-Reports-Results-From-Clinical-QT/ArticleNewsFeed/Article/detail/818576?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Mast-Therapeutics-Reports-Results-From-Clinical-QT/ArticleNewsFeed/Article/detail/818576",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/The-Natural-Dentist-Announces-Partnership-With-Dr-/ArticleNewsFeed/Article/detail/819694?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/The-Natural-Dentist-Announces-Partnership-With-Dr-/ArticleNewsFeed/Article/detail/819694",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ULURU-Inc-Announces-A-Publication-In-The-Internati/ArticleNewsFeed/Article/detail/821186?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ULURU-Inc-Announces-A-Publication-In-The-Internati/ArticleNewsFeed/Article/detail/821186",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ACLA-Endorses-Bill-To-Reduce-Overutilization-Incre/ArticleNewsFeed/Article/detail/819627?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ACLA-Endorses-Bill-To-Reduce-Overutilization-Incre/ArticleNewsFeed/Article/detail/819627",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Boehringer-Ingelheim-Expands-Investigation-of-Inte/ArticleNewsFeed/Article/detail/822481?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Boehringer-Ingelheim-Expands-Investigation-of-Inte/ArticleNewsFeed/Article/detail/822481",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/DebMed-to-Present-Efficacy-of-Electronic-Monitorin/ArticleNewsFeed/Article/detail/824119?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/DebMed-to-Present-Efficacy-of-Electronic-Monitorin/ArticleNewsFeed/Article/detail/824119",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Metabolic-Solutions-Development-Company-presents-P/ArticleNewsFeed/Article/detail/822372?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Metabolic-Solutions-Development-Company-presents-P/ArticleNewsFeed/Article/detail/822372",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Sanarias-Malaria-Vaccine-Yields-Unprecedented-Prot/ArticleNewsFeed/Article/detail/820139?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Sanarias-Malaria-Vaccine-Yields-Unprecedented-Prot/ArticleNewsFeed/Article/detail/820139",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/CenterWatch-Revamps-the-Clinical-Trials-Listing-Se/ArticleStandard/Article/detail/822182?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/CenterWatch-Revamps-the-Clinical-Trials-Listing-Se/ArticleStandard/Article/detail/822182",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Certara-Partners-with-Critical-Path-Institute-to-D/ArticleStandard/Article/detail/822494?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Certara-Partners-with-Critical-Path-Institute-to-D/ArticleStandard/Article/detail/822494",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Circassias-Rapid-Grass-Allergy-Treatment-Achieves-/ArticleNewsFeed/Article/detail/824429?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Circassias-Rapid-Grass-Allergy-Treatment-Achieves-/ArticleNewsFeed/Article/detail/824429",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Tarsa-Therapeutics-Presents-Meta-Analysis-At-ASBMR/ArticleNewsFeed/Article/detail/825022?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Tarsa-Therapeutics-Presents-Meta-Analysis-At-ASBMR/ArticleNewsFeed/Article/detail/825022",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Woodley-Announces-the-Appointment-of-Vijay-Manchha/ArticleStandard/Article/detail/820716?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Woodley-Announces-the-Appointment-of-Vijay-Manchha/ArticleStandard/Article/detail/820716",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Academic-led-research-at-Memorial-University-recei/ArticleNewsFeed/Article/detail/824307?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Academic-led-research-at-Memorial-University-recei/ArticleNewsFeed/Article/detail/824307",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/AcelRx-Pharmaceuticals-Provides-Update-on-its-Pate/ArticleNewsFeed/Article/detail/825115?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/AcelRx-Pharmaceuticals-Provides-Update-on-its-Pate/ArticleNewsFeed/Article/detail/825115",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Edison-Pharmaceuticals-Announces-Initiation-of-NIH/ArticleNewsFeed/Article/detail/823828?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Edison-Pharmaceuticals-Announces-Initiation-of-NIH/ArticleNewsFeed/Article/detail/823828",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Kinex-Receives-Research-Support-from-the-Hong-Kong/ArticleNewsFeed/Article/detail/819461?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Kinex-Receives-Research-Support-from-the-Hong-Kong/ArticleNewsFeed/Article/detail/819461",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Prolong-Pharmaceuticals-Presents-Phase-1-Results-F/ArticleNewsFeed/Article/detail/824867?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Prolong-Pharmaceuticals-Presents-Phase-1-Results-F/ArticleNewsFeed/Article/detail/824867",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Viralytics-Advances-CAVATAK-Clinical-Programs-in-L/ArticleNewsFeed/Article/detail/819062?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Viralytics-Advances-CAVATAK-Clinical-Programs-in-L/ArticleNewsFeed/Article/detail/819062",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/Practical-Thoughts-on-Common-Standards-CDASH-and-E/ArticleStandard/Article/detail/821936?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/Practical-Thoughts-on-Common-Standards-CDASH-and-E/ArticleStandard/Article/detail/821936",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ARRAYit-Technology-Used-By-Researchers-at-NIH-For-/ArticleNewsFeed/Article/detail/825107?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ARRAYit-Technology-Used-By-Researchers-at-NIH-For-/ArticleNewsFeed/Article/detail/825107",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioAxone-BioSciences-Inc-Announces-Publication-of-/ArticleNewsFeed/Article/detail/823927?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioAxone-BioSciences-Inc-Announces-Publication-of-/ArticleNewsFeed/Article/detail/823927",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Tips-on-Writing-Risk-Based-Monitoring-Plans/ArticleStandard/Article/detail/821561?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Tips-on-Writing-Risk-Based-Monitoring-Plans/ArticleStandard/Article/detail/821561",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/Higher-Quality-at-Lower-Cost-The-Benefits-of-Portf/ArticleStandard/Article/detail/821184?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/Higher-Quality-at-Lower-Cost-The-Benefits-of-Portf/ArticleStandard/Article/detail/821184",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Alvi-Armani-Hair-Loss-Research-Discontinues-Hair-C/ArticleNewsFeed/Article/detail/822950?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Alvi-Armani-Hair-Loss-Research-Discontinues-Hair-C/ArticleNewsFeed/Article/detail/822950",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/AtheroMed-Announces-Completion-of-Patient-Enrollme/ArticleNewsFeed/Article/detail/824581?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/AtheroMed-Announces-Completion-of-Patient-Enrollme/ArticleNewsFeed/Article/detail/824581",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cardiometabolic-Health-Congress-Faculty-Deliver-Ex/ArticleNewsFeed/Article/detail/824433?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cardiometabolic-Health-Congress-Faculty-Deliver-Ex/ArticleNewsFeed/Article/detail/824433",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/CSL-Behring-Gains-Approval-to-License-Hizentra-in-/ArticleNewsFeed/Article/detail/824115?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/CSL-Behring-Gains-Approval-to-License-Hizentra-in-/ArticleNewsFeed/Article/detail/824115",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/K94-Discoveries-Inc-Announces-Seed-Financing-To-Ad/ArticleNewsFeed/Article/detail/823781?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/K94-Discoveries-Inc-Announces-Seed-Financing-To-Ad/ArticleNewsFeed/Article/detail/823781",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Moms-weight-gain-during-pregnancy-tied-to-childhoo/ArticleNewsFeed/Article/detail/824570?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Moms-weight-gain-during-pregnancy-tied-to-childhoo/ArticleNewsFeed/Article/detail/824570",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Simcyp-Releases-Version-13-of-its-Widely-Used-Simu/ArticleStandard/Article/detail/821515?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Simcyp-Releases-Version-13-of-its-Widely-Used-Simu/ArticleStandard/Article/detail/821515",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/High-Performing-Study-Start-Ups/ArticleStandard/Article/detail/820226?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/High-Performing-Study-Start-Ups/ArticleStandard/Article/detail/820226",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Nuvo-Research-announces-that-FDA-has-accepted-Penn/ArticleNewsFeed/Article/detail/820965?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Nuvo-Research-announces-that-FDA-has-accepted-Penn/ArticleNewsFeed/Article/detail/820965",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/True-Pharma-Innovation-Lies-in-Quality---Not-Quant/ArticleStandard/Article/detail/819880?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/True-Pharma-Innovation-Lies-in-Quality---Not-Quant/ArticleStandard/Article/detail/819880",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Clinical-Research-Advantage-Acquires-Late-Phase-Di/ArticleStandard/Article/detail/818765?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Clinical-Research-Advantage-Acquires-Late-Phase-Di/ArticleStandard/Article/detail/818765",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Andrew-Technologies-Announces-Positive-Results-of-/ArticleNewsFeed/Article/detail/820719?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Andrew-Technologies-Announces-Positive-Results-of-/ArticleNewsFeed/Article/detail/820719",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Final-Patient-Completes-Prosonix-Phase-2-Clinical-/ArticleNewsFeed/Article/detail/820605?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Final-Patient-Completes-Prosonix-Phase-2-Clinical-/ArticleNewsFeed/Article/detail/820605",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Heart-Imaging-Technologies-Wins-25M-NIH-Grant-for-/ArticleNewsFeed/Article/detail/821995?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Heart-Imaging-Technologies-Wins-25M-NIH-Grant-for-/ArticleNewsFeed/Article/detail/821995",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lupin-Receives-Tentative-FDA-Approvals-for-Generic/ArticleNewsFeed/Article/detail/819400?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lupin-Receives-Tentative-FDA-Approvals-for-Generic/ArticleNewsFeed/Article/detail/819400",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/CAP-and-ASCO-Release-Updated-Guideline-on-HER2-Tes/ArticleNewsFeed/Article/detail/825103?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/CAP-and-ASCO-Release-Updated-Guideline-on-HER2-Tes/ArticleNewsFeed/Article/detail/825103",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Debiopharm-Group-and-TCG-Lifesciences-Ltd-Enter-in/ArticleNewsFeed/Article/detail/822406?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Debiopharm-Group-and-TCG-Lifesciences-Ltd-Enter-in/ArticleNewsFeed/Article/detail/822406",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Elusys-Therapeutics-Presents-Efficacy-Results-And-/ArticleNewsFeed/Article/detail/822239?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Elusys-Therapeutics-Presents-Efficacy-Results-And-/ArticleNewsFeed/Article/detail/822239",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/InspireMD-Announces-First-Patient-Enrolled-in-US-R/ArticleNewsFeed/Article/detail/819086?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/InspireMD-Announces-First-Patient-Enrolled-in-US-R/ArticleNewsFeed/Article/detail/819086",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/WorldCare-Clinical-Introduces-New-Service-for-Onco/ArticleStandard/Article/detail/820222?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/WorldCare-Clinical-Introduces-New-Service-for-Onco/ArticleStandard/Article/detail/820222",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Adamas-Pharmaceuticals-Presents-Positive-Clinical-/ArticleNewsFeed/Article/detail/824659?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Adamas-Pharmaceuticals-Presents-Positive-Clinical-/ArticleNewsFeed/Article/detail/824659",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Adynxx-Completes-Patient-Enrollment-in-Phase-2-Cli/ArticleNewsFeed/Article/detail/822159?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Adynxx-Completes-Patient-Enrollment-in-Phase-2-Cli/ArticleNewsFeed/Article/detail/822159",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Auxilium-Pharmaceuticals-Inc-Presented-Data-At-The/ArticleNewsFeed/Article/detail/825021?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Auxilium-Pharmaceuticals-Inc-Presented-Data-At-The/ArticleNewsFeed/Article/detail/825021",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Israeli-Medical-Device-Company-FlowSense-Acquired-/ArticleNewsFeed/Article/detail/822551?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Israeli-Medical-Device-Company-FlowSense-Acquired-/ArticleNewsFeed/Article/detail/822551",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ViiV-Healthcare-announces-US-approval-of-Tivicay-d/ArticleNewsFeed/Article/detail/820330?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ViiV-Healthcare-announces-US-approval-of-Tivicay-d/ArticleNewsFeed/Article/detail/820330",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/New-Strategies-to-Expedite-GoNo-Go-Decisions-in-On/ArticleStandard/Article/detail/821212?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/New-Strategies-to-Expedite-GoNo-Go-Decisions-in-On/ArticleStandard/Article/detail/821212",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Anthera-Pharmaceuticals-Announces-Emerging-Data-fr/ArticleNewsFeed/Article/detail/823915?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Anthera-Pharmaceuticals-Announces-Emerging-Data-fr/ArticleNewsFeed/Article/detail/823915",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lilly-Roswell-Park-Cancer-Institute-Partner-to-Tra/ArticleNewsFeed/Article/detail/819448?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lilly-Roswell-Park-Cancer-Institute-Partner-to-Tra/ArticleNewsFeed/Article/detail/819448",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Study-Shows-Mesh-Not-Beneficial-for-Repairing-Vagi/ArticleNewsFeed/Article/detail/825276?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Study-Shows-Mesh-Not-Beneficial-for-Repairing-Vagi/ArticleNewsFeed/Article/detail/825276",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Sponsor-Buy-In-for-TransCelerate/ArticleStandard/Article/detail/819512?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Sponsor-Buy-In-for-TransCelerate/ArticleStandard/Article/detail/819512",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/American-Society-of-Breast-Surgeons-Release-MammoS/ArticleNewsFeed/Article/detail/824616?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/American-Society-of-Breast-Surgeons-Release-MammoS/ArticleNewsFeed/Article/detail/824616",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Isis-Reports-Interim-Phase-2-Data-on-ISIS-APOCIII-/ArticleNewsFeed/Article/detail/821836?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Isis-Reports-Interim-Phase-2-Data-on-ISIS-APOCIII-/ArticleNewsFeed/Article/detail/821836",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Multiple-International-Breast-Cancer-Guidelines-Co/ArticleNewsFeed/Article/detail/822446?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Multiple-International-Breast-Cancer-Guidelines-Co/ArticleNewsFeed/Article/detail/822446",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Multiplicom-Launches-Three-New-Mutation-Detection-/ArticleNewsFeed/Article/detail/824274?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Multiplicom-Launches-Three-New-Mutation-Detection-/ArticleNewsFeed/Article/detail/824274",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Single-Agent-Ramucirumab-Significantly-Improves-Ov/ArticleNewsFeed/Article/detail/824729?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Single-Agent-Ramucirumab-Significantly-Improves-Ov/ArticleNewsFeed/Article/detail/824729",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Celladon-Corporation-Announces-Pre-clinical-Study-/ArticleNewsFeed/Article/detail/819164?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Celladon-Corporation-Announces-Pre-clinical-Study-/ArticleNewsFeed/Article/detail/819164",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/CROS-NT-becomes-DATATRAK-Connect-Partner/ArticleNewsFeed/Article/detail/818460?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/CROS-NT-becomes-DATATRAK-Connect-Partner/ArticleNewsFeed/Article/detail/818460",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Mechanism-offers-promising-new-approach-for-harnes/ArticleNewsFeed/Article/detail/819666?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Mechanism-offers-promising-new-approach-for-harnes/ArticleNewsFeed/Article/detail/819666",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/SanBio-Announces-The-Completion-Of-Enrollment-Of-I/ArticleNewsFeed/Article/detail/822004?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/SanBio-Announces-The-Completion-Of-Enrollment-Of-I/ArticleNewsFeed/Article/detail/822004",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Crown-Bioscience-Strengthens-Oncology-Expertise-wi/ArticleStandard/Article/detail/819394?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Crown-Bioscience-Strengthens-Oncology-Expertise-wi/ArticleStandard/Article/detail/819394",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MD-Stem-Cells-Begins-the-Largest-Stem-Cell-Eye-Tre/ArticleNewsFeed/Article/detail/822623?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MD-Stem-Cells-Begins-the-Largest-Stem-Cell-Eye-Tre/ArticleNewsFeed/Article/detail/822623",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Rigel-To-Focus-On-ITP-DLE-And-Dry-Eye/ArticleNewsFeed/Article/detail/822153?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Rigel-To-Focus-On-ITP-DLE-And-Dry-Eye/ArticleNewsFeed/Article/detail/822153",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/St-Jude-Childrens-Research-Hospital-recognizes-Chi/ArticleNewsFeed/Article/detail/822090?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/St-Jude-Childrens-Research-Hospital-recognizes-Chi/ArticleNewsFeed/Article/detail/822090",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cardiome-Announces-Publication-of-Positive-Data-fr/ArticleNewsFeed/Article/detail/825032?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cardiome-Announces-Publication-of-Positive-Data-fr/ArticleNewsFeed/Article/detail/825032",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MEI-Pharma-Announces-Topline-Data-From-Phase-I-Cli/ArticleNewsFeed/Article/detail/825335?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MEI-Pharma-Announces-Topline-Data-From-Phase-I-Cli/ArticleNewsFeed/Article/detail/825335",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Mimedx-Scientific-Study-Is-Electronically-Publishe/ArticleNewsFeed/Article/detail/819549?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Mimedx-Scientific-Study-Is-Electronically-Publishe/ArticleNewsFeed/Article/detail/819549",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Northwestern-Medicine-Researchers-Study-New-Heart-/ArticleNewsFeed/Article/detail/825278?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Northwestern-Medicine-Researchers-Study-New-Heart-/ArticleNewsFeed/Article/detail/825278",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/OncoGenex-Announces-that-the-Rainier-Clinical-Tria/ArticleNewsFeed/Article/detail/821253?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/OncoGenex-Announces-that-the-Rainier-Clinical-Tria/ArticleNewsFeed/Article/detail/821253",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Celsion-Announces-Official-ThermoDox-HEAT-Study-Re/ArticleNewsFeed/Article/detail/820877?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Celsion-Announces-Official-ThermoDox-HEAT-Study-Re/ArticleNewsFeed/Article/detail/820877",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Football-Helmet-Research-Aimed-at-Reducing-Concuss/ArticleNewsFeed/Article/detail/821933?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Football-Helmet-Research-Aimed-at-Reducing-Concuss/ArticleNewsFeed/Article/detail/821933",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MicroConstants-China-In-licenses-Phase-2-Liver-Can/ArticleNewsFeed/Article/detail/822379?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MicroConstants-China-In-licenses-Phase-2-Liver-Can/ArticleNewsFeed/Article/detail/822379",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Data-Confirms-Circulating-Tumor-Cells-Are-Usef/ArticleNewsFeed/Article/detail/819818?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Data-Confirms-Circulating-Tumor-Cells-Are-Usef/ArticleNewsFeed/Article/detail/819818",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ResearchMozus-Obesity-Therapeutics-to-2019---Safet/ArticleNewsFeed/Article/detail/822003?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ResearchMozus-Obesity-Therapeutics-to-2019---Safet/ArticleNewsFeed/Article/detail/822003",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Interactive-Informed-Consent-Better-Informed-Patie/ArticleStandard/Article/detail/819756?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Interactive-Informed-Consent-Better-Informed-Patie/ArticleStandard/Article/detail/819756",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Colon-Polyps-in-Elderly-Patients-Are-More-Likely-t/ArticleNewsFeed/Article/detail/825175?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Colon-Polyps-in-Elderly-Patients-Are-More-Likely-t/ArticleNewsFeed/Article/detail/825175",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MedNet-Solutions-Partners-With-Heart-Imaging-Techn/ArticleNewsFeed/Article/detail/820048?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MedNet-Solutions-Partners-With-Heart-Imaging-Techn/ArticleNewsFeed/Article/detail/820048",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Rigels-R343-Did-Not-Meet-Primary-Endpoint-in-Asthm/ArticleNewsFeed/Article/detail/821176?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Rigels-R343-Did-Not-Meet-Primary-Endpoint-in-Asthm/ArticleNewsFeed/Article/detail/821176",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/The-Partnership-at-Drugfreeorg-and-the-Center-for-/ArticleNewsFeed/Article/detail/822310?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/The-Partnership-at-Drugfreeorg-and-the-Center-for-/ArticleNewsFeed/Article/detail/822310",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Trial+Design+News/Controversy-Grows-Over-How-Best-to-Share-Data/ArticleStandard/Article/detail/820679?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Trial+Design+News/Controversy-Grows-Over-How-Best-to-Share-Data/ArticleStandard/Article/detail/820679",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Clinical-Conductor-Site-CTMS-Releases-Third-Major-/ArticleNewsFeed/Article/detail/825148?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Clinical-Conductor-Site-CTMS-Releases-Third-Major-/ArticleNewsFeed/Article/detail/825148",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Genocea-Reports-Positive-Initial-Phase-12a-Results/ArticleNewsFeed/Article/detail/822956?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Genocea-Reports-Positive-Initial-Phase-12a-Results/ArticleNewsFeed/Article/detail/822956",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Bavarian-Nordic-Receives-European-Marketing-Author/ArticleNewsFeed/Article/detail/820020?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Bavarian-Nordic-Receives-European-Marketing-Author/ArticleNewsFeed/Article/detail/820020",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/FIU-nursing-study-When-a-baby-dies-parents-health-/ArticleNewsFeed/Article/detail/825176?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/FIU-nursing-study-When-a-baby-dies-parents-health-/ArticleNewsFeed/Article/detail/825176",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ImThera-Medical-Completes-Enrollment-in-Multi-cent/ArticleNewsFeed/Article/detail/824305?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ImThera-Medical-Completes-Enrollment-in-Multi-cent/ArticleNewsFeed/Article/detail/824305",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Heptares-Delivers-First-Stabilised-GPCR-StaR-to-Mo/ArticleNewsFeed/Article/detail/825316?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Heptares-Delivers-First-Stabilised-GPCR-StaR-to-Mo/ArticleNewsFeed/Article/detail/825316",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lpath-Provides-Update-on-Plans-for-iSONEP-Option/ArticleNewsFeed/Article/detail/825221?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lpath-Provides-Update-on-Plans-for-iSONEP-Option/ArticleNewsFeed/Article/detail/825221",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oncos-Therapeutics-Granted-Orphan-Drug-Designation/ArticleNewsFeed/Article/detail/819401?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oncos-Therapeutics-Granted-Orphan-Drug-Designation/ArticleNewsFeed/Article/detail/819401",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Risk-Based-Monitoring-In-Clinical-Studies---Brochu/ArticleStandard/Article/detail/818927?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Risk-Based-Monitoring-In-Clinical-Studies---Brochu/ArticleStandard/Article/detail/818927",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Landmark-TIOSPIR-trial-demonstrates-comparable-lon/ArticleNewsFeed/Article/detail/822355?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Landmark-TIOSPIR-trial-demonstrates-comparable-lon/ArticleNewsFeed/Article/detail/822355",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MaxHealthLabs-Intra-Cellular-Liposomal-Vitamin-D-S/ArticleNewsFeed/Article/detail/825169?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MaxHealthLabs-Intra-Cellular-Liposomal-Vitamin-D-S/ArticleNewsFeed/Article/detail/825169",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Nektar-Completes-Enrollment-in-Phase-3-BEACON-Stud/ArticleNewsFeed/Article/detail/819188?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Nektar-Completes-Enrollment-in-Phase-3-BEACON-Stud/ArticleNewsFeed/Article/detail/819188",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Trial+Design+Articles/Paradigm-Shift/ArticleStandard/Article/detail/820671?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Trial+Design+Articles/Paradigm-Shift/ArticleStandard/Article/detail/820671",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/The-Long-Curve-Behind-CNS-Drug-Testing/ArticleStandard/Article/detail/818570?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/The-Long-Curve-Behind-CNS-Drug-Testing/ArticleStandard/Article/detail/818570",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Viroclinics-Biosciences-expands-with-Clinical-Tria/ArticleStandard/Article/detail/824607?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Viroclinics-Biosciences-expands-with-Clinical-Tria/ArticleStandard/Article/detail/824607",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/Speeding-the-eTMF-Process-with-Cloud-Technology/ArticleStandard/Article/detail/822227?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/Speeding-the-eTMF-Process-with-Cloud-Technology/ArticleStandard/Article/detail/822227",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Elcelyx-Therapeutics-NewMet-for-Type-2-Diabetes-Me/ArticleNewsFeed/Article/detail/822002?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Elcelyx-Therapeutics-NewMet-for-Type-2-Diabetes-Me/ArticleNewsFeed/Article/detail/822002",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Generex-Announces-Publication-of-Follow-up-Studies/ArticleNewsFeed/Article/detail/820806?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Generex-Announces-Publication-of-Follow-up-Studies/ArticleNewsFeed/Article/detail/820806",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Questcor-to-Commence-Phase-2-Study-of-Acthar-for-A/ArticleNewsFeed/Article/detail/818793?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Questcor-to-Commence-Phase-2-Study-of-Acthar-for-A/ArticleNewsFeed/Article/detail/818793",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Sanofi-Pasteur-Initiates-Phase-III-Study-of-Invest/ArticleNewsFeed/Article/detail/819693?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Sanofi-Pasteur-Initiates-Phase-III-Study-of-Invest/ArticleNewsFeed/Article/detail/819693",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/PPD---Advancing-Early-Phase-Oncology-Trials-in-the/ArticleStandard/Article/detail/818654?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/PPD---Advancing-Early-Phase-Oncology-Trials-in-the/ArticleStandard/Article/detail/818654",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Triangles---Not-from-Bermuda-Yet/ArticleStandard/Article/detail/821770?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Triangles---Not-from-Bermuda-Yet/ArticleStandard/Article/detail/821770",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Investigational-interferon-free-regimen-demonstrat/ArticleNewsFeed/Article/detail/825116?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Investigational-interferon-free-regimen-demonstrat/ArticleNewsFeed/Article/detail/825116",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Synthetic-Biologics-Reports-Second-Quarter-2013-Fi/ArticleNewsFeed/Article/detail/820422?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Synthetic-Biologics-Reports-Second-Quarter-2013-Fi/ArticleNewsFeed/Article/detail/820422",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Transition-Therapeutics-Enters-Osteoarthritis-Lice/ArticleNewsFeed/Article/detail/818672?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Transition-Therapeutics-Enters-Osteoarthritis-Lice/ArticleNewsFeed/Article/detail/818672",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Patient-Reported-Outcomes-in-Oncology-If-No-One-Pa/ArticleStandard/Article/detail/824611?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Patient-Reported-Outcomes-in-Oncology-If-No-One-Pa/ArticleStandard/Article/detail/824611",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Shutdown-Forces-FDA-HHS-No-Shows/ArticleStandard/Article/detail/824881?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Shutdown-Forces-FDA-HHS-No-Shows/ArticleStandard/Article/detail/824881",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/MedTrials-Inc-Taps-M-Files-for-Management-of-Clini/ArticleStandard/Article/detail/819249?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/MedTrials-Inc-Taps-M-Files-for-Management-of-Clini/ArticleStandard/Article/detail/819249",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Advanced-Germ-Eliminating-Technology-Improves-Pati/ArticleNewsFeed/Article/detail/818892?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Advanced-Germ-Eliminating-Technology-Improves-Pati/ArticleNewsFeed/Article/detail/818892",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Breakthrough-Case-Study-Highlights-New-Biomarker-f/ArticleNewsFeed/Article/detail/820692?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Breakthrough-Case-Study-Highlights-New-Biomarker-f/ArticleNewsFeed/Article/detail/820692",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cumberland-Pharmaceuticals-Reports-Second-Quarter-/ArticleNewsFeed/Article/detail/819932?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cumberland-Pharmaceuticals-Reports-Second-Quarter-/ArticleNewsFeed/Article/detail/819932",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Heptares-Achieves-First-Research-Milestone-in-Rese/ArticleNewsFeed/Article/detail/818443?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Heptares-Achieves-First-Research-Milestone-in-Rese/ArticleNewsFeed/Article/detail/818443",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/KalVista-Pharmaceuticals-Brings-Expertise-to-New-E/ArticleNewsFeed/Article/detail/823882?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/KalVista-Pharmaceuticals-Brings-Expertise-to-New-E/ArticleNewsFeed/Article/detail/823882",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/CBINET---SponsorCRO-Systems-and-Business-Process-I/ArticleStandard/Article/detail/825044?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/CBINET---SponsorCRO-Systems-and-Business-Process-I/ArticleStandard/Article/detail/825044",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/An-In-Depth-Understanding-of-the-Chinese-Pharmaceu/ArticleNewsFeed/Article/detail/824434?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/An-In-Depth-Understanding-of-the-Chinese-Pharmaceu/ArticleNewsFeed/Article/detail/824434",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Hospiras-Inflectra-infliximab-the-first-biosimilar/ArticleNewsFeed/Article/detail/822479?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Hospiras-Inflectra-infliximab-the-first-biosimilar/ArticleNewsFeed/Article/detail/822479",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/KLOX-Technologies-Announces-Approval-in-Canada-of-/ArticleNewsFeed/Article/detail/824577?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/KLOX-Technologies-Announces-Approval-in-Canada-of-/ArticleNewsFeed/Article/detail/824577",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Naurex-Announces-Issuance-Of-New-Patent-For-Novel-/ArticleNewsFeed/Article/detail/819163?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Naurex-Announces-Issuance-Of-New-Patent-For-Novel-/ArticleNewsFeed/Article/detail/819163",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/GenoVive-is-changing-the-face-of-personalized-heal/ArticleNewsFeed/Article/detail/823928?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/GenoVive-is-changing-the-face-of-personalized-heal/ArticleNewsFeed/Article/detail/823928",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/KemPharms-KP201-Demonstrates-Bioequivalence-Compar/ArticleNewsFeed/Article/detail/823920?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/KemPharms-KP201-Demonstrates-Bioequivalence-Compar/ArticleNewsFeed/Article/detail/823920",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/NovaRx-Announces-Results-of-Lucanix-Phase-III-Ther/ArticleNewsFeed/Article/detail/823888?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/NovaRx-Announces-Results-of-Lucanix-Phase-III-Ther/ArticleNewsFeed/Article/detail/823888",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ViiV-Healthcare-Presents-Positive-Data-from-Phase-/ArticleNewsFeed/Article/detail/822964?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ViiV-Healthcare-Presents-Positive-Data-from-Phase-/ArticleNewsFeed/Article/detail/822964",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Regulatory+Articles/Looking-Further-Into-Transparency/ArticleStandard/Article/detail/820677?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Regulatory+Articles/Looking-Further-Into-Transparency/ArticleStandard/Article/detail/820677",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Certara-Announces-Acquisition-of-Great-Lakes-Drug-/ArticleStandard/Article/detail/820721?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Certara-Announces-Acquisition-of-Great-Lakes-Drug-/ArticleStandard/Article/detail/820721",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Ampio-Pharmaceuticals-Inc-Announces-Positive-Resul/ArticleNewsFeed/Article/detail/825031?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Ampio-Pharmaceuticals-Inc-Announces-Positive-Resul/ArticleNewsFeed/Article/detail/825031",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Velocity-Pharmaceutical-Development-and-Tigercat-P/ArticleNewsFeed/Article/detail/820684?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Velocity-Pharmaceutical-Development-and-Tigercat-P/ArticleNewsFeed/Article/detail/820684",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/World-first-Trial-for-Tendon-Repair-Using-Tendon-S/ArticleNewsFeed/Article/detail/824572?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/World-first-Trial-for-Tendon-Repair-Using-Tendon-S/ArticleNewsFeed/Article/detail/824572",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Amorfix-Reports-Update-on-Lead-Ovarian-Cancer-Prog/ArticleNewsFeed/Article/detail/820430?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Amorfix-Reports-Update-on-Lead-Ovarian-Cancer-Prog/ArticleNewsFeed/Article/detail/820430",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Inovio-Pharmaceuticals-Malaria-DNA-Vaccine-Demonst/ArticleNewsFeed/Article/detail/820521?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Inovio-Pharmaceuticals-Malaria-DNA-Vaccine-Demonst/ArticleNewsFeed/Article/detail/820521",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/TVA-Medicals-Minimally-Invasive-System-for-Hemodia/ArticleNewsFeed/Article/detail/824071?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/TVA-Medicals-Minimally-Invasive-System-for-Hemodia/ArticleNewsFeed/Article/detail/824071",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Huron-Consulting-Group-and-Forte-Research-Systems-/ArticleStandard/Article/detail/820793?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Huron-Consulting-Group-and-Forte-Research-Systems-/ArticleStandard/Article/detail/820793",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Actinium-Pharmaceuticals-Announces-Upcoming-Webina/ArticleNewsFeed/Article/detail/824897?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Actinium-Pharmaceuticals-Announces-Upcoming-Webina/ArticleNewsFeed/Article/detail/824897",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Case-Report-on-14-Year-Old-Pediatric-Patient-Bridg/ArticleNewsFeed/Article/detail/824476?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Case-Report-on-14-Year-Old-Pediatric-Patient-Bridg/ArticleNewsFeed/Article/detail/824476",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Foot-Treatment-Moves-Forward-with-Platelet-Rich-Pl/ArticleNewsFeed/Article/detail/820497?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Foot-Treatment-Moves-Forward-with-Platelet-Rich-Pl/ArticleNewsFeed/Article/detail/820497",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Varians-Calypso-Tumor-Tracking-System-Used-in-Lung/ArticleNewsFeed/Article/detail/824303?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Varians-Calypso-Tumor-Tracking-System-Used-in-Lung/ArticleNewsFeed/Article/detail/824303",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Catalyst-Biosciences-And-Isu-Abxis-Announce-Collab/ArticleNewsFeed/Article/detail/825246?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Catalyst-Biosciences-And-Isu-Abxis-Announce-Collab/ArticleNewsFeed/Article/detail/825246",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/CRO-Solutions-Inc-Announces-Opening-of-New-Divisio/ArticleNewsFeed/Article/detail/818507?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/CRO-Solutions-Inc-Announces-Opening-of-New-Divisio/ArticleNewsFeed/Article/detail/818507",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Keryx-Biopharmaceuticals-Announces-New-Drug-Applic/ArticleNewsFeed/Article/detail/820087?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Keryx-Biopharmaceuticals-Announces-New-Drug-Applic/ArticleNewsFeed/Article/detail/820087",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Moleculin-Reports-Positive-Data-From-Controlled-St/ArticleNewsFeed/Article/detail/824306?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Moleculin-Reports-Positive-Data-From-Controlled-St/ArticleNewsFeed/Article/detail/824306",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Simeprevir-Data-in-Hepatitis-C-Patients-to-be-Pres/ArticleNewsFeed/Article/detail/824452?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Simeprevir-Data-in-Hepatitis-C-Patients-to-be-Pres/ArticleNewsFeed/Article/detail/824452",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Venaxis-APPY1-Test-Passes-Final-Futility-Analysis-/ArticleNewsFeed/Article/detail/824009?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Venaxis-APPY1-Test-Passes-Final-Futility-Analysis-/ArticleNewsFeed/Article/detail/824009",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Virtify-CTRR-To-Be-Used-by-Indiana-Purdue-U-Notre-/ArticleStandard/Article/detail/820794?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Virtify-CTRR-To-Be-Used-by-Indiana-Purdue-U-Notre-/ArticleStandard/Article/detail/820794",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/AbbVie-To-Present-Investigational-Data-From-Phase-/ArticleNewsFeed/Article/detail/824477?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/AbbVie-To-Present-Investigational-Data-From-Phase-/ArticleNewsFeed/Article/detail/824477",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Data-Published-in-the-New-England-Journal-of-Medic/ArticleNewsFeed/Article/detail/820943?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Data-Published-in-the-New-England-Journal-of-Medic/ArticleNewsFeed/Article/detail/820943",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Laser-Proton-Therapy-Working-Group-Takes-Second-Lo/ArticleNewsFeed/Article/detail/823991?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Laser-Proton-Therapy-Working-Group-Takes-Second-Lo/ArticleNewsFeed/Article/detail/823991",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Appendectomy-Cases-on-the-Simbionix-Lap-Mentor/ArticleNewsFeed/Article/detail/824989?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Appendectomy-Cases-on-the-Simbionix-Lap-Mentor/ArticleNewsFeed/Article/detail/824989",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/ACT-Cover/ArticleStandard/Article/detail/820673?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/ACT-Cover/ArticleStandard/Article/detail/820673",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/A-World-of-Processes/ArticleStandard/Article/detail/820282?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/A-World-of-Processes/ArticleStandard/Article/detail/820282",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/ICON-Signs-Collaboration-Agreement-with-the-Taiwan/ArticleStandard/Article/detail/819980?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/ICON-Signs-Collaboration-Agreement-with-the-Taiwan/ArticleStandard/Article/detail/819980",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/PPD-Acquires-Acurian-Patient-Recruitment-and-Reten/ArticleStandard/Article/detail/821307?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/PPD-Acquires-Acurian-Patient-Recruitment-and-Reten/ArticleStandard/Article/detail/821307",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/High-Impact-of-Arthritis-in-the-Workplace-Draws-Fo/ArticleNewsFeed/Article/detail/821950?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/High-Impact-of-Arthritis-in-the-Workplace-Draws-Fo/ArticleNewsFeed/Article/detail/821950",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Life-Line-Screening-Garners-Significant-Interest-i/ArticleNewsFeed/Article/detail/819705?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Life-Line-Screening-Garners-Significant-Interest-i/ArticleNewsFeed/Article/detail/819705",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Novartis-continues-to-build-its-COPD-pipeline-and-/ArticleNewsFeed/Article/detail/822403?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Novartis-continues-to-build-its-COPD-pipeline-and-/ArticleNewsFeed/Article/detail/822403",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Upsher-Smith-Receives-Tentative-NDA-Approval-for-V/ArticleNewsFeed/Article/detail/820658?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Upsher-Smith-Receives-Tentative-NDA-Approval-for-V/ArticleNewsFeed/Article/detail/820658",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioLineRx-Announces-Receipt-of-Notice-of-Allowance/ArticleNewsFeed/Article/detail/825020?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioLineRx-Announces-Receipt-of-Notice-of-Allowance/ArticleNewsFeed/Article/detail/825020",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Studies-Presented-at-AOSSM-Confirm-Significant-Ben/ArticleNewsFeed/Article/detail/818882?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Studies-Presented-at-AOSSM-Confirm-Significant-Ben/ArticleNewsFeed/Article/detail/818882",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Transdermal-Spray-Developers-See-Opportunity-for-I/ArticleStandard/Article/detail/822016?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Transdermal-Spray-Developers-See-Opportunity-for-I/ArticleStandard/Article/detail/822016",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/eClinical-Forum-Risk-Based-Monitoring-Taskforce-Of/ArticleStandard/Article/detail/819393?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/eClinical-Forum-Risk-Based-Monitoring-Taskforce-Of/ArticleStandard/Article/detail/819393",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Dance-Biopharm-Announces-Encouraging-Clinical-Data/ArticleNewsFeed/Article/detail/820350?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Dance-Biopharm-Announces-Encouraging-Clinical-Data/ArticleNewsFeed/Article/detail/820350",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Isis-Pharmaceuticals-Reports-Data-From-a-Phase-2-S/ArticleNewsFeed/Article/detail/819687?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Isis-Pharmaceuticals-Reports-Data-From-a-Phase-2-S/ArticleNewsFeed/Article/detail/819687",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Evidence-Based-Guidelines-For-Long-Term-Management/ArticleNewsFeed/Article/detail/818505?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Evidence-Based-Guidelines-For-Long-Term-Management/ArticleNewsFeed/Article/detail/818505",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BGI-Tech-and-South-Texas-Accelerated-Research-Ther/ArticleNewsFeed/Article/detail/822861?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BGI-Tech-and-South-Texas-Accelerated-Research-Ther/ArticleNewsFeed/Article/detail/822861",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cell-Therapeutics-Announces-Agreement-with-the-FDA/ArticleNewsFeed/Article/detail/825013?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cell-Therapeutics-Announces-Agreement-with-the-FDA/ArticleNewsFeed/Article/detail/825013",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cytos-Biotechnology-Presents-Additional-Results-Fr/ArticleNewsFeed/Article/detail/822359?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cytos-Biotechnology-Presents-Additional-Results-Fr/ArticleNewsFeed/Article/detail/822359",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/DATATRAK-to-Participate-in-Global-Industry-Events/ArticleNewsFeed/Article/detail/824290?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/DATATRAK-to-Participate-in-Global-Industry-Events/ArticleNewsFeed/Article/detail/824290",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/GW-Pharmaceuticals-Announces-New-Sativex-Data-at-E/ArticleNewsFeed/Article/detail/824615?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/GW-Pharmaceuticals-Announces-New-Sativex-Data-at-E/ArticleNewsFeed/Article/detail/824615",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lilly-Announces-Second-Positive-Ramucirumab-Phase-/ArticleNewsFeed/Article/detail/824008?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lilly-Announces-Second-Positive-Ramucirumab-Phase-/ArticleNewsFeed/Article/detail/824008",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oramed-Submits-Pre-IND-Package-to-FDA-for-ORMD-090/ArticleNewsFeed/Article/detail/821892?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oramed-Submits-Pre-IND-Package-to-FDA-for-ORMD-090/ArticleNewsFeed/Article/detail/821892",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Peripheral-Neuropathy-Sensory-Neuropathy-Global-Cl/ArticleNewsFeed/Article/detail/818823?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Peripheral-Neuropathy-Sensory-Neuropathy-Global-Cl/ArticleNewsFeed/Article/detail/818823",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/The-Michael-J-Fox-Foundation-Hosts-First-Clinical-/ArticleNewsFeed/Article/detail/822306?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/The-Michael-J-Fox-Foundation-Hosts-First-Clinical-/ArticleNewsFeed/Article/detail/822306",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Tisch-MS-Researchers-Announce-Breakthrough-in-Dise/ArticleNewsFeed/Article/detail/819165?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Tisch-MS-Researchers-Announce-Breakthrough-in-Dise/ArticleNewsFeed/Article/detail/819165",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Amgen-Presents-New-Data-From-Phase-3-Study-Of-Tali/ArticleNewsFeed/Article/detail/824275?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Amgen-Presents-New-Data-From-Phase-3-Study-Of-Tali/ArticleNewsFeed/Article/detail/824275",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Ampio-Pharmaceuticals-Inc-Announces-Additional-Pos/ArticleNewsFeed/Article/detail/824301?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Ampio-Pharmaceuticals-Inc-Announces-Additional-Pos/ArticleNewsFeed/Article/detail/824301",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Genetic-Test-Highly-Accurate-in-Differentiating-Th/ArticleNewsFeed/Article/detail/823914?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Genetic-Test-Highly-Accurate-in-Differentiating-Th/ArticleNewsFeed/Article/detail/823914",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Study-Shows-Oral-Nutritional-Supplement-Use-in/ArticleNewsFeed/Article/detail/825451?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Study-Shows-Oral-Nutritional-Supplement-Use-in/ArticleNewsFeed/Article/detail/825451",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Neurocrine-Biosciences-Reports-Second-Quarter-2013/ArticleNewsFeed/Article/detail/818938?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Neurocrine-Biosciences-Reports-Second-Quarter-2013/ArticleNewsFeed/Article/detail/818938",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Orexigen-Therapeutics-Prepares-for-the-Light-Study/ArticleNewsFeed/Article/detail/821259?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Orexigen-Therapeutics-Prepares-for-the-Light-Study/ArticleNewsFeed/Article/detail/821259",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Sangamo-BioSciences-Announces-Notice-Of-Allowance-/ArticleNewsFeed/Article/detail/820421?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Sangamo-BioSciences-Announces-Notice-Of-Allowance-/ArticleNewsFeed/Article/detail/820421",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Sealantis-Receives-CE-Mark-for-Seal-V/ArticleNewsFeed/Article/detail/819467?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Sealantis-Receives-CE-Mark-for-Seal-V/ArticleNewsFeed/Article/detail/819467",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Signature-Therapeutics-Receives-BrIDGs-Award-to-Ad/ArticleNewsFeed/Article/detail/819118?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Signature-Therapeutics-Receives-BrIDGs-Award-to-Ad/ArticleNewsFeed/Article/detail/819118",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Sorrento-Therapeutics-and-IGDRASOL-Proceed-with-De/ArticleNewsFeed/Article/detail/819692?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Sorrento-Therapeutics-and-IGDRASOL-Proceed-with-De/ArticleNewsFeed/Article/detail/819692",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/CROS-NT-SRL-Announces-Acquisition-of-Stat-Tech-Ser/ArticleStandard/Article/detail/822497?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/CROS-NT-SRL-Announces-Acquisition-of-Stat-Tech-Ser/ArticleStandard/Article/detail/822497",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Study-Clinical-Research-Organizations-Continue-to-/ArticleStandard/Article/detail/820742?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Study-Clinical-Research-Organizations-Continue-to-/ArticleStandard/Article/detail/820742",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/Risk-Based-Monitoring-Shifts-Equal-Huge-Operationa/ArticleStandard/Article/detail/818646?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/Risk-Based-Monitoring-Shifts-Equal-Huge-Operationa/ArticleStandard/Article/detail/818646",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/AcelRx-Pharmaceuticals-Submits-New-Drug-Applicatio/ArticleNewsFeed/Article/detail/824289?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/AcelRx-Pharmaceuticals-Submits-New-Drug-Applicatio/ArticleNewsFeed/Article/detail/824289",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioLife-Solutions-HypoThermosol-Embedded-in-Two-In/ArticleNewsFeed/Article/detail/820960?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioLife-Solutions-HypoThermosol-Embedded-in-Two-In/ArticleNewsFeed/Article/detail/820960",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ISIS-Pharmaceuticals-Advances-Phase-2-Study-of-ISI/ArticleNewsFeed/Article/detail/824878?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ISIS-Pharmaceuticals-Advances-Phase-2-Study-of-ISI/ArticleNewsFeed/Article/detail/824878",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Metamark-Announces-Positive-Results-of-ProMark-Pro/ArticleNewsFeed/Article/detail/822474?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Metamark-Announces-Positive-Results-of-ProMark-Pro/ArticleNewsFeed/Article/detail/822474",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Are-Regulators-Using-RBM-Tools/ArticleStandard/Article/detail/819084?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Are-Regulators-Using-RBM-Tools/ArticleStandard/Article/detail/819084",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ATA-Applauds-Introduction-of-Sleep-Apnea-Legislati/ArticleNewsFeed/Article/detail/822924?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ATA-Applauds-Introduction-of-Sleep-Apnea-Legislati/ArticleNewsFeed/Article/detail/822924",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Boston-Scientific-Reports-Favorable-Clinical-Trial/ArticleNewsFeed/Article/detail/825217?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Boston-Scientific-Reports-Favorable-Clinical-Trial/ArticleNewsFeed/Article/detail/825217",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Simultaneous-Applications-Submitted-to-FDA-and-EMA/ArticleNewsFeed/Article/detail/821887?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Simultaneous-Applications-Submitted-to-FDA-and-EMA/ArticleNewsFeed/Article/detail/821887",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Trial+Design+Articles/Impact-on-the-Future/ArticleStandard/Article/detail/820669?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Trial+Design+Articles/Impact-on-the-Future/ArticleStandard/Article/detail/820669",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Daiichi-Sankyos-Once-Daily-Edoxaban-Shows-Comparab/ArticleNewsFeed/Article/detail/821838?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Daiichi-Sankyos-Once-Daily-Edoxaban-Shows-Comparab/ArticleNewsFeed/Article/detail/821838",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ImmusanT-Initiates-Study-at-Joslin-Diabetes-Center/ArticleNewsFeed/Article/detail/819817?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ImmusanT-Initiates-Study-at-Joslin-Diabetes-Center/ArticleNewsFeed/Article/detail/819817",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/inVentiv-Health-Partner-Mytrus-Inc-Wins-Prestigiou/ArticleNewsFeed/Article/detail/821192?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/inVentiv-Health-Partner-Mytrus-Inc-Wins-Prestigiou/ArticleNewsFeed/Article/detail/821192",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lupus-Research-Institute-Announces-New-Global-Rese/ArticleNewsFeed/Article/detail/825277?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lupus-Research-Institute-Announces-New-Global-Rese/ArticleNewsFeed/Article/detail/825277",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Measuring-Up-How-Often-is-PRO-Data-Being-Used-in-H/ArticleStandard/Article/detail/819073?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Measuring-Up-How-Often-is-PRO-Data-Being-Used-in-H/ArticleStandard/Article/detail/819073",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Caldolor-Studies-to-be-Presented-at-the-Annual-Mee/ArticleNewsFeed/Article/detail/825400?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Caldolor-Studies-to-be-Presented-at-the-Annual-Mee/ArticleNewsFeed/Article/detail/825400",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Guidelines-on-Diagnosis-and-Management-of-Acha/ArticleNewsFeed/Article/detail/818573?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Guidelines-on-Diagnosis-and-Management-of-Acha/ArticleNewsFeed/Article/detail/818573",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ViiV-Healthcare-announces-US-approval-of-Tivicayre/ArticleNewsFeed/Article/detail/820330?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ViiV-Healthcare-announces-US-approval-of-Tivicayre/ArticleNewsFeed/Article/detail/820330",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/The-Science-of-Engagement-in-Clinical-Trial-Subjec/ArticleStandard/Article/detail/819243?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/The-Science-of-Engagement-in-Clinical-Trial-Subjec/ArticleStandard/Article/detail/819243",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Theorem-Adds-RadMD-to-its-Roster-of-Strategic-Alli/ArticleStandard/Article/detail/820718?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Theorem-Adds-RadMD-to-its-Roster-of-Strategic-Alli/ArticleStandard/Article/detail/820718",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/The-Qs-of-Risk-Based-Monitoring/ArticleStandard/Article/detail/818643?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/The-Qs-of-Risk-Based-Monitoring/ArticleStandard/Article/detail/818643",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/CFDA-Accepts-Sihuan-Pharmaceuticals-Application-fo/ArticleNewsFeed/Article/detail/825347?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/CFDA-Accepts-Sihuan-Pharmaceuticals-Application-fo/ArticleNewsFeed/Article/detail/825347",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Covance-Central-Laboratory-Services-Again-Ranks-1-/ArticleNewsFeed/Article/detail/819130?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Covance-Central-Laboratory-Services-Again-Ranks-1-/ArticleNewsFeed/Article/detail/819130",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Evidence-Published-in-Muscle-and-Nerve-on-Meas/ArticleNewsFeed/Article/detail/821188?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Evidence-Published-in-Muscle-and-Nerve-on-Meas/ArticleNewsFeed/Article/detail/821188",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Terry-Fox-Research-Institute-led-study-develops-ne/ArticleNewsFeed/Article/detail/822099?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Terry-Fox-Research-Institute-led-study-develops-ne/ArticleNewsFeed/Article/detail/822099",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/viDA-Therapeutics-announces-publication-of-data-de/ArticleNewsFeed/Article/detail/820560?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/viDA-Therapeutics-announces-publication-of-data-de/ArticleNewsFeed/Article/detail/820560",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Health-Care-Executives-Say-Collaboration-Improves-/ArticleStandard/Article/detail/818891?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Health-Care-Executives-Say-Collaboration-Improves-/ArticleStandard/Article/detail/818891",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Nektar-Reports-on-Advancements-with-Clinical-Pipel/ArticleNewsFeed/Article/detail/825173?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Nektar-Reports-on-Advancements-with-Clinical-Pipel/ArticleNewsFeed/Article/detail/825173",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Guidelines-on-the-Management-of-Acute-Pancreat/ArticleNewsFeed/Article/detail/822160?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Guidelines-on-the-Management-of-Acute-Pancreat/ArticleNewsFeed/Article/detail/822160",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Nutranomics-Announces-Glucozyme-Human-Clinical-Stu/ArticleNewsFeed/Article/detail/824998?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Nutranomics-Announces-Glucozyme-Human-Clinical-Stu/ArticleNewsFeed/Article/detail/824998",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Recently-Patented-Technology-Poised-To-Disrupt-The/ArticleNewsFeed/Article/detail/822498?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Recently-Patented-Technology-Poised-To-Disrupt-The/ArticleNewsFeed/Article/detail/822498",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Tengion-Provides-Business-Update-and-Reports-Secon/ArticleNewsFeed/Article/detail/820498?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Tengion-Provides-Business-Update-and-Reports-Secon/ArticleNewsFeed/Article/detail/820498",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/PSI-Expands-International-Clinical-Trial-Presence-/ArticleStandard/Article/detail/818742?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/PSI-Expands-International-Clinical-Trial-Presence-/ArticleStandard/Article/detail/818742",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioLineRx-Reports-Second-Quarter-2013-Results/ArticleNewsFeed/Article/detail/819804?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioLineRx-Reports-Second-Quarter-2013-Results/ArticleNewsFeed/Article/detail/819804",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Convergence-Pharmaceuticals-Receives-Orphan-Drug-D/ArticleNewsFeed/Article/detail/819149?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Convergence-Pharmaceuticals-Receives-Orphan-Drug-D/ArticleNewsFeed/Article/detail/819149",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Nutritional-Probiotic-Supplement-Delpro-Found-to-H/ArticleNewsFeed/Article/detail/818468?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Nutritional-Probiotic-Supplement-Delpro-Found-to-H/ArticleNewsFeed/Article/detail/818468",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Ampio-Pharmaceuticals-Inc-Announces-Positive-Resul/ArticleNewsFeed/Article/detail/820431?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Ampio-Pharmaceuticals-Inc-Announces-Positive-Resul/ArticleNewsFeed/Article/detail/820431",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Generex-Announces-Podium-Presentation-on-Antigen-E/ArticleNewsFeed/Article/detail/820362?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Generex-Announces-Podium-Presentation-on-Antigen-E/ArticleNewsFeed/Article/detail/820362",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Olodaterol-Shows-Sustained-Improvements-in-Lung-Fu/ArticleNewsFeed/Article/detail/822354?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Olodaterol-Shows-Sustained-Improvements-in-Lung-Fu/ArticleNewsFeed/Article/detail/822354",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Omeros-Reports-Additional-Positive-Results-from-OM/ArticleNewsFeed/Article/detail/822840?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Omeros-Reports-Additional-Positive-Results-from-OM/ArticleNewsFeed/Article/detail/822840",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Phase-3-Trial-Comparing-Vectibix-Panitumumab-to-Er/ArticleNewsFeed/Article/detail/824263?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Phase-3-Trial-Comparing-Vectibix-Panitumumab-to-Er/ArticleNewsFeed/Article/detail/824263",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Are-You-Fit-to-Practice/ArticleStandard/Article/detail/822332?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Are-You-Fit-to-Practice/ArticleStandard/Article/detail/822332",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Boston-Scientific-Concludes-Enrollment-In-Randomiz/ArticleNewsFeed/Article/detail/822958?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Boston-Scientific-Concludes-Enrollment-In-Randomiz/ArticleNewsFeed/Article/detail/822958",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/KaloBios-to-Present-at-Stifel-Healthcare-Conferenc/ArticleNewsFeed/Article/detail/822266?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/KaloBios-to-Present-at-Stifel-Healthcare-Conferenc/ArticleNewsFeed/Article/detail/822266",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MPI-Research-Breaks-Ground-On-New-World-Class-Imag/ArticleNewsFeed/Article/detail/822305?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MPI-Research-Breaks-Ground-On-New-World-Class-Imag/ArticleNewsFeed/Article/detail/822305",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/NW-Bio-Receives-Regulatory-Decision-That-Will-Enab/ArticleNewsFeed/Article/detail/820204?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/NW-Bio-Receives-Regulatory-Decision-That-Will-Enab/ArticleNewsFeed/Article/detail/820204",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Janssen-Acquires-Investigational-NS5A-Inhibitor-fo/ArticleNewsFeed/Article/detail/825127?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Janssen-Acquires-Investigational-NS5A-Inhibitor-fo/ArticleNewsFeed/Article/detail/825127",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MacroGenics-to-Receive-10-Million-Milestone-Paymen/ArticleNewsFeed/Article/detail/820779?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/MacroGenics-to-Receive-10-Million-Milestone-Paymen/ArticleNewsFeed/Article/detail/820779",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Europe-Aims-to-be-Squeaky-Clean-Over-Transparency/ArticleStandard/Article/detail/820695?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Europe-Aims-to-be-Squeaky-Clean-Over-Transparency/ArticleStandard/Article/detail/820695",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Amgen-Presents-Nearly-Two-Dozen-Abstracts-From-Rom/ArticleNewsFeed/Article/detail/824950?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Amgen-Presents-Nearly-Two-Dozen-Abstracts-From-Rom/ArticleNewsFeed/Article/detail/824950",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Auxilium-Pharmaceuticals-Inc-to-Present-Data-on-XI/ArticleNewsFeed/Article/detail/824709?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Auxilium-Pharmaceuticals-Inc-to-Present-Data-on-XI/ArticleNewsFeed/Article/detail/824709",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Kidney-Care-Partners-to-Host-Webinar-to-Discuss-th/ArticleNewsFeed/Article/detail/825058?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Kidney-Care-Partners-to-Host-Webinar-to-Discuss-th/ArticleNewsFeed/Article/detail/825058",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/VolitionRx-led-Consortium-Awarded-euro-780-000-1M-/ArticleNewsFeed/Article/detail/821881?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/VolitionRx-led-Consortium-Awarded-euro-780-000-1M-/ArticleNewsFeed/Article/detail/821881",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Absorption-Systems-Scientists-Publish-Peer-reviewe/ArticleNewsFeed/Article/detail/822501?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Absorption-Systems-Scientists-Publish-Peer-reviewe/ArticleNewsFeed/Article/detail/822501",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Data-From-Post-Hoc-Analyses-Presented-at-EASD-Exam/ArticleNewsFeed/Article/detail/823769?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Data-From-Post-Hoc-Analyses-Presented-at-EASD-Exam/ArticleNewsFeed/Article/detail/823769",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/InspireMD-Completes-First-Phase-of-Manufacturing-U/ArticleNewsFeed/Article/detail/821193?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/InspireMD-Completes-First-Phase-of-Manufacturing-U/ArticleNewsFeed/Article/detail/821193",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Scottish-Medicines-Consortium-Accepts-TARGAXAN-550/ArticleNewsFeed/Article/detail/822419?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Scottish-Medicines-Consortium-Accepts-TARGAXAN-550/ArticleNewsFeed/Article/detail/822419",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/ACRP-and-ACRES-Create-Strategic-Alliance-to-Improv/ArticleStandard/Article/detail/820729?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/ACRP-and-ACRES-Create-Strategic-Alliance-to-Improv/ArticleStandard/Article/detail/820729",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cerulean-Announces-Publication-of-Data-from-Compan/ArticleNewsFeed/Article/detail/822402?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cerulean-Announces-Publication-of-Data-from-Compan/ArticleNewsFeed/Article/detail/822402",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/LipiGesic-M-is-the-only-recommended-first-line-the/ArticleNewsFeed/Article/detail/819760?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/LipiGesic-M-is-the-only-recommended-first-line-the/ArticleNewsFeed/Article/detail/819760",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/NextGxDx-Adds-Cancer-Genetics-Inc-to-Genetic-Testi/ArticleNewsFeed/Article/detail/822404?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/NextGxDx-Adds-Cancer-Genetics-Inc-to-Genetic-Testi/ArticleNewsFeed/Article/detail/822404",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/UKs-NICE-Issues-Final-Appraisal-Determination-Reco/ArticleNewsFeed/Article/detail/824419?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/UKs-NICE-Issues-Final-Appraisal-Determination-Reco/ArticleNewsFeed/Article/detail/824419",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/The-HIPAAHITECH-Omnibus-Final-Rule-Compliance-and-/ArticleStandard/Article/detail/823004?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/The-HIPAAHITECH-Omnibus-Final-Rule-Compliance-and-/ArticleStandard/Article/detail/823004",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Data-Presented-at-49th-EASD-Annual-Meeting-Show-Tr/ArticleNewsFeed/Article/detail/824005?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Data-Presented-at-49th-EASD-Annual-Meeting-Show-Tr/ArticleNewsFeed/Article/detail/824005",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/First-Presentation-of-GLISSADE-Results-on-the-Glyd/ArticleNewsFeed/Article/detail/825101?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/First-Presentation-of-GLISSADE-Results-on-the-Glyd/ArticleNewsFeed/Article/detail/825101",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Meningitis-Angels-Meningococcal-Meningitis-Prevent/ArticleNewsFeed/Article/detail/819709?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Meningitis-Angels-Meningococcal-Meningitis-Prevent/ArticleNewsFeed/Article/detail/819709",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Research-Shows-Genetic-Anti-Inflammatory-Defect-Pr/ArticleNewsFeed/Article/detail/824640?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Research-Shows-Genetic-Anti-Inflammatory-Defect-Pr/ArticleNewsFeed/Article/detail/824640",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Clinverse-Inc-Announces-Strategic-Partnership-with/ArticleStandard/Article/detail/822031?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Clinverse-Inc-Announces-Strategic-Partnership-with/ArticleStandard/Article/detail/822031",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/Academic-Medical-Centers-Can-Tackle-CTMS-Successfu/ArticleStandard/Article/detail/821771?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/Academic-Medical-Centers-Can-Tackle-CTMS-Successfu/ArticleStandard/Article/detail/821771",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Tafinlar-and-Mekinist-approved-in-Canada-for-metas/ArticleNewsFeed/Article/detail/818732?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Tafinlar-and-Mekinist-approved-in-Canada-for-metas/ArticleNewsFeed/Article/detail/818732",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/The-Changing-Landscape-of-Cardiometabolic-Risk-Inf/ArticleNewsFeed/Article/detail/824123?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/The-Changing-Landscape-of-Cardiometabolic-Risk-Inf/ArticleNewsFeed/Article/detail/824123",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Genalyte-And-Barbara-Davis-Diabetes-Center-Collabo/ArticleNewsFeed/Article/detail/820526?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Genalyte-And-Barbara-Davis-Diabetes-Center-Collabo/ArticleNewsFeed/Article/detail/820526",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Neuralstem-CEO-To-Present-At-Stem-Cells-amp-Regene/ArticleNewsFeed/Article/detail/824038?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Neuralstem-CEO-To-Present-At-Stem-Cells-amp-Regene/ArticleNewsFeed/Article/detail/824038",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Virtify-Partners-with-Forte-Research-Systems-to-Op/ArticleStandard/Article/detail/823938?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Virtify-Partners-with-Forte-Research-Systems-to-Op/ArticleStandard/Article/detail/823938",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Applied-Proteomics-Inc-Collaborates-With-German-Ca/ArticleNewsFeed/Article/detail/825247?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Applied-Proteomics-Inc-Collaborates-With-German-Ca/ArticleNewsFeed/Article/detail/825247",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Data-Show-Sanofis-Lyxumia-Added-to-Basal-Insulin-L/ArticleNewsFeed/Article/detail/823768?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Data-Show-Sanofis-Lyxumia-Added-to-Basal-Insulin-L/ArticleNewsFeed/Article/detail/823768",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/European-Patent-Office-Grants-a-Patent-for-the-Tre/ArticleNewsFeed/Article/detail/821959?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/European-Patent-Office-Grants-a-Patent-for-the-Tre/ArticleNewsFeed/Article/detail/821959",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/HuREL-Enters-Into-Cell-Based-RampD-Collaboration-W/ArticleNewsFeed/Article/detail/824466?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/HuREL-Enters-Into-Cell-Based-RampD-Collaboration-W/ArticleNewsFeed/Article/detail/824466",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ViroPharma-Provides-Update-On-Phase-2-Clinical-Eva/ArticleNewsFeed/Article/detail/819444?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ViroPharma-Provides-Update-On-Phase-2-Clinical-Eva/ArticleNewsFeed/Article/detail/819444",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Trial+Design+Articles/RBM-in-Late-Phase/ArticleStandard/Article/detail/820667?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Trial+Design+Articles/RBM-in-Late-Phase/ArticleStandard/Article/detail/820667",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Alcon-Canada-receives-approval-for-JETREA-ocriplas/ArticleNewsFeed/Article/detail/820627?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Alcon-Canada-receives-approval-for-JETREA-ocriplas/ArticleNewsFeed/Article/detail/820627",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cellular-Biomedicine-Group-Announces-Positive-Inte/ArticleNewsFeed/Article/detail/822293?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cellular-Biomedicine-Group-Announces-Positive-Inte/ArticleNewsFeed/Article/detail/822293",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Helsinn-to-Launch-Sales-Organization-in-the-United/ArticleNewsFeed/Article/detail/824467?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Helsinn-to-Launch-Sales-Organization-in-the-United/ArticleNewsFeed/Article/detail/824467",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Neuralstem-President-And-CEO-To-Present-At-The-201/ArticleNewsFeed/Article/detail/821908?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Neuralstem-President-And-CEO-To-Present-At-The-201/ArticleNewsFeed/Article/detail/821908",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Otonomy-Announces-Positive-Phase-1b-Results-for-OT/ArticleNewsFeed/Article/detail/820778?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Otonomy-Announces-Positive-Phase-1b-Results-for-OT/ArticleNewsFeed/Article/detail/820778",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/XBiotech-Announces-it-is-Developing-Therapy-for-MR/ArticleNewsFeed/Article/detail/822033?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/XBiotech-Announces-it-is-Developing-Therapy-for-MR/ArticleNewsFeed/Article/detail/822033",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/The-505b2-NDA-Leveraging-Other-Peoples-Data/ArticleStandard/Article/detail/824680?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Online+Extras/The-505b2-NDA-Leveraging-Other-Peoples-Data/ArticleStandard/Article/detail/824680",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Arisaph-Pharmaceuticals-Awarded-Phase-I-STTR-Grant/ArticleNewsFeed/Article/detail/819414?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Arisaph-Pharmaceuticals-Awarded-Phase-I-STTR-Grant/ArticleNewsFeed/Article/detail/819414",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Elseviers-Geofacets-Adds-More-Than-80000-Maps-in-C/ArticleNewsFeed/Article/detail/824468?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Elseviers-Geofacets-Adds-More-Than-80000-Maps-in-C/ArticleNewsFeed/Article/detail/824468",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Data-Suggests-Abbotts-High-Sensitive-Troponin-/ArticleNewsFeed/Article/detail/821981?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Data-Suggests-Abbotts-High-Sensitive-Troponin-/ArticleNewsFeed/Article/detail/821981",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Halozyme-to-Present-New-Data-on-PEGPH20-in-Pancrea/ArticleNewsFeed/Article/detail/822889?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Halozyme-to-Present-New-Data-on-PEGPH20-in-Pancrea/ArticleNewsFeed/Article/detail/822889",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Inovio-Pharmaceuticals-Targets-Transformation-of-M/ArticleNewsFeed/Article/detail/823767?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Inovio-Pharmaceuticals-Targets-Transformation-of-M/ArticleNewsFeed/Article/detail/823767",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/The-Role-of-Technology-in-Risk-Based-Monitoring/ArticleStandard/Article/detail/819367?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/The-Role-of-Technology-in-Risk-Based-Monitoring/ArticleStandard/Article/detail/819367",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/First-in-Class-Once-Daily-Dual-Bronchodilator-Ulti/ArticleNewsFeed/Article/detail/819044?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/First-in-Class-Once-Daily-Dual-Bronchodilator-Ulti/ArticleNewsFeed/Article/detail/819044",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Novoteris-LLC-Medical-Device-and-Pharmaceutical-Pr/ArticleNewsFeed/Article/detail/825245?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Novoteris-LLC-Medical-Device-and-Pharmaceutical-Pr/ArticleNewsFeed/Article/detail/825245",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/OncoGenex-Pharmaceuticals-Inc-Provides-Clinical-De/ArticleNewsFeed/Article/detail/820151?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/OncoGenex-Pharmaceuticals-Inc-Provides-Clinical-De/ArticleNewsFeed/Article/detail/820151",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Phase-III-Clinical-Study-Data-Demonstrating-LCP-Ta/ArticleNewsFeed/Article/detail/822006?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Phase-III-Clinical-Study-Data-Demonstrating-LCP-Ta/ArticleNewsFeed/Article/detail/822006",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/World-Molecular-Imaging-Congress-to-Feature-Scient/ArticleNewsFeed/Article/detail/821895?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/World-Molecular-Imaging-Congress-to-Feature-Scient/ArticleNewsFeed/Article/detail/821895",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Smart-Patients-Smarter-Trials/ArticleStandard/Article/detail/824864?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/Smart-Patients-Smarter-Trials/ArticleStandard/Article/detail/824864",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Gene-Test-Highly-Accurate-in-Predicting-Metastasis/ArticleNewsFeed/Article/detail/818808?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Gene-Test-Highly-Accurate-in-Predicting-Metastasis/ArticleNewsFeed/Article/detail/818808",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Germanys-IQWiG-Confirms-That-ThromboGenics-JETREA-/ArticleNewsFeed/Article/detail/819554?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Germanys-IQWiG-Confirms-That-ThromboGenics-JETREA-/ArticleNewsFeed/Article/detail/819554",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/GW-Pharmaceuticals-Announces-Results-of-MS-Spastic/ArticleNewsFeed/Article/detail/819672?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/GW-Pharmaceuticals-Announces-Results-of-MS-Spastic/ArticleNewsFeed/Article/detail/819672",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/OphthaliX-to-Present-at-the-Ophthalmology-Futures-/ArticleNewsFeed/Article/detail/824673?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/OphthaliX-to-Present-at-the-Ophthalmology-Futures-/ArticleNewsFeed/Article/detail/824673",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Unique-New-PIR-Knee-System-Receives-CE-Mark/ArticleNewsFeed/Article/detail/822458?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Unique-New-PIR-Knee-System-Receives-CE-Mark/ArticleNewsFeed/Article/detail/822458",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Covance-and-the-Indiana-Clinical-and-Translational/ArticleStandard/Article/detail/822026?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Covance-and-the-Indiana-Clinical-and-Translational/ArticleStandard/Article/detail/822026",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Aeterna-Zentaris-to-Raise-US78-Million-in-Register/ArticleNewsFeed/Article/detail/818881?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Aeterna-Zentaris-to-Raise-US78-Million-in-Register/ArticleNewsFeed/Article/detail/818881",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ARRY-502-Meets-Primary-And-Key-Secondary-Endpoints/ArticleNewsFeed/Article/detail/818557?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ARRY-502-Meets-Primary-And-Key-Secondary-Endpoints/ArticleNewsFeed/Article/detail/818557",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Case-Report-Suggests-Microbiome-Therapeutics-NM504/ArticleNewsFeed/Article/detail/822652?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Case-Report-Suggests-Microbiome-Therapeutics-NM504/ArticleNewsFeed/Article/detail/822652",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cohera-Medical-Completes-Sylys-Surgical-Sealant-Cl/ArticleNewsFeed/Article/detail/821888?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cohera-Medical-Completes-Sylys-Surgical-Sealant-Cl/ArticleNewsFeed/Article/detail/821888",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Imprimis-Pharmaceuticals-Inc-Comments-on-Delay-in-/ArticleNewsFeed/Article/detail/820275?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Imprimis-Pharmaceuticals-Inc-Comments-on-Delay-in-/ArticleNewsFeed/Article/detail/820275",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Study-Shows-Circulating-Tumor-Cell-Enumeration/ArticleNewsFeed/Article/detail/824264?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Study-Shows-Circulating-Tumor-Cell-Enumeration/ArticleNewsFeed/Article/detail/824264",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Nuvo-Research-announces-update-to-Pennsaid-2-Compl/ArticleNewsFeed/Article/detail/818558?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Nuvo-Research-announces-update-to-Pennsaid-2-Compl/ArticleNewsFeed/Article/detail/818558",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oramed-Submits-Pre-IND-Meeting-Request-to-FDA-for-/ArticleNewsFeed/Article/detail/819187?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oramed-Submits-Pre-IND-Meeting-Request-to-FDA-for-/ArticleNewsFeed/Article/detail/819187",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Trial+Design+Articles/Risk-Based-Approaches/ArticleStandard/Article/detail/820668?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Trial+Design+Articles/Risk-Based-Approaches/ArticleStandard/Article/detail/820668",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ELIMOX---Partners-Start-Drug-Development-in-Hypero/ArticleNewsFeed/Article/detail/824698?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ELIMOX---Partners-Start-Drug-Development-in-Hypero/ArticleNewsFeed/Article/detail/824698",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Halozyme-Presents-PEGPH20-Phase-1b-Clinical-Trial-/ArticleNewsFeed/Article/detail/824302?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Halozyme-Presents-PEGPH20-Phase-1b-Clinical-Trial-/ArticleNewsFeed/Article/detail/824302",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Data+Analysis/Oncology-Subject-Recruitment-Trending-Down-in-All-/ArticleStandard/Article/detail/821214?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Data+Analysis/Oncology-Subject-Recruitment-Trending-Down-in-All-/ArticleStandard/Article/detail/821214",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lilly-Announces-Phase-III-Necitumumab-Study-Meets-/ArticleNewsFeed/Article/detail/820352?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Lilly-Announces-Phase-III-Necitumumab-Study-Meets-/ArticleNewsFeed/Article/detail/820352",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Research-Uses-Ethical-Stem-Cells-to-Create-Liv/ArticleNewsFeed/Article/detail/819375?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/New-Research-Uses-Ethical-Stem-Cells-to-Create-Liv/ArticleNewsFeed/Article/detail/819375",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oramed-Granted-Patents-in-Japan-and-Canada-for-its/ArticleNewsFeed/Article/detail/824853?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Oramed-Granted-Patents-in-Japan-and-Canada-for-its/ArticleNewsFeed/Article/detail/824853",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Results-of-First-Multi-Center-Trial-of-NovoTTF-The/ArticleNewsFeed/Article/detail/821996?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Results-of-First-Multi-Center-Trial-of-NovoTTF-The/ArticleNewsFeed/Article/detail/821996",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Trovagene-collaborates-with-USC-in-clinical-study-/ArticleNewsFeed/Article/detail/822287?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Trovagene-collaborates-with-USC-in-clinical-study-/ArticleNewsFeed/Article/detail/822287",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioCer-Present-Newly-EU-Approved-Super-Rapid-Plant/ArticleNewsFeed/Article/detail/823810?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/BioCer-Present-Newly-EU-Approved-Super-Rapid-Plant/ArticleNewsFeed/Article/detail/823810",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Experimental-Therapeutics-Centre-and-Debiopharm-Gr/ArticleNewsFeed/Article/detail/825015?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Experimental-Therapeutics-Centre-and-Debiopharm-Gr/ArticleNewsFeed/Article/detail/825015",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Health-Robotics-Releases-ivSTATIONs-63-Annual-Savi/ArticleNewsFeed/Article/detail/822388?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Health-Robotics-Releases-ivSTATIONs-63-Annual-Savi/ArticleNewsFeed/Article/detail/822388",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Sanofi-Pasteurs-Fluzone-High-Dose-Vaccine-Signific/ArticleNewsFeed/Article/detail/821187?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Sanofi-Pasteurs-Fluzone-High-Dose-Vaccine-Signific/ArticleNewsFeed/Article/detail/821187",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Covance-Launches-External-Laboratory-Management-Se/ArticleStandard/Article/detail/823955?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/Covance-Launches-External-Laboratory-Management-Se/ArticleStandard/Article/detail/823955",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/New-Research-Triangle-Company-Provides-Innovative-/ArticleStandard/Article/detail/824056?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/News/New-Research-Triangle-Company-Provides-Innovative-/ArticleStandard/Article/detail/824056",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/American-Society-of-Hematology-Awards-Additional-G/ArticleNewsFeed/Article/detail/820440?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/American-Society-of-Hematology-Awards-Additional-G/ArticleNewsFeed/Article/detail/820440",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Data-Published-in-the-New-England-Journal-of-Medic/ArticleNewsFeed/Article/detail/820942?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Data-Published-in-the-New-England-Journal-of-Medic/ArticleNewsFeed/Article/detail/820942",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Janssen-RampD-Ireland-Announces-Agreement-with-PAT/ArticleNewsFeed/Article/detail/823884?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Janssen-RampD-Ireland-Announces-Agreement-with-PAT/ArticleNewsFeed/Article/detail/823884",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/NovelMeds-Anti-Complement-Antibody-Demonstrates-Ef/ArticleNewsFeed/Article/detail/823919?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/NovelMeds-Anti-Complement-Antibody-Demonstrates-Ef/ArticleNewsFeed/Article/detail/823919",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/University-Of-Michigan-Health-System-Treats-Its-Fi/ArticleNewsFeed/Article/detail/825263?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/University-Of-Michigan-Health-System-Treats-Its-Fi/ArticleNewsFeed/Article/detail/825263",
		"http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Warnings-for-Hepatitis-B-Reactivation-in-Cancer-Pa/ArticleNewsFeed/Article/detail/824408?ref=25": "http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Warnings-for-Hepatitis-B-Reactivation-in-Cancer-Pa/ArticleNewsFeed/Article/detail/824408",
	}
	testURLs(t, urls)
}
func Test_akamai_infoworld_com(t *testing.T) {
	urls := map[string]string{
		"http://akamai.infoworld.com/d/cloud-computing/microsoft-plans-changes-office-365-targeted-sharepoint-online-users-226267?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/microsoft-plans-changes-office-365-targeted-sharepoint-online-users-226267",
		"http://akamai.infoworld.com/d/data-center/hp-brings-converged-infrastructure-smarts-its-servers-227546?source=rss_data_center": "http://akamai.infoworld.com/d/data-center/hp-brings-converged-infrastructure-smarts-its-servers-227546",
		"http://akamai.infoworld.com/d/microsoft-windows/microsofts-app-gap-just-54-percent-of-the-top-100-apps-are-windows-8-224442?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/microsoft-windows/microsofts-app-gap-just-54-percent-of-the-top-100-apps-are-windows-8-224442",
		"http://akamai.infoworld.com/d/microsoft-windows/windows-server-2012-r2-and-azure-pack-work-better-together-226050?source=rss_cloud_computing": "http://akamai.infoworld.com/d/microsoft-windows/windows-server-2012-r2-and-azure-pack-work-better-together-226050",
		"http://akamai.infoworld.com/t/microsoft-windows/why-im-keeping-my-windows-xp-machine-223671?source=rss_computer_hardware": "http://akamai.infoworld.com/t/microsoft-windows/why-im-keeping-my-windows-xp-machine-223671",
		"http://akamai.infoworld.com/t/nosql/datastax-primps-cassandra-developers-223222?source=rss_open_source_software": "http://akamai.infoworld.com/t/nosql/datastax-primps-cassandra-developers-223222",
		"http://akamai.infoworld.com/t/technology-consulting/nsa-privacy-rule-violations-vastly-greater-believed-clash-tanks-dell-72-google-heisman-windows-phone-?source=rss_business_intelligence": "http://akamai.infoworld.com/t/technology-consulting/nsa-privacy-rule-violations-vastly-greater-believed-clash-tanks-dell-72-google-heisman-windows-phone-",
		"http://akamai.infoworld.com/d/business-intelligence/oracle-unveils-html5-based-mobile-bi-app-designer-225138?source=rss_business_intelligence": "http://akamai.infoworld.com/d/business-intelligence/oracle-unveils-html5-based-mobile-bi-app-designer-225138",
		"http://akamai.infoworld.com/t/data-security/tor-browser-bundle-windows-users-susceptible-info-stealing-attack-224157?source=rss_networking": "http://akamai.infoworld.com/t/data-security/tor-browser-bundle-windows-users-susceptible-info-stealing-attack-224157",
		"http://akamai.infoworld.com/d/mobile-technology/more-android-malware-distributed-through-mobile-ad-networks-224815?source=rss_security": "http://akamai.infoworld.com/d/mobile-technology/more-android-malware-distributed-through-mobile-ad-networks-224815",
		"http://akamai.infoworld.com/d/the-industry-standard/microsoft-ceo-steve-ballmer-retire-in-12-months-225486?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/microsoft-ceo-steve-ballmer-retire-in-12-months-225486",
		"http://akamai.infoworld.com/t/data-security/aarp-website-hacked-224206?source=rss_security": "http://akamai.infoworld.com/t/data-security/aarp-website-hacked-224206",
		"http://akamai.infoworld.com/d/cloud-computing/benioff-lays-out-salesforcecoms-future-strategies-225959?source=rss_applications": "http://akamai.infoworld.com/d/cloud-computing/benioff-lays-out-salesforcecoms-future-strategies-225959",
		"http://akamai.infoworld.com/d/virtualization/review-new-parallels-fusion-virtual-desktops-os-x-fail-the-smell-test-226160?source=rss_virtualization": "http://akamai.infoworld.com/d/virtualization/review-new-parallels-fusion-virtual-desktops-os-x-fail-the-smell-test-226160",
		"http://akamai.infoworld.com/t/microsoft-windows/acer-latest-tablet-maker-moving-away-the-windows-fold-224592?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/t/microsoft-windows/acer-latest-tablet-maker-moving-away-the-windows-fold-224592",
		"http://akamai.infoworld.com/d/data-center/zombie-scripts-can-attack-any-time-225426?source=rss_networking": "http://akamai.infoworld.com/d/data-center/zombie-scripts-can-attack-any-time-225426",
		"http://akamai.infoworld.com/d/security/google-bumps-browser-bug-bounty-224806?source=rss_security": "http://akamai.infoworld.com/d/security/google-bumps-browser-bug-bounty-224806",
		"http://akamai.infoworld.com/d/the-industry-standard/apple-acquisition-spree-continues-data-compression-firm-algotrim-225782?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/apple-acquisition-spree-continues-data-compression-firm-algotrim-225782",
		"http://akamai.infoworld.com/t/intellectual-property/microsoft-plus-nokia-pending-patent-troll-226057?source=rss_open_source_software": "http://akamai.infoworld.com/t/intellectual-property/microsoft-plus-nokia-pending-patent-troll-226057",
		"http://akamai.infoworld.com/t/technology-business/ballmer-fallout-pushed-nadella-next-chinas-largest-dos-attack-nosql-insecurity-new-google-dev-policy-ch?source=rss_business_intelligence": "http://akamai.infoworld.com/t/technology-business/ballmer-fallout-pushed-nadella-next-chinas-largest-dos-attack-nosql-insecurity-new-google-dev-policy-ch",
		"http://akamai.infoworld.com/d/virtualization/vmware-refreshes-workstation-10-windows-81-and-more-226332?source=rss_virtualization": "http://akamai.infoworld.com/d/virtualization/vmware-refreshes-workstation-10-windows-81-and-more-226332",
		"http://akamai.infoworld.com/d/data-center/review-chef-cooks-configuration-management-224178?source=rss_cloud_computing": "http://akamai.infoworld.com/d/data-center/review-chef-cooks-configuration-management-224178",
		"http://akamai.infoworld.com/d/mobile-technology/canonical-crowdfund-first-batch-of-ubuntu-edge-phones-223195?source=rss_open_source_software": "http://akamai.infoworld.com/d/mobile-technology/canonical-crowdfund-first-batch-of-ubuntu-edge-phones-223195",
		"http://akamai.infoworld.com/d/open-source-software/open-source-influence-sale-in-defense-of-sponsors-226773?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/open-source-influence-sale-in-defense-of-sponsors-226773",
		"http://akamai.infoworld.com/d/the-industry-standard/verizons-diabolical-plan-turn-the-web-pay-view-226662?source=rss_networking": "http://akamai.infoworld.com/d/the-industry-standard/verizons-diabolical-plan-turn-the-web-pay-view-226662",
		"http://akamai.infoworld.com/d/security/researchers-demo-exploits-bypass-windows-8-secure-boot-223980?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/security/researchers-demo-exploits-bypass-windows-8-secure-boot-223980",
		"http://akamai.infoworld.com/d/mobile-technology/finally-google-unveils-android-device-manager-protect-your-misplaced-phone-224097?source=rss_security": "http://akamai.infoworld.com/d/mobile-technology/finally-google-unveils-android-device-manager-protect-your-misplaced-phone-224097",
		"http://akamai.infoworld.com/d/open-source-software/in-their-own-words-unix-pioneers-remember-the-good-times-225113?source=rss_networking": "http://akamai.infoworld.com/d/open-source-software/in-their-own-words-unix-pioneers-remember-the-good-times-225113",
		"http://akamai.infoworld.com/t/technology-consulting/pirated-win81-in-the-wild-twitter-adds-conversations-view-google-agog-over-affairs-top-ios-app-publis?source=rss_business_intelligence": "http://akamai.infoworld.com/t/technology-consulting/pirated-win81-in-the-wild-twitter-adds-conversations-view-google-agog-over-affairs-top-ios-app-publis",
		"http://akamai.infoworld.com/d/applications/browser-based-ad-blockers-threaten-free-all-internet-225434?source=rss_applications": "http://akamai.infoworld.com/d/applications/browser-based-ad-blockers-threaten-free-all-internet-225434",
		"http://akamai.infoworld.com/d/cloud-computing/service-governance-morphs-cloud-api-management-209183?source=rss_enterprise_architecture": "http://akamai.infoworld.com/d/cloud-computing/service-governance-morphs-cloud-api-management-209183",
		"http://akamai.infoworld.com/d/computer-hardware/hefty-price-premium-awaits-early-ddr4-memory-adopters-227731?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/hefty-price-premium-awaits-early-ddr4-memory-adopters-227731",
		"http://akamai.infoworld.com/d/security/detect-the-undetectable-start-event-logs-224173?source=rss_data_center": "http://akamai.infoworld.com/d/security/detect-the-undetectable-start-event-logs-224173",
		"http://akamai.infoworld.com/d/storage/nand-flash-use-apples-buying-binge-slows-226915?source=rss_storage": "http://akamai.infoworld.com/d/storage/nand-flash-use-apples-buying-binge-slows-226915",
		"http://akamai.infoworld.com/d/the-industry-standard/android-product-head-hugo-barra-leave-google-225844?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/android-product-head-hugo-barra-leave-google-225844",
		"http://akamai.infoworld.com/d/the-industry-standard/ibm-acquire-endpoint-security-company-trusteer-224984?source=rss_security": "http://akamai.infoworld.com/d/the-industry-standard/ibm-acquire-endpoint-security-company-trusteer-224984",
		"http://akamai.infoworld.com/t/it-jobs/look-out-below-young-techie-coming-through-224258?source=rss_computer_hardware": "http://akamai.infoworld.com/t/it-jobs/look-out-below-young-techie-coming-through-224258",
		"http://akamai.infoworld.com/d/applications/after-getting-star-billing-oracles-fusion-applications-take-supporting-role-227853?source=rss_applications": "http://akamai.infoworld.com/d/applications/after-getting-star-billing-oracles-fusion-applications-take-supporting-role-227853",
		"http://akamai.infoworld.com/d/open-source-software/blackberry-and-nokia-the-perils-of-closed-strategy-227592?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/blackberry-and-nokia-the-perils-of-closed-strategy-227592",
		"http://akamai.infoworld.com/t/html5/mark-zuckerbergs-opinion-of-html5-meaningless-202460?source=rss_html5": "http://akamai.infoworld.com/t/html5/mark-zuckerbergs-opinion-of-html5-meaningless-202460",
		"http://akamai.infoworld.com/d/application-development/how-provision-users-in-cloud-world-227362?source=rss_computer_hardware": "http://akamai.infoworld.com/d/application-development/how-provision-users-in-cloud-world-227362",
		"http://akamai.infoworld.com/d/application-development/the-uss-crap-infrastructure-threatens-the-cloud-226917?source=rss_networking": "http://akamai.infoworld.com/d/application-development/the-uss-crap-infrastructure-threatens-the-cloud-226917",
		"http://akamai.infoworld.com/d/microsoft-windows/windows-azure-pack-cloud-app-convenience-meets-in-house-hosting-225705?source=rss_application_development": "http://akamai.infoworld.com/d/microsoft-windows/windows-azure-pack-cloud-app-convenience-meets-in-house-hosting-225705",
		"http://akamai.infoworld.com/d/security/google-pay-rewards-open-source-code-security-fixes-228536?source=rss_open_source_software": "http://akamai.infoworld.com/d/security/google-pay-rewards-open-source-code-security-fixes-228536",
		"http://akamai.infoworld.com/d/virtualization/hp-juniper-help-vmware-take-networks-nsx-225666?source=rss_networking": "http://akamai.infoworld.com/d/virtualization/hp-juniper-help-vmware-take-networks-nsx-225666",
		"http://akamai.infoworld.com/t/application-development/cello-could-be-music-the-ears-of-c-developers-222963?source=rss_application_development": "http://akamai.infoworld.com/t/application-development/cello-could-be-music-the-ears-of-c-developers-222963",
		"http://akamai.infoworld.com/d/mobile-technology/how-apple-could-make-truly-cheap-iphone-5c-223637?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/mobile-technology/how-apple-could-make-truly-cheap-iphone-5c-223637",
		"http://akamai.infoworld.com/d/security/5-reasons-im-not-too-upset-over-cryptogeddon-226431?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/security/5-reasons-im-not-too-upset-over-cryptogeddon-226431",
		"http://akamai.infoworld.com/t/cringely/no-winners-in-google-microsoft-spat-one-clear-loser-users-everywhere-225062?source=rss_mobile_technology": "http://akamai.infoworld.com/t/cringely/no-winners-in-google-microsoft-spat-one-clear-loser-users-everywhere-225062",
		"http://akamai.infoworld.com/t/desktop-macs/radical-ideas-new-macs-steve-jobs-returned-apple-225103?source=rss_computer_hardware": "http://akamai.infoworld.com/t/desktop-macs/radical-ideas-new-macs-steve-jobs-returned-apple-225103",
		"http://akamai.infoworld.com/d/applications/move-over-android-the-future-will-be-chrome-223630?source=rss_computer_hardware": "http://akamai.infoworld.com/d/applications/move-over-android-the-future-will-be-chrome-223630",
		"http://akamai.infoworld.com/d/consumerization-of-it/go-free-chat-disruptive-services-outrun-big-brother-225282?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/consumerization-of-it/go-free-chat-disruptive-services-outrun-big-brother-225282",
		"http://akamai.infoworld.com/d/data-center/restore-the-right-privacy-self-signed-certificates-226725?source=rss_data_center": "http://akamai.infoworld.com/d/data-center/restore-the-right-privacy-self-signed-certificates-226725",
		"http://akamai.infoworld.com/d/mobile-technology/smart-bins-spy-londoners-smartphones-224673?source=rss_security": "http://akamai.infoworld.com/d/mobile-technology/smart-bins-spy-londoners-smartphones-224673",
		"http://akamai.infoworld.com/t/cringely/hint-htc-iron-man-alone-wont-save-your-company-224721?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/t/cringely/hint-htc-iron-man-alone-wont-save-your-company-224721",
		"http://akamai.infoworld.com/d/mobile-technology/review-new-nexus-7-takes-ipad-mini-and-kindle-fire-hd-224483?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/mobile-technology/review-new-nexus-7-takes-ipad-mini-and-kindle-fire-hd-224483",
		"http://akamai.infoworld.com/t/data-center/understanding-the-software-defined-data-center-225652?source=rss_networking": "http://akamai.infoworld.com/t/data-center/understanding-the-software-defined-data-center-225652",
		"http://akamai.infoworld.com/t/processors/apples-64-bit-a7-no-gimmick-227390?source=rss_computer_hardware": "http://akamai.infoworld.com/t/processors/apples-64-bit-a7-no-gimmick-227390",
		"http://akamai.infoworld.com/d/applications/microsofts-skydrive-outlookcom-are-down-some-users-224940?source=rss_applications": "http://akamai.infoworld.com/d/applications/microsofts-skydrive-outlookcom-are-down-some-users-224940",
		"http://akamai.infoworld.com/d/consumerization-of-it/apples-next-revolution-may-be-bluetooth-powered-ibeacons-227574?source=rss_computer_hardware": "http://akamai.infoworld.com/d/consumerization-of-it/apples-next-revolution-may-be-bluetooth-powered-ibeacons-227574",
		"http://akamai.infoworld.com/d/data-center/no-google-fiber-doesnt-violate-net-neutrality-223828?source=rss_data_center": "http://akamai.infoworld.com/d/data-center/no-google-fiber-doesnt-violate-net-neutrality-223828",
		"http://akamai.infoworld.com/d/microsoft-windows/windows-81-rtm-leaks-internet-225889?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/microsoft-windows/windows-81-rtm-leaks-internet-225889",
		"http://akamai.infoworld.com/d/mobile-technology/blackberry-10s-flop-wont-help-windows-phone-222700?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/mobile-technology/blackberry-10s-flop-wont-help-windows-phone-222700",
		"http://akamai.infoworld.com/t/applications/processmaker-25-open-source-workflow-made-faster-simpler-225159?source=rss_applications": "http://akamai.infoworld.com/t/applications/processmaker-25-open-source-workflow-made-faster-simpler-225159",
		"http://akamai.infoworld.com/d/application-development/amazon-offers-mobile-developers-cross-platform-push-notifications-224814?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/amazon-offers-mobile-developers-cross-platform-push-notifications-224814",
		"http://akamai.infoworld.com/d/application-development/java-faces-tough-climb-catch-net-224372?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/application-development/java-faces-tough-climb-catch-net-224372",
		"http://akamai.infoworld.com/d/business-intelligence/sap-takes-the-fight-salesforcecom-oracle-social-intelligence-app-225286?source=rss_business_intelligence": "http://akamai.infoworld.com/d/business-intelligence/sap-takes-the-fight-salesforcecom-oracle-social-intelligence-app-225286",
		"http://akamai.infoworld.com/d/security/unisys-going-offense-in-server-and-security-markets-225586?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/security/unisys-going-offense-in-server-and-security-markets-225586",
		"http://akamai.infoworld.com/d/the-industry-standard/facebook-snatches-startup-monoidics-assets-support-mobile-apps-223024?source=rss_application_development": "http://akamai.infoworld.com/d/the-industry-standard/facebook-snatches-startup-monoidics-assets-support-mobile-apps-223024",
		"http://akamai.infoworld.com/t/technology-business/the-steve-jobs-story-you-should-see-isnt-told-in-jobs-225101?source=rss_the_industry_standard": "http://akamai.infoworld.com/t/technology-business/the-steve-jobs-story-you-should-see-isnt-told-in-jobs-225101",
		"http://akamai.infoworld.com/d/application-development/amazon-offers-mobile-developers-cross-platform-push-notifications-224814?source=rss_mobile_technology": "http://akamai.infoworld.com/d/application-development/amazon-offers-mobile-developers-cross-platform-push-notifications-224814",
		"http://akamai.infoworld.com/d/application-development/review-4-supercool-javascript-tools-data-visualization-227954?source=rss_open_source_software": "http://akamai.infoworld.com/d/application-development/review-4-supercool-javascript-tools-data-visualization-227954",
		"http://akamai.infoworld.com/d/mobile-technology/some-privacy-advocates-question-mobile-apps-agreement-223536?source=rss_application_development": "http://akamai.infoworld.com/d/mobile-technology/some-privacy-advocates-question-mobile-apps-agreement-223536",
		"http://akamai.infoworld.com/d/open-source-software/review-5-free-linux-text-editors-developer-could-love-223848?source=rss_application_development": "http://akamai.infoworld.com/d/open-source-software/review-5-free-linux-text-editors-developer-could-love-223848",
		"http://akamai.infoworld.com/d/the-industry-standard/china-prepares-stimulus-program-possibly-spark-pc-handset-sales-224888?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/china-prepares-stimulus-program-possibly-spark-pc-handset-sales-224888",
		"http://akamai.infoworld.com/d/the-industry-standard/state-dumping-ibm-after-it-project-runs-42-months-late-60-million-over-budget-223947?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/state-dumping-ibm-after-it-project-runs-42-months-late-60-million-over-budget-223947",
		"http://akamai.infoworld.com/d/application-development/diy-dev-should-you-build-your-own-app-225321?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/diy-dev-should-you-build-your-own-app-225321",
		"http://akamai.infoworld.com/d/cloud-computing/benioff-lays-out-salesforcecoms-future-strategies-225959?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/benioff-lays-out-salesforcecoms-future-strategies-225959",
		"http://akamai.infoworld.com/d/cloud-computing/defining-the-elusive-cloud-architect-207172?source=rss_enterprise_architecture": "http://akamai.infoworld.com/d/cloud-computing/defining-the-elusive-cloud-architect-207172",
		"http://akamai.infoworld.com/d/cloud-computing/google-relaxes-access-controls-apps-documents-228362?source=rss_applications": "http://akamai.infoworld.com/d/cloud-computing/google-relaxes-access-controls-apps-documents-228362",
		"http://akamai.infoworld.com/d/consumerization-of-it/9-dumb-differences-between-ios-and-os-x-apple-should-fix-227787?source=rss_applications": "http://akamai.infoworld.com/d/consumerization-of-it/9-dumb-differences-between-ios-and-os-x-apple-should-fix-227787",
		"http://akamai.infoworld.com/slideshow/115621/10-microscopic-devices-are-changing-our-world-225061?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/slideshow/115621/10-microscopic-devices-are-changing-our-world-225061",
		"http://akamai.infoworld.com/t/nosql/nosql-shadow-it-could-sink-you-208861?source=rss_enterprise_architecture": "http://akamai.infoworld.com/t/nosql/nosql-shadow-it-could-sink-you-208861",
		"http://akamai.infoworld.com/d/cloud-computing/if-ibm-cloud-washed-its-earnings-results-its-likely-not-alone-225192?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/if-ibm-cloud-washed-its-earnings-results-its-likely-not-alone-225192",
		"http://akamai.infoworld.com/d/data-explosion/whats-worse-system-failure-what-you-say-about-it-224751?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/data-explosion/whats-worse-system-failure-what-you-say-about-it-224751",
		"http://akamai.infoworld.com/d/security/larry-ellison-some-government-surveillance-essential-fight-terror-224808?source=rss_security": "http://akamai.infoworld.com/d/security/larry-ellison-some-government-surveillance-essential-fight-terror-224808",
		"http://akamai.infoworld.com/d/virtualization/review-vmware-workstation-10-turns-tablets-226573?source=rss_mobile_technology": "http://akamai.infoworld.com/d/virtualization/review-vmware-workstation-10-turns-tablets-226573",
		"http://akamai.infoworld.com/node/224212?source=rss_cloud_computing": "http://akamai.infoworld.com/node/224212",
		"http://akamai.infoworld.com/d/security/anonymous-not-anonymous-224783?source=rss_security": "http://akamai.infoworld.com/d/security/anonymous-not-anonymous-224783",
		"http://akamai.infoworld.com/d/open-source-software/free-unix-the-world-changing-proclamation-made-30-years-ago-today-227766?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/free-unix-the-world-changing-proclamation-made-30-years-ago-today-227766",
		"http://akamai.infoworld.com/t/storage/video-cloud-storage-the-openstack-way-revealed-227840?source=rss_storage": "http://akamai.infoworld.com/t/storage/video-cloud-storage-the-openstack-way-revealed-227840",
		"http://akamai.infoworld.com/d/data-center/it-projects-should-start-it-people-213314?source=rss_enterprise_architecture": "http://akamai.infoworld.com/d/data-center/it-projects-should-start-it-people-213314",
		"http://akamai.infoworld.com/t/java-programming/java-tops-c-most-popular-language-in-developer-index-224781?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/t/java-programming/java-tops-c-most-popular-language-in-developer-index-224781",
		"http://akamai.infoworld.com/d/application-development/want-app-go-rad-studio-dev-tool-now-supports-android-ios-226647?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/want-app-go-rad-studio-dev-tool-now-supports-android-ios-226647",
		"http://akamai.infoworld.com/d/applications/codependent-no-more-onenote-ipad-liberated-desktop-app-226304?source=rss_mobile_technology": "http://akamai.infoworld.com/d/applications/codependent-no-more-onenote-ipad-liberated-desktop-app-226304",
		"http://akamai.infoworld.com/d/microsoft-windows/could-surface-rt-2-be-the-windows-tablet-weve-been-waiting-224844?source=rss_mobile_technology": "http://akamai.infoworld.com/d/microsoft-windows/could-surface-rt-2-be-the-windows-tablet-weve-been-waiting-224844",
		"http://akamai.infoworld.com/d/mobile-technology/google-blocks-microsofts-youtube-app-windows-phone-again-225045?source=rss_mobile_technology": "http://akamai.infoworld.com/d/mobile-technology/google-blocks-microsofts-youtube-app-windows-phone-again-225045",
		"http://akamai.infoworld.com/d/security/bitcoin-wallets-android-risk-of-theft-developers-say-224676?source=rss_security": "http://akamai.infoworld.com/d/security/bitcoin-wallets-android-risk-of-theft-developers-say-224676",
		"http://akamai.infoworld.com/t/open-source-software/open-source-races-the-top-223569?source=rss_open_source_software": "http://akamai.infoworld.com/t/open-source-software/open-source-races-the-top-223569",
		"http://akamai.infoworld.com/d/microsoft-windows/windows-server-2012-r2-kicks-hyper-v-another-notch-225288?source=rss_virtualization": "http://akamai.infoworld.com/d/microsoft-windows/windows-server-2012-r2-kicks-hyper-v-another-notch-225288",
		"http://akamai.infoworld.com/d/mobile-technology/moto-x-motorolas-chance-break-free-of-the-middle-223325?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/mobile-technology/moto-x-motorolas-chance-break-free-of-the-middle-223325",
		"http://akamai.infoworld.com/d/mobile-technology/salesforcecom-mobile-app-developers-gain-security-tools-225935?source=rss_application_development": "http://akamai.infoworld.com/d/mobile-technology/salesforcecom-mobile-app-developers-gain-security-tools-225935",
		"http://akamai.infoworld.com/t/startups/are-we-in-enterprise-startup-bubble-223138?source=rss_open_source_software": "http://akamai.infoworld.com/t/startups/are-we-in-enterprise-startup-bubble-223138",
		"http://akamai.infoworld.com/node/224662?source=rss_cloud_computing": "http://akamai.infoworld.com/node/224662",
		"http://akamai.infoworld.com/t/smartphones/mark-shuttleworth-takes-his-case-the-ubuntu-edge-reddit-223487?source=rss_open_source_software": "http://akamai.infoworld.com/t/smartphones/mark-shuttleworth-takes-his-case-the-ubuntu-edge-reddit-223487",
		"http://akamai.infoworld.com/d/application-development/the-10-hottest-javascript-framework-projects-228335?source=rss_open_source_software": "http://akamai.infoworld.com/d/application-development/the-10-hottest-javascript-framework-projects-228335",
		"http://akamai.infoworld.com/node/224397?source=rss_cloud_computing": "http://akamai.infoworld.com/node/224397",
		"http://akamai.infoworld.com/slideshow/117202/12-terrific-new-updates-in-vmware-vsphere-55-225744?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/slideshow/117202/12-terrific-new-updates-in-vmware-vsphere-55-225744",
		"http://akamai.infoworld.com/t/applications/the-devil-in-the-subscription-licensing-details-224737?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/t/applications/the-devil-in-the-subscription-licensing-details-224737",
		"http://akamai.infoworld.com/t/web-development/internet-explorer-takes-the-lead-most-error-prone-browser-225212?source=rss_application_development": "http://akamai.infoworld.com/t/web-development/internet-explorer-takes-the-lead-most-error-prone-browser-225212",
		"http://akamai.infoworld.com/d/applications/heavy-traffic-hampers-healthcare-exchanges-227979?source=rss_applications": "http://akamai.infoworld.com/d/applications/heavy-traffic-hampers-healthcare-exchanges-227979",
		"http://akamai.infoworld.com/d/cloud-computing/using-private-clouds-all-the-right-reasons-226204?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/using-private-clouds-all-the-right-reasons-226204",
		"http://akamai.infoworld.com/d/microsoft-windows/its-time-give-bing-the-respect-it-deserves-227473?source=rss_applications": "http://akamai.infoworld.com/d/microsoft-windows/its-time-give-bing-the-respect-it-deserves-227473",
		"http://akamai.infoworld.com/d/the-industry-standard/the-surface-fiasco-fallout-ballmer-youre-fired-223821?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/the-industry-standard/the-surface-fiasco-fallout-ballmer-youre-fired-223821",
		"http://akamai.infoworld.com/d/the-industry-standard/cisco-invests-10-million-in-log-management-startup-loggly-226091?source=rss_cloud_computing": "http://akamai.infoworld.com/d/the-industry-standard/cisco-invests-10-million-in-log-management-startup-loggly-226091",
		"http://akamai.infoworld.com/t/paas/ibm-support-cloud-foundry-stands-benefit-openstack-java-too-223331?source=rss_open_source_software": "http://akamai.infoworld.com/t/paas/ibm-support-cloud-foundry-stands-benefit-openstack-java-too-223331",
		"http://akamai.infoworld.com/d/data-explosion/7-simple-rules-better-systems-testing-227834?source=rss_data_center": "http://akamai.infoworld.com/d/data-explosion/7-simple-rules-better-systems-testing-227834",
		"http://akamai.infoworld.com/d/mobile-technology/moto-x-refines-usability-otherwise-just-another-smartphone-223952?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/mobile-technology/moto-x-refines-usability-otherwise-just-another-smartphone-223952",
		"http://akamai.infoworld.com/d/application-development/microsoft-updates-windows-phone-app-studio-after-developer-projects-soar-225231?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/microsoft-updates-windows-phone-app-studio-after-developer-projects-soar-225231",
		"http://akamai.infoworld.com/t/big-data/joyent-cto-how-big-data-platforms-should-work-224299?source=rss_storage": "http://akamai.infoworld.com/t/big-data/joyent-cto-how-big-data-platforms-should-work-224299",
		"http://akamai.infoworld.com/t/desktop-macs/radical-ideas-new-macs-steve-jobs-returned-apple-225103?source=rss_the_industry_standard": "http://akamai.infoworld.com/t/desktop-macs/radical-ideas-new-macs-steve-jobs-returned-apple-225103",
		"http://akamai.infoworld.com/d/cloud-computing/happy-birthday-openstack-dont-get-too-comfortable-223212?source=rss_open_source_software": "http://akamai.infoworld.com/d/cloud-computing/happy-birthday-openstack-dont-get-too-comfortable-223212",
		"http://akamai.infoworld.com/d/consumerization-of-it/it-no-show-when-it-comes-mobile-apps-223926?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/consumerization-of-it/it-no-show-when-it-comes-mobile-apps-223926",
		"http://akamai.infoworld.com/d/microsoft-windows/microsoft-releases-windows-81-enterprise-preview-vdi-windows-go-support-223784?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/microsoft-windows/microsoft-releases-windows-81-enterprise-preview-vdi-windows-go-support-223784",
		"http://akamai.infoworld.com/d/mobile-technology/mobile-apps-death-wish-221904?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/mobile-technology/mobile-apps-death-wish-221904",
		"http://akamai.infoworld.com/d/security/5-security-best-practices-your-business-222961?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/security/5-security-best-practices-your-business-222961",
		"http://akamai.infoworld.com/d/virtualization/review-vmware-workstation-10-turns-tablets-226573?source=rss_virtualization": "http://akamai.infoworld.com/d/virtualization/review-vmware-workstation-10-turns-tablets-226573",
		"http://akamai.infoworld.com/d/application-development/beginners-guide-r-introduction-225210?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/beginners-guide-r-introduction-225210",
		"http://akamai.infoworld.com/d/consumerization-of-it/apples-next-revolution-may-be-bluetooth-powered-ibeacons-227574?source=rss_networking": "http://akamai.infoworld.com/d/consumerization-of-it/apples-next-revolution-may-be-bluetooth-powered-ibeacons-227574",
		"http://akamai.infoworld.com/d/mobile-technology/heed-these-10-expert-tips-mobile-app-design-227481?source=rss_applications": "http://akamai.infoworld.com/d/mobile-technology/heed-these-10-expert-tips-mobile-app-design-227481",
		"http://akamai.infoworld.com/d/the-industry-standard/blackberrys-bleak-options-will-anyone-really-want-buy-it-224782?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/blackberrys-bleak-options-will-anyone-really-want-buy-it-224782",
		"http://akamai.infoworld.com/d/security/detect-the-undetectable-start-event-logs-224173?source=rss_security": "http://akamai.infoworld.com/d/security/detect-the-undetectable-start-event-logs-224173",
		"http://akamai.infoworld.com/d/the-industry-standard/microsoft-who-sinofsky-adds-another-scene-his-second-act-signs-box-225888?source=rss_cloud_computing": "http://akamai.infoworld.com/d/the-industry-standard/microsoft-who-sinofsky-adds-another-scene-his-second-act-signs-box-225888",
		"http://akamai.infoworld.com/d/the-industry-standard/nbc-news-buys-stringwire-smartphone-streaming-video-service-224743?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/nbc-news-buys-stringwire-smartphone-streaming-video-service-224743",
		"http://akamai.infoworld.com/t/applications/bmc-buys-partnerpedia-secure-app-store-technology-224204?source=rss_the_industry_standard": "http://akamai.infoworld.com/t/applications/bmc-buys-partnerpedia-secure-app-store-technology-224204",
		"http://akamai.infoworld.com/d/consumerization-of-it/apple-google-or-microsoft-your-platform-will-dictate-your-office-app-226213?source=rss_applications": "http://akamai.infoworld.com/d/consumerization-of-it/apple-google-or-microsoft-your-platform-will-dictate-your-office-app-226213",
		"http://akamai.infoworld.com/d/data-explosion/the-modern-data-centers-hidden-risks-2-key-lessons-222075?source=rss_data_center": "http://akamai.infoworld.com/d/data-explosion/the-modern-data-centers-hidden-risks-2-key-lessons-222075",
		"http://akamai.infoworld.com/d/mobile-technology/the-iphone-5s-fingerprint-reader-what-you-need-know-226695?source=rss_mobile_technology": "http://akamai.infoworld.com/d/mobile-technology/the-iphone-5s-fingerprint-reader-what-you-need-know-226695",
		"http://akamai.infoworld.com/d/cloud-computing/box-swivels-small-businesses-new-subscription-plan-225346?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/box-swivels-small-businesses-new-subscription-plan-225346",
		"http://akamai.infoworld.com/d/mobile-technology/new-iphones-help-lay-groundwork-global-lte-roaming-226717?source=rss_mobile_technology": "http://akamai.infoworld.com/d/mobile-technology/new-iphones-help-lay-groundwork-global-lte-roaming-226717",
		"http://akamai.infoworld.com/d/mobile-technology/official-youtube-app-back-in-windows-phone-store-224891?source=rss_mobile_technology": "http://akamai.infoworld.com/d/mobile-technology/official-youtube-app-back-in-windows-phone-store-224891",
		"http://akamai.infoworld.com/d/mobile-technology/parallels-access-shows-why-ipad-poor-pc-or-mac-225833?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/mobile-technology/parallels-access-shows-why-ipad-poor-pc-or-mac-225833",
		"http://akamai.infoworld.com/d/mobile-technology/review-acer-iconia-w3-810-too-little-too-lame-225819?source=rss_computer_hardware": "http://akamai.infoworld.com/d/mobile-technology/review-acer-iconia-w3-810-too-little-too-lame-225819",
		"http://akamai.infoworld.com/d/open-source-software/percona-challenges-oracle-alternate-mysql-release-228630?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/percona-challenges-oracle-alternate-mysql-release-228630",
		"http://akamai.infoworld.com/d/security/startup-defensenet-debuts-anti-ddos-service-224221?source=rss_cloud_computing": "http://akamai.infoworld.com/d/security/startup-defensenet-debuts-anti-ddos-service-224221",
		"http://akamai.infoworld.com/d/cloud-computing/cache-warfare-azure-and-aws-get-updated-caching-services-226167?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/cache-warfare-azure-and-aws-get-updated-caching-services-226167",
		"http://akamai.infoworld.com/d/mobile-technology/wireless-charging-30-feet-away-does-startup-have-game-changer-226538?source=rss_mobile_technology": "http://akamai.infoworld.com/d/mobile-technology/wireless-charging-30-feet-away-does-startup-have-game-changer-226538",
		"http://akamai.infoworld.com/d/the-industry-standard/facebook-and-infosys-working-hard-perpetuate-h-1b-hypocrisy-224422?source=rss_application_development": "http://akamai.infoworld.com/d/the-industry-standard/facebook-and-infosys-working-hard-perpetuate-h-1b-hypocrisy-224422",
		"http://akamai.infoworld.com/d/virtualization/oracles-next-engineered-system-involve-virtualization-223808?source=rss_computer_hardware": "http://akamai.infoworld.com/d/virtualization/oracles-next-engineered-system-involve-virtualization-223808",
		"http://akamai.infoworld.com/d/application-development/facebook-invents-php-virtual-machine-223555?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/facebook-invents-php-virtual-machine-223555",
		"http://akamai.infoworld.com/d/applications/get-know-google-introduction-223679?source=rss_applications": "http://akamai.infoworld.com/d/applications/get-know-google-introduction-223679",
		"http://akamai.infoworld.com/d/applications/review-apache-openoffice-4-vs-libreoffice-41-224280?source=rss_applications": "http://akamai.infoworld.com/d/applications/review-apache-openoffice-4-vs-libreoffice-41-224280",
		"http://akamai.infoworld.com/d/data-center/intel-partners-startup-tools-app-level-energy-management-227798?source=rss_data_center": "http://akamai.infoworld.com/d/data-center/intel-partners-startup-tools-app-level-energy-management-227798",
		"http://akamai.infoworld.com/d/microsoft-windows/windows-server-2012-r2-kicks-hyper-v-another-notch-225288?source=rss_networking": "http://akamai.infoworld.com/d/microsoft-windows/windows-server-2012-r2-kicks-hyper-v-another-notch-225288",
		"http://akamai.infoworld.com/d/mobile-technology/review-new-nexus-7-takes-ipad-mini-and-kindle-fire-hd-224483?source=rss_mobile_technology": "http://akamai.infoworld.com/d/mobile-technology/review-new-nexus-7-takes-ipad-mini-and-kindle-fire-hd-224483",
		"http://akamai.infoworld.com/d/applications/mozilla-ship-metro-ized-firefox-dec-10-225067?source=rss_applications": "http://akamai.infoworld.com/d/applications/mozilla-ship-metro-ized-firefox-dec-10-225067",
		"http://akamai.infoworld.com/d/microsoft-windows/windows-azure-pack-cloud-app-convenience-meets-in-house-hosting-225705?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/microsoft-windows/windows-azure-pack-cloud-app-convenience-meets-in-house-hosting-225705",
		"http://akamai.infoworld.com/d/security/microsoft-pays-out-28k-ie-bug-hunters-in-its-first-ever-bounty-program-228326?source=rss_applications": "http://akamai.infoworld.com/d/security/microsoft-pays-out-28k-ie-bug-hunters-in-its-first-ever-bounty-program-228326",
		"http://akamai.infoworld.com/d/the-industry-standard/blackberry-reportedly-plans-spin-of-instant-messaging-software-225736?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/blackberry-reportedly-plans-spin-of-instant-messaging-software-225736",
		"http://akamai.infoworld.com/t/cloud-computing/openstack-turns-the-heat-216920?source=rss_enterprise_architecture": "http://akamai.infoworld.com/t/cloud-computing/openstack-turns-the-heat-216920",
		"http://akamai.infoworld.com/t/computer-memory/startup-crossbar-pits-rram-against-dram-and-flash-storage-224099?source=rss_storage": "http://akamai.infoworld.com/t/computer-memory/startup-crossbar-pits-rram-against-dram-and-flash-storage-224099",
		"http://akamai.infoworld.com/d/consumerization-of-it/the-wireless-revolutions-forgotten-victim-the-phone-itself-225797?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/consumerization-of-it/the-wireless-revolutions-forgotten-victim-the-phone-itself-225797",
		"http://akamai.infoworld.com/d/open-source-software/7-ways-your-company-can-support-open-source-227212?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/7-ways-your-company-can-support-open-source-227212",
		"http://akamai.infoworld.com/d/open-source-software/linus-torvalds-announces-linux-311-release-nostalgic-message-225581?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/linus-torvalds-announces-linux-311-release-nostalgic-message-225581",
		"http://akamai.infoworld.com/d/storage/ssd-shipments-skyrocketed-in-the-first-quarter-of-2013-224464?source=rss_storage": "http://akamai.infoworld.com/d/storage/ssd-shipments-skyrocketed-in-the-first-quarter-of-2013-224464",
		"http://akamai.infoworld.com/d/data-explosion/twist-cloud-backup-protecting-your-data-you-223080?source=rss_storage": "http://akamai.infoworld.com/d/data-explosion/twist-cloud-backup-protecting-your-data-you-223080",
		"http://akamai.infoworld.com/t/it-jobs/cut-throat-culture-sinks-it-project-212706?source=rss_enterprise_architecture": "http://akamai.infoworld.com/t/it-jobs/cut-throat-culture-sinks-it-project-212706",
		"http://akamai.infoworld.com/d/application-development/in-defense-of-apache-225555?source=rss_open_source_software": "http://akamai.infoworld.com/d/application-development/in-defense-of-apache-225555",
		"http://akamai.infoworld.com/d/networking/sdn-the-security-pros-and-cons-of-using-it-in-your-organization-228384?source=rss_networking": "http://akamai.infoworld.com/d/networking/sdn-the-security-pros-and-cons-of-using-it-in-your-organization-228384",
		"http://akamai.infoworld.com/d/applications/hp-equips-worksite-file-sharing-service-225289?source=rss_cloud_computing": "http://akamai.infoworld.com/d/applications/hp-equips-worksite-file-sharing-service-225289",
		"http://akamai.infoworld.com/d/the-industry-standard/whose-self-driving-car-will-you-trust-google-or-the-automakers-225799?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/whose-self-driving-car-will-you-trust-google-or-the-automakers-225799",
		"http://akamai.infoworld.com/d/mobile-technology/windows-rt-arm-chips-not-promising-asus-exec-says-223702?source=rss_computer_hardware": "http://akamai.infoworld.com/d/mobile-technology/windows-rt-arm-chips-not-promising-asus-exec-says-223702",
		"http://akamai.infoworld.com/t/data-security/lavabit-founder-says-he-cant-legally-explain-why-he-shut-down-email-service-224924?source=rss_security": "http://akamai.infoworld.com/t/data-security/lavabit-founder-says-he-cant-legally-explain-why-he-shut-down-email-service-224924",
		"http://akamai.infoworld.com/t/microsoft-windows/leaked-windows-81-build-9471-surprises-disappoints-224715?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/t/microsoft-windows/leaked-windows-81-build-9471-surprises-disappoints-224715",
		"http://akamai.infoworld.com/d/computer-hardware/windows-81-wont-rescue-pc-market-year-idc-says-225910?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/windows-81-wont-rescue-pc-market-year-idc-says-225910",
		"http://akamai.infoworld.com/d/consumerization-of-it/go-free-chat-disruptive-services-outrun-big-brother-225282?source=rss_networking": "http://akamai.infoworld.com/d/consumerization-of-it/go-free-chat-disruptive-services-outrun-big-brother-225282",
		"http://akamai.infoworld.com/d/open-source-software/nginx-takes-the-slippery-road-away-open-source-225473?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/nginx-takes-the-slippery-road-away-open-source-225473",
		"http://akamai.infoworld.com/d/virtualization/5-big-things-watch-vmworld-225401?source=rss_virtualization": "http://akamai.infoworld.com/d/virtualization/5-big-things-watch-vmworld-225401",
		"http://akamai.infoworld.com/t/application-development/why-have-apples-dev-center-and-forums-have-been-down-more-24-hours-223112?source=rss_application_development": "http://akamai.infoworld.com/t/application-development/why-have-apples-dev-center-and-forums-have-been-down-more-24-hours-223112",
		"http://akamai.infoworld.com/t/enterprise-architecture/call-entries-the-2013-enterprise-architecture-awards-214684?source=rss_enterprise_architecture": "http://akamai.infoworld.com/t/enterprise-architecture/call-entries-the-2013-enterprise-architecture-awards-214684",
		"http://akamai.infoworld.com/d/data-center/what-if-verizon-succeeds-in-killing-the-internet-227175?source=rss_networking": "http://akamai.infoworld.com/d/data-center/what-if-verizon-succeeds-in-killing-the-internet-227175",
		"http://akamai.infoworld.com/d/data-explosion/those-invisible-servers-could-open-your-network-hackers-224019?source=rss_data_center": "http://akamai.infoworld.com/d/data-explosion/those-invisible-servers-could-open-your-network-hackers-224019",
		"http://akamai.infoworld.com/d/open-source-software/in-their-own-words-unix-pioneers-remember-the-good-times-225113?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/in-their-own-words-unix-pioneers-remember-the-good-times-225113",
		"http://akamai.infoworld.com/d/security/attackers-turning-legit-cloud-services-firms-plant-malware-224046?source=rss_cloud_computing": "http://akamai.infoworld.com/d/security/attackers-turning-legit-cloud-services-firms-plant-malware-224046",
		"http://akamai.infoworld.com/t/microsoft-windows/microsoft-surface-naming-debacle-about-get-worse-225683?source=rss_microsoft_windows": "http://akamai.infoworld.com/t/microsoft-windows/microsoft-surface-naming-debacle-about-get-worse-225683",
		"http://akamai.infoworld.com/t/storage/modernizing-the-storage-stack-225741?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/t/storage/modernizing-the-storage-stack-225741",
		"http://akamai.infoworld.com/d/cloud-computing/the-cloud-no-cure-all-neither-your-data-center-225556?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/the-cloud-no-cure-all-neither-your-data-center-225556",
		"http://akamai.infoworld.com/t/technology-consulting/google-huddles-nfl-tv-rights-bitcoin-boom-in-china-twitter-shops-ipo-android-eats-apple-in-china-in-q?source=rss_business_intelligence": "http://akamai.infoworld.com/t/technology-consulting/google-huddles-nfl-tv-rights-bitcoin-boom-in-china-twitter-shops-ipo-android-eats-apple-in-china-in-q",
		"http://akamai.infoworld.com/d/microsoft-windows/could-surface-rt-2-be-the-windows-tablet-weve-been-waiting-224844?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/microsoft-windows/could-surface-rt-2-be-the-windows-tablet-weve-been-waiting-224844",
		"http://akamai.infoworld.com/d/networking/review-top-4-open-source-network-management-tools-222262?source=rss_networking": "http://akamai.infoworld.com/d/networking/review-top-4-open-source-network-management-tools-222262",
		"http://akamai.infoworld.com/d/open-source-software/apache-launches-major-revision-of-openoffice-suite-223231?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/apache-launches-major-revision-of-openoffice-suite-223231",
		"http://akamai.infoworld.com/d/security/google-patches-android-after-bitcoin-wallet-issue-224982?source=rss_mobile_technology": "http://akamai.infoworld.com/d/security/google-patches-android-after-bitcoin-wallet-issue-224982",
		"http://akamai.infoworld.com/t/it-strategy/yahoo-snags-rockmelt-plans-kill-its-aggregation-apps-224041?source=rss_the_industry_standard": "http://akamai.infoworld.com/t/it-strategy/yahoo-snags-rockmelt-plans-kill-its-aggregation-apps-224041",
		"http://akamai.infoworld.com/t/linux/canonical-pursues-android-users-ubuntu-touch-227206?source=rss_open_source_software": "http://akamai.infoworld.com/t/linux/canonical-pursues-android-users-ubuntu-touch-227206",
		"http://akamai.infoworld.com/d/applications/hp-equips-worksite-file-sharing-service-225289?source=rss_applications": "http://akamai.infoworld.com/d/applications/hp-equips-worksite-file-sharing-service-225289",
		"http://akamai.infoworld.com/d/networking/feedly-big-beneficiary-of-google-reader-demise-launches-paid-rss-service-224127?source=rss_networking": "http://akamai.infoworld.com/d/networking/feedly-big-beneficiary-of-google-reader-demise-launches-paid-rss-service-224127",
		"http://akamai.infoworld.com/d/the-industry-standard/lenovos-smartphone-tablets-outsell-pcs-in-first-quarter-224981?source=rss_mobile_technology": "http://akamai.infoworld.com/d/the-industry-standard/lenovos-smartphone-tablets-outsell-pcs-in-first-quarter-224981",
		"http://akamai.infoworld.com/d/consumerization-of-it/wishful-thinking-wont-reverse-microsofts-misfortune-224877?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/consumerization-of-it/wishful-thinking-wont-reverse-microsofts-misfortune-224877",
		"http://akamai.infoworld.com/d/mobile-technology/review-new-nexus-7-takes-ipad-mini-and-kindle-fire-hd-224483?source=rss_applications": "http://akamai.infoworld.com/d/mobile-technology/review-new-nexus-7-takes-ipad-mini-and-kindle-fire-hd-224483",
		"http://akamai.infoworld.com/t/internet-privacy/censor-busting-piratebrowser-works-within-limits-224886?source=rss_security": "http://akamai.infoworld.com/t/internet-privacy/censor-busting-piratebrowser-works-within-limits-224886",
		"http://akamai.infoworld.com/t/java-programming/jave-ee-tough-sell-spring-framework-users-226761?source=rss_application_development": "http://akamai.infoworld.com/t/java-programming/jave-ee-tough-sell-spring-framework-users-226761",
		"http://akamai.infoworld.com/d/cloud-computing/dell-goes-private-shareholders-approve-249-billion-deal-226718?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/dell-goes-private-shareholders-approve-249-billion-deal-226718",
		"http://akamai.infoworld.com/d/mobile-technology/the-apple-newton-messagepad-revisited-warts-wins-and-all-225184?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/mobile-technology/the-apple-newton-messagepad-revisited-warts-wins-and-all-225184",
		"http://akamai.infoworld.com/t/cringely/its-never-too-early-plan-sysadmin-day-2014-223625?source=rss_networking": "http://akamai.infoworld.com/t/cringely/its-never-too-early-plan-sysadmin-day-2014-223625",
		"http://akamai.infoworld.com/t/data-center/understanding-the-software-defined-data-center-225652?source=rss_storage": "http://akamai.infoworld.com/t/data-center/understanding-the-software-defined-data-center-225652",
		"http://akamai.infoworld.com/t/development-environments/adobes-phonegap-30-smooths-the-way-plug-ins-223130?source=rss_application_development": "http://akamai.infoworld.com/t/development-environments/adobes-phonegap-30-smooths-the-way-plug-ins-223130",
		"http://akamai.infoworld.com/d/application-development/17-things-you-should-go-ahead-and-cloud-226546?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/17-things-you-should-go-ahead-and-cloud-226546",
		"http://akamai.infoworld.com/d/computer-hardware/windows-8-comes-open-source-pcs-gizmosphere-board-225010?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/computer-hardware/windows-8-comes-open-source-pcs-gizmosphere-board-225010",
		"http://akamai.infoworld.com/d/mobile-technology/more-android-malware-distributed-through-mobile-ad-networks-224815?source=rss_mobile_technology": "http://akamai.infoworld.com/d/mobile-technology/more-android-malware-distributed-through-mobile-ad-networks-224815",
		"http://akamai.infoworld.com/d/security/w3c-rejects-ad-industry-attempt-hijack-do-not-track-specs-222818?source=rss_networking": "http://akamai.infoworld.com/d/security/w3c-rejects-ad-industry-attempt-hijack-do-not-track-specs-222818",
		"http://akamai.infoworld.com/d/the-industry-standard/it-certifications-are-finally-helping-your-paycheck-again-224832?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/it-certifications-are-finally-helping-your-paycheck-again-224832",
		"http://akamai.infoworld.com/t/mobile-development/reality-windows-developers-users-want-android-ios-apps-226578?source=rss_application_development": "http://akamai.infoworld.com/t/mobile-development/reality-windows-developers-users-want-android-ios-apps-226578",
		"http://akamai.infoworld.com/d/networking/juniper-ships-sdn-controller-dismisses-opendaylight-technology-226996?source=rss_open_source_software": "http://akamai.infoworld.com/d/networking/juniper-ships-sdn-controller-dismisses-opendaylight-technology-226996",
		"http://akamai.infoworld.com/d/application-development/apples-developer-site-overhaul-continues-following-breach-223429?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/apples-developer-site-overhaul-continues-following-breach-223429",
		"http://akamai.infoworld.com/d/cloud-computing/what-the-cloud-will-look-in-3-years-224170?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/what-the-cloud-will-look-in-3-years-224170",
		"http://akamai.infoworld.com/d/consumerization-of-it/giving-kids-ipads-wont-solve-the-education-challenge-224485?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/consumerization-of-it/giving-kids-ipads-wont-solve-the-education-challenge-224485",
		"http://akamai.infoworld.com/d/consumerization-of-it/the-wireless-revolutions-forgotten-victim-the-phone-itself-225797?source=rss_networking": "http://akamai.infoworld.com/d/consumerization-of-it/the-wireless-revolutions-forgotten-victim-the-phone-itself-225797",
		"http://akamai.infoworld.com/d/mobile-technology/microsoft-office-android-pathetically-bad-too-223816?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/mobile-technology/microsoft-office-android-pathetically-bad-too-223816",
		"http://akamai.infoworld.com/d/open-source-software/couchbase-open-source-data-store-goes-mobile-226815?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/couchbase-open-source-data-store-goes-mobile-226815",
		"http://akamai.infoworld.com/d/the-industry-standard/cisco-slash-4000-jobs-in-bid-move-faster-224972?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/cisco-slash-4000-jobs-in-bid-move-faster-224972",
		"http://akamai.infoworld.com/d/the-industry-standard/the-surface-fiasco-fallout-ballmer-youre-fired-223821?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/the-industry-standard/the-surface-fiasco-fallout-ballmer-youre-fired-223821",
		"http://akamai.infoworld.com/d/the-industry-standard/sprint-reports-16b-net-loss-it-shuts-down-nextel-platform-223675?source=rss_networking": "http://akamai.infoworld.com/d/the-industry-standard/sprint-reports-16b-net-loss-it-shuts-down-nextel-platform-223675",
		"http://akamai.infoworld.com/d/computer-hardware/ibm-starts-restricting-hardware-patches-paying-customers-225813?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/ibm-starts-restricting-hardware-patches-paying-customers-225813",
		"http://akamai.infoworld.com/d/computer-hardware/intel-ships-power-efficient-haswell-processors-tablets-226391?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/intel-ships-power-efficient-haswell-processors-tablets-226391",
		"http://akamai.infoworld.com/d/computer-hardware/canonical-looking-team-dell-chinese-version-of-ubuntu-os-225754?source=rss_open_source_software": "http://akamai.infoworld.com/d/computer-hardware/canonical-looking-team-dell-chinese-version-of-ubuntu-os-225754",
		"http://akamai.infoworld.com/d/open-source-software/linux-gets-boost-mobile-226912?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/linux-gets-boost-mobile-226912",
		"http://akamai.infoworld.com/d/security/report-uk-and-us-spies-have-cracked-blackberrys-bes-encryption-226383?source=rss_mobile_technology": "http://akamai.infoworld.com/d/security/report-uk-and-us-spies-have-cracked-blackberrys-bes-encryption-226383",
		"http://akamai.infoworld.com/d/the-industry-standard/cisco-ceo-we-will-become-the-no-1-it-company-223210?source=rss_networking": "http://akamai.infoworld.com/d/the-industry-standard/cisco-ceo-we-will-become-the-no-1-it-company-223210",
		"http://akamai.infoworld.com/t/storage/nand-flash-sales-and-prices-surge-224331?source=rss_storage": "http://akamai.infoworld.com/t/storage/nand-flash-sales-and-prices-surge-224331",
		"http://akamai.infoworld.com/d/open-source-software/oracle-sues-companies-it-says-provide-solaris-os-support-in-illegal-manner-223485?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/oracle-sues-companies-it-says-provide-solaris-os-support-in-illegal-manner-223485",
		"http://akamai.infoworld.com/t/microsoft-windows/microsofts-terrible-horrible-no-good-very-bad-week-225027?source=rss_microsoft_windows": "http://akamai.infoworld.com/t/microsoft-windows/microsofts-terrible-horrible-no-good-very-bad-week-225027",
		"http://akamai.infoworld.com/d/business-intelligence/software-ag-acquires-jackbe-mashup-tooling-real-time-analytics-225419?source=rss_business_intelligence": "http://akamai.infoworld.com/d/business-intelligence/software-ag-acquires-jackbe-mashup-tooling-real-time-analytics-225419",
		"http://akamai.infoworld.com/d/consumerization-of-it/the-savvy-tech-strategy-behind-obamacare-222251?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/consumerization-of-it/the-savvy-tech-strategy-behind-obamacare-222251",
		"http://akamai.infoworld.com/d/open-source-software/how-it-measures-sourceforges-new-revenue-sharing-developers-223046?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/how-it-measures-sourceforges-new-revenue-sharing-developers-223046",
		"http://akamai.infoworld.com/d/the-industry-standard/samsung-buys-german-oled-specialist-224615?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/samsung-buys-german-oled-specialist-224615",
		"http://akamai.infoworld.com/d/cloud-computing/gartner-saas-contract-language-regarding-security-lacking-223915?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/gartner-saas-contract-language-regarding-security-lacking-223915",
		"http://akamai.infoworld.com/d/mobile-technology/android-tablet-app-availability-still-trailing-ipad-225046?source=rss_mobile_technology": "http://akamai.infoworld.com/d/mobile-technology/android-tablet-app-availability-still-trailing-ipad-225046",
		"http://akamai.infoworld.com/t/applications/processmaker-25-open-source-workflow-made-faster-simpler-225159?source=rss_application_development": "http://akamai.infoworld.com/t/applications/processmaker-25-open-source-workflow-made-faster-simpler-225159",
		"http://akamai.infoworld.com/t/development-tools/salesforce-touts-new-mobile-tools-developers-223661?source=rss_open_source_software": "http://akamai.infoworld.com/t/development-tools/salesforce-touts-new-mobile-tools-developers-223661",
		"http://akamai.infoworld.com/d/computer-hardware/nvidia-drops-tegra-revenue-forecast-windows-rt-woes-loom-224570?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/computer-hardware/nvidia-drops-tegra-revenue-forecast-windows-rt-woes-loom-224570",
		"http://akamai.infoworld.com/t/web-applications/netflix-set-abandon-silverlight-introduce-drm-web-video-216621?source=rss_html5": "http://akamai.infoworld.com/t/web-applications/netflix-set-abandon-silverlight-introduce-drm-web-video-216621",
		"http://akamai.infoworld.com/t/cringely/windows-rt-more-windows-wtf-224950?source=rss_mobile_technology": "http://akamai.infoworld.com/t/cringely/windows-rt-more-windows-wtf-224950",
		"http://akamai.infoworld.com/d/application-development/what-are-graph-databases-good-heres-killer-app-223729?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/application-development/what-are-graph-databases-good-heres-killer-app-223729",
		"http://akamai.infoworld.com/d/cloud-computing/googles-cloud-encryption-good-pr-and-users-too-225179?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/cloud-computing/googles-cloud-encryption-good-pr-and-users-too-225179",
		"http://akamai.infoworld.com/d/data-center/why-openflow-the-next-big-thing-221692?source=rss_data_center": "http://akamai.infoworld.com/d/data-center/why-openflow-the-next-big-thing-221692",
		"http://akamai.infoworld.com/d/storage/sony-and-panasonic-collaborate-develop-300gb-optical-disc-223664?source=rss_storage": "http://akamai.infoworld.com/d/storage/sony-and-panasonic-collaborate-develop-300gb-optical-disc-223664",
		"http://akamai.infoworld.com/d/applications/sap-user-group-lobbying-leads-more-flexible-premises-licensing-policy-225439?source=rss_applications": "http://akamai.infoworld.com/d/applications/sap-user-group-lobbying-leads-more-flexible-premises-licensing-policy-225439",
		"http://akamai.infoworld.com/d/mobile-technology/samsung-claims-ericsson-demanding-billions-more-patent-licenses-225679?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/mobile-technology/samsung-claims-ericsson-demanding-billions-more-patent-licenses-225679",
		"http://akamai.infoworld.com/t/it-strategy/parable-of-business-change-turning-prey-predators-213036?source=rss_enterprise_architecture": "http://akamai.infoworld.com/t/it-strategy/parable-of-business-change-turning-prey-predators-213036",
		"http://akamai.infoworld.com/d/application-development/6-technologies-you-should-learn-year-225344?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/6-technologies-you-should-learn-year-225344",
		"http://akamai.infoworld.com/d/cloud-computing/rackspace-growing-its-cloud-still-tiny-next-aws-224674?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/rackspace-growing-its-cloud-still-tiny-next-aws-224674",
		"http://akamai.infoworld.com/d/cloud-computing/why-rms-built-its-cloud-environment-in-iceland-227710?source=rss_data_center": "http://akamai.infoworld.com/d/cloud-computing/why-rms-built-its-cloud-environment-in-iceland-227710",
		"http://akamai.infoworld.com/d/security/cisco-releases-security-patches-unified-communications-manager-223006?source=rss_networking": "http://akamai.infoworld.com/d/security/cisco-releases-security-patches-unified-communications-manager-223006",
		"http://akamai.infoworld.com/t/microsoft-windows/the-end-of-windows-we-know-it-226353?source=rss_microsoft_windows": "http://akamai.infoworld.com/t/microsoft-windows/the-end-of-windows-we-know-it-226353",
		"http://akamai.infoworld.com/d/computer-hardware/intel-ships-power-efficient-haswell-processors-tablets-226391?source=rss_mobile_technology": "http://akamai.infoworld.com/d/computer-hardware/intel-ships-power-efficient-haswell-processors-tablets-226391",
		"http://akamai.infoworld.com/t/it-jobs/if-you-want-job-done-right-dont-send-the-boss-227450?source=rss_networking": "http://akamai.infoworld.com/t/it-jobs/if-you-want-job-done-right-dont-send-the-boss-227450",
		"http://akamai.infoworld.com/d/consumerization-of-it/apple-google-or-microsoft-your-platform-will-dictate-your-office-app-226213?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/consumerization-of-it/apple-google-or-microsoft-your-platform-will-dictate-your-office-app-226213",
		"http://akamai.infoworld.com/d/mobile-technology/4g-the-new-enterprise-network-225424?source=rss_networking": "http://akamai.infoworld.com/d/mobile-technology/4g-the-new-enterprise-network-225424",
		"http://akamai.infoworld.com/d/mobile-technology/the-5-flaws-ios-7-isnt-likely-fix-224752?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/mobile-technology/the-5-flaws-ios-7-isnt-likely-fix-224752",
		"http://akamai.infoworld.com/d/the-industry-standard/us-patent-office-rejects-claims-of-apple-pinch-zoom-patent-223579?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/us-patent-office-rejects-claims-of-apple-pinch-zoom-patent-223579",
		"http://akamai.infoworld.com/t/internet/lawyer-verizon-should-be-able-block-websites-226398?source=rss_networking": "http://akamai.infoworld.com/t/internet/lawyer-verizon-should-be-able-block-websites-226398",
		"http://akamai.infoworld.com/t/microsoft-windows/microsofts-terrible-horrible-no-good-very-bad-week-225027?source=rss_the_industry_standard": "http://akamai.infoworld.com/t/microsoft-windows/microsofts-terrible-horrible-no-good-very-bad-week-225027",
		"http://akamai.infoworld.com/d/data-center/what-if-verizon-succeeds-in-killing-the-internet-227175?source=rss_data_center": "http://akamai.infoworld.com/d/data-center/what-if-verizon-succeeds-in-killing-the-internet-227175",
		"http://akamai.infoworld.com/d/security/ie-zero-day-vulnerability-exploited-more-widely-previously-thought-227729?source=rss_applications": "http://akamai.infoworld.com/d/security/ie-zero-day-vulnerability-exploited-more-widely-previously-thought-227729",
		"http://akamai.infoworld.com/d/computer-hardware/intel-customize-chips-big-data-applications-225031?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/intel-customize-chips-big-data-applications-225031",
		"http://akamai.infoworld.com/d/mobile-technology/finally-mobile-management-both-it-and-users-can-get-behind-225449?source=rss_applications": "http://akamai.infoworld.com/d/mobile-technology/finally-mobile-management-both-it-and-users-can-get-behind-225449",
		"http://akamai.infoworld.com/t/mobile-security/new-tools-let-cyber-criminals-easily-trojanize-legit-android-apps-222942?source=rss_open_source_software": "http://akamai.infoworld.com/t/mobile-security/new-tools-let-cyber-criminals-easily-trojanize-legit-android-apps-222942",
		"http://akamai.infoworld.com/d/mobile-technology/the-5-flaws-ios-7-isnt-likely-fix-224752?source=rss_applications": "http://akamai.infoworld.com/d/mobile-technology/the-5-flaws-ios-7-isnt-likely-fix-224752",
		"http://akamai.infoworld.com/d/mobile-technology/the-5-flaws-ios-7-isnt-likely-fix-224752?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/mobile-technology/the-5-flaws-ios-7-isnt-likely-fix-224752",
		"http://akamai.infoworld.com/t/big-data/why-you-should-jump-big-data-211604?source=rss_enterprise_architecture": "http://akamai.infoworld.com/t/big-data/why-you-should-jump-big-data-211604",
		"http://akamai.infoworld.com/t/smartphones/iphones-share-of-smartphone-market-drops-13-percent-224400?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/t/smartphones/iphones-share-of-smartphone-market-drops-13-percent-224400",
		"http://akamai.infoworld.com/d/cloud-computing/serious-action-needed-undo-nsas-damage-us-cloud-providers-224667?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/cloud-computing/serious-action-needed-undo-nsas-damage-us-cloud-providers-224667",
		"http://akamai.infoworld.com/d/cloud-computing/if-ibm-cloud-washed-its-earnings-results-its-likely-not-alone-225192?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/cloud-computing/if-ibm-cloud-washed-its-earnings-results-its-likely-not-alone-225192",
		"http://akamai.infoworld.com/t/technology-business/icahn-long-big-apple-position-msft-shareholder-revolt-over-surface-rt-disaster-40-of-americans-facebook?source=rss_business_intelligence": "http://akamai.infoworld.com/t/technology-business/icahn-long-big-apple-position-msft-shareholder-revolt-over-surface-rt-disaster-40-of-americans-facebook",
		"http://akamai.infoworld.com/d/cloud-computing/the-cloud-no-cure-all-neither-your-data-center-225556?source=rss_data_center": "http://akamai.infoworld.com/d/cloud-computing/the-cloud-no-cure-all-neither-your-data-center-225556",
		"http://akamai.infoworld.com/t/technology-business/declassified-docs-nail-nsa-domestic-spying-hp-way-down-donatelli-out-veghte-in-yahoo-passes-google-ubun?source=rss_business_intelligence": "http://akamai.infoworld.com/t/technology-business/declassified-docs-nail-nsa-domestic-spying-hp-way-down-donatelli-out-veghte-in-yahoo-passes-google-ubun",
		"http://akamai.infoworld.com/d/applications/microsofts-skydrive-outlookcom-are-down-some-users-224940?source=rss_cloud_computing": "http://akamai.infoworld.com/d/applications/microsofts-skydrive-outlookcom-are-down-some-users-224940",
		"http://akamai.infoworld.com/d/cloud-computing/akamai-partner-cisco-worlds-first-enterprise-wan-228526?source=rss_networking": "http://akamai.infoworld.com/d/cloud-computing/akamai-partner-cisco-worlds-first-enterprise-wan-228526",
		"http://akamai.infoworld.com/d/the-industry-standard/microsoft-acquire-nokias-mobile-business-226011?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/the-industry-standard/microsoft-acquire-nokias-mobile-business-226011",
		"http://akamai.infoworld.com/d/open-source-software/jeff-hawkins-where-open-source-and-machine-learning-meet-big-data-224069?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/open-source-software/jeff-hawkins-where-open-source-and-machine-learning-meet-big-data-224069",
		"http://akamai.infoworld.com/d/the-industry-standard/update-hp-replaces-enterprise-chief-posts-q3-sales-drop-225378?source=rss_computer_hardware": "http://akamai.infoworld.com/d/the-industry-standard/update-hp-replaces-enterprise-chief-posts-q3-sales-drop-225378",
		"http://akamai.infoworld.com/t/consumerization-of-it/the-futility-of-the-single-device-solution-224850?source=rss_computer_hardware": "http://akamai.infoworld.com/t/consumerization-of-it/the-futility-of-the-single-device-solution-224850",
		"http://akamai.infoworld.com/d/applications/google-previews-chrome-app-launcher-macs-226283?source=rss_applications": "http://akamai.infoworld.com/d/applications/google-previews-chrome-app-launcher-macs-226283",
		"http://akamai.infoworld.com/d/applications/the-blink-tag-finally-dead-killed-firefox-23-224363?source=rss_applications": "http://akamai.infoworld.com/d/applications/the-blink-tag-finally-dead-killed-firefox-23-224363",
		"http://akamai.infoworld.com/d/computer-hardware/samsung-starts-mass-production-of-ddr4-memories-225928?source=rss_data_center": "http://akamai.infoworld.com/d/computer-hardware/samsung-starts-mass-production-of-ddr4-memories-225928",
		"http://akamai.infoworld.com/d/consumerization-of-it/apples-next-revolution-may-be-bluetooth-powered-ibeacons-227574?source=rss_applications": "http://akamai.infoworld.com/d/consumerization-of-it/apples-next-revolution-may-be-bluetooth-powered-ibeacons-227574",
		"http://akamai.infoworld.com/d/mobile-technology/facebook-offers-free-wi-fi-in-exchange-check-ins-228089?source=rss_applications": "http://akamai.infoworld.com/d/mobile-technology/facebook-offers-free-wi-fi-in-exchange-check-ins-228089",
		"http://akamai.infoworld.com/d/mobile-technology/most-americans-dont-want-wearable-tech-iwatch-google-glass-222042?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/mobile-technology/most-americans-dont-want-wearable-tech-iwatch-google-glass-222042",
		"http://akamai.infoworld.com/t/technology-consulting/software-patents-banned-in-new-zealand-worldwide-hackathon-hits-nytimes-win8-apps-may-not-run-win81-b?source=rss_business_intelligence": "http://akamai.infoworld.com/t/technology-consulting/software-patents-banned-in-new-zealand-worldwide-hackathon-hits-nytimes-win8-apps-may-not-run-win81-b",
		"http://akamai.infoworld.com/d/application-development/10-things-never-do-relational-database-206944?source=rss_enterprise_architecture": "http://akamai.infoworld.com/d/application-development/10-things-never-do-relational-database-206944",
		"http://akamai.infoworld.com/t/cringely/apples-special-event-minus-the-special-226636?source=rss_mobile_technology": "http://akamai.infoworld.com/t/cringely/apples-special-event-minus-the-special-226636",
		"http://akamai.infoworld.com/d/computer-hardware/oracle-switches-software-pricing-exalytics-appliance-224169?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/oracle-switches-software-pricing-exalytics-appliance-224169",
		"http://akamai.infoworld.com/d/data-center/dont-count-consistent-server-performance-in-the-cloud-222077?source=rss_data_center": "http://akamai.infoworld.com/d/data-center/dont-count-consistent-server-performance-in-the-cloud-222077",
		"http://akamai.infoworld.com/d/microsoft-windows/getting-started-windows-azure-223758?source=rss_cloud_computing": "http://akamai.infoworld.com/d/microsoft-windows/getting-started-windows-azure-223758",
		"http://akamai.infoworld.com/t/chrome-os/googles-new-desktop-strategy-invade-and-conquer-228300?source=rss_applications": "http://akamai.infoworld.com/t/chrome-os/googles-new-desktop-strategy-invade-and-conquer-228300",
		"http://akamai.infoworld.com/t/it-jobs/if-you-want-job-done-right-dont-send-the-boss-227450?source=rss_data_center": "http://akamai.infoworld.com/t/it-jobs/if-you-want-job-done-right-dont-send-the-boss-227450",
		"http://akamai.infoworld.com/d/computer-hardware/server-revenue-continued-slide-in-q2-weak-demand-says-idc-225751?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/server-revenue-continued-slide-in-q2-weak-demand-says-idc-225751",
		"http://akamai.infoworld.com/d/microsoft-windows/windows-8-surpasses-vistas-uptake-rate-10-months-after-launch-225982?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/microsoft-windows/windows-8-surpasses-vistas-uptake-rate-10-months-after-launch-225982",
		"http://akamai.infoworld.com/d/computer-hardware/intel-pushes-speed-reliability-claims-new-mxc-cable-226170?source=rss_data_center": "http://akamai.infoworld.com/d/computer-hardware/intel-pushes-speed-reliability-claims-new-mxc-cable-226170",
		"http://akamai.infoworld.com/t/web-browsers/internet-explorer-11-release-preview-now-available-windows-7-228091?source=rss_applications": "http://akamai.infoworld.com/t/web-browsers/internet-explorer-11-release-preview-now-available-windows-7-228091",
		"http://akamai.infoworld.com/d/cloud-computing/dropbox-takes-peek-files-226776?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/dropbox-takes-peek-files-226776",
		"http://akamai.infoworld.com/t/cringely/watch-the-throne-the-cruelest-hack-of-all-224391?source=rss_security": "http://akamai.infoworld.com/t/cringely/watch-the-throne-the-cruelest-hack-of-all-224391",
		"http://akamai.infoworld.com/t/sdn/infoblox-shows-the-promise-of-openflow-227486?source=rss_networking": "http://akamai.infoworld.com/t/sdn/infoblox-shows-the-promise-of-openflow-227486",
		"http://akamai.infoworld.com/t/technology-business/why-steve-ballmer-headed-the-exit-225562?source=rss_the_industry_standard": "http://akamai.infoworld.com/t/technology-business/why-steve-ballmer-headed-the-exit-225562",
		"http://akamai.infoworld.com/d/computer-hardware/pc-satisfaction-scores-dip-customers-drift-tablets-226992?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/pc-satisfaction-scores-dip-customers-drift-tablets-226992",
		"http://akamai.infoworld.com/d/mobile-technology/parallels-access-shows-why-ipad-poor-pc-or-mac-225833?source=rss_virtualization": "http://akamai.infoworld.com/d/mobile-technology/parallels-access-shows-why-ipad-poor-pc-or-mac-225833",
		"http://akamai.infoworld.com/d/security/researcher-builds-botnet-powered-distributed-file-storage-system-using-javascript-224132?source=rss_cloud_computing": "http://akamai.infoworld.com/d/security/researcher-builds-botnet-powered-distributed-file-storage-system-using-javascript-224132",
		"http://akamai.infoworld.com/d/microsoft-windows/in-reversal-microsoft-gives-snarling-developers-win-81-rtm-chew-226439?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/microsoft-windows/in-reversal-microsoft-gives-snarling-developers-win-81-rtm-chew-226439",
		"http://akamai.infoworld.com/t/big-data/oracles-in-memory-database-ripe-the-picking-open-source-227369?source=rss_open_source_software": "http://akamai.infoworld.com/t/big-data/oracles-in-memory-database-ripe-the-picking-open-source-227369",
		"http://akamai.infoworld.com/d/cloud-computing/google-nsa-youll-have-take-our-data-the-hard-way-226407?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/cloud-computing/google-nsa-youll-have-take-our-data-the-hard-way-226407",
		"http://akamai.infoworld.com/d/data-center/track-hack-find-out-whos-hitting-your-servers-228163?source=rss_data_center": "http://akamai.infoworld.com/d/data-center/track-hack-find-out-whos-hitting-your-servers-228163",
		"http://akamai.infoworld.com/d/networking/connectivity-issue-caused-trading-problems-nasdaq-says-225461?source=rss_networking": "http://akamai.infoworld.com/d/networking/connectivity-issue-caused-trading-problems-nasdaq-says-225461",
		"http://akamai.infoworld.com/d/open-source-software/nginx-web-server-goes-commercial-new-release-225395?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/nginx-web-server-goes-commercial-new-release-225395",
		"http://akamai.infoworld.com/d/security/how-roll-your-own-vpn-223650?source=rss_networking": "http://akamai.infoworld.com/d/security/how-roll-your-own-vpn-223650",
		"http://akamai.infoworld.com/d/virtualization/vmwares-virtualization-quest-could-help-shake-storage-too-225792?source=rss_virtualization": "http://akamai.infoworld.com/d/virtualization/vmwares-virtualization-quest-could-help-shake-storage-too-225792",
		"http://akamai.infoworld.com/d/data-center/the-coming-push-open-source-everything-223011?source=rss_data_center": "http://akamai.infoworld.com/d/data-center/the-coming-push-open-source-everything-223011",
		"http://akamai.infoworld.com/d/data-explosion/lessons-nasa-how-solve-problems-quickly-under-pressure-225209?source=rss_data_center": "http://akamai.infoworld.com/d/data-explosion/lessons-nasa-how-solve-problems-quickly-under-pressure-225209",
		"http://akamai.infoworld.com/slideshow/112788/heroes-and-zeroes-techs-best-and-worst-of-2013-so-far-223765?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/slideshow/112788/heroes-and-zeroes-techs-best-and-worst-of-2013-so-far-223765",
		"http://akamai.infoworld.com/d/application-development/why-mongodb-worth-12-billion-228510?source=rss_open_source_software": "http://akamai.infoworld.com/d/application-development/why-mongodb-worth-12-billion-228510",
		"http://akamai.infoworld.com/d/applications/firefox-chrome-strengthen-in-browser-debugging-224333?source=rss_applications": "http://akamai.infoworld.com/d/applications/firefox-chrome-strengthen-in-browser-debugging-224333",
		"http://akamai.infoworld.com/d/business-intelligence/microsoft-sharpens-office-365-tool-slice-and-dice-data-227558?source=rss_applications": "http://akamai.infoworld.com/d/business-intelligence/microsoft-sharpens-office-365-tool-slice-and-dice-data-227558",
		"http://akamai.infoworld.com/d/consumerization-of-it/it-no-show-when-it-comes-mobile-apps-223926?source=rss_application_development": "http://akamai.infoworld.com/d/consumerization-of-it/it-no-show-when-it-comes-mobile-apps-223926",
		"http://akamai.infoworld.com/d/mobile-technology/how-google-should-fix-androids-shortcomings-217823?source=rss_html5": "http://akamai.infoworld.com/d/mobile-technology/how-google-should-fix-androids-shortcomings-217823",
		"http://akamai.infoworld.com/d/mobile-technology/the-apple-newton-messagepad-revisited-warts-wins-and-all-225184?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/mobile-technology/the-apple-newton-messagepad-revisited-warts-wins-and-all-225184",
		"http://akamai.infoworld.com/t/computer-hardware/debunked-5-myths-of-thin-client-computing-227483?source=rss_computer_hardware": "http://akamai.infoworld.com/t/computer-hardware/debunked-5-myths-of-thin-client-computing-227483",
		"http://akamai.infoworld.com/t/computer-memory/startup-crossbar-pits-rram-against-dram-and-flash-storage-224099?source=rss_computer_hardware": "http://akamai.infoworld.com/t/computer-memory/startup-crossbar-pits-rram-against-dram-and-flash-storage-224099",
		"http://akamai.infoworld.com/t/green-it/data-center-innovator-ken-brill-dies-68-223979?source=rss_data_center": "http://akamai.infoworld.com/t/green-it/data-center-innovator-ken-brill-dies-68-223979",
		"http://akamai.infoworld.com/t/smartphones/the-ubuntu-edge-good-fit-the-enterprise-223552?source=rss_application_development": "http://akamai.infoworld.com/t/smartphones/the-ubuntu-edge-good-fit-the-enterprise-223552",
		"http://akamai.infoworld.com/d/mobile-technology/iphone-jailbreakers-begin-cracking-their-knuckles-over-ios-7-226611?source=rss_mobile_technology": "http://akamai.infoworld.com/d/mobile-technology/iphone-jailbreakers-begin-cracking-their-knuckles-over-ios-7-226611",
		"http://akamai.infoworld.com/t/cloud-computing/dont-let-consumerization-be-the-free-lunch-eats-you-213800?source=rss_enterprise_architecture": "http://akamai.infoworld.com/t/cloud-computing/dont-let-consumerization-be-the-free-lunch-eats-you-213800",
		"http://akamai.infoworld.com/d/cloud-computing/the-virtues-of-database-service-223607?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/the-virtues-of-database-service-223607",
		"http://akamai.infoworld.com/d/cloud-computing/want-good-cloud-job-better-know-traditional-it-too-226418?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/want-good-cloud-job-better-know-traditional-it-too-226418",
		"http://akamai.infoworld.com/d/networking/facebook-networking-chief-no-more-secret-asic-commands-228242?source=rss_networking": "http://akamai.infoworld.com/d/networking/facebook-networking-chief-no-more-secret-asic-commands-228242",
		"http://akamai.infoworld.com/d/application-development/hsa-targets-native-parallel-execution-in-java-virtual-machines-2015-225564?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/hsa-targets-native-parallel-execution-in-java-virtual-machines-2015-225564",
		"http://akamai.infoworld.com/d/application-development/sap-creates-lava-design-language-heat-analytics-225089?source=rss_business_intelligence": "http://akamai.infoworld.com/d/application-development/sap-creates-lava-design-language-heat-analytics-225089",
		"http://akamai.infoworld.com/d/cloud-computing/update-microsoft-lures-nonprofits-office-365-freebie-226451?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/update-microsoft-lures-nonprofits-office-365-freebie-226451",
		"http://akamai.infoworld.com/d/computer-hardware/ibm-improves-density-of-new-flex-system-servers-224203?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/ibm-improves-density-of-new-flex-system-servers-224203",
		"http://akamai.infoworld.com/d/microsoft-windows/windows-81-enterprise-3-features-admins-should-know-226517?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/microsoft-windows/windows-81-enterprise-3-features-admins-should-know-226517",
		"http://akamai.infoworld.com/d/the-industry-standard/read-microsoft-ceo-steve-ballmers-retirement-announcement-letter-225490?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/read-microsoft-ceo-steve-ballmers-retirement-announcement-letter-225490",
		"http://akamai.infoworld.com/t/development-tools/salesforce-touts-new-mobile-tools-developers-223661?source=rss_application_development": "http://akamai.infoworld.com/t/development-tools/salesforce-touts-new-mobile-tools-developers-223661",
		"http://akamai.infoworld.com/t/virtualization/vmworld-2013-networking-and-storage-take-center-stage-225563?source=rss_virtualization": "http://akamai.infoworld.com/t/virtualization/vmworld-2013-networking-and-storage-take-center-stage-225563",
		"http://akamai.infoworld.com/d/microsoft-windows/windows-azure-pack-cloud-app-convenience-meets-in-house-hosting-225705?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/microsoft-windows/windows-azure-pack-cloud-app-convenience-meets-in-house-hosting-225705",
		"http://akamai.infoworld.com/t/it-management/the-big-shift-in-business-technology-222038?source=rss_consumerization_of_it": "http://akamai.infoworld.com/t/it-management/the-big-shift-in-business-technology-222038",
		"http://akamai.infoworld.com/d/computer-hardware/4-things-love-about-googles-chromebook-pixel-and-4-things-hate-224990?source=rss_mobile_technology": "http://akamai.infoworld.com/d/computer-hardware/4-things-love-about-googles-chromebook-pixel-and-4-things-hate-224990",
		"http://akamai.infoworld.com/d/computer-hardware/fujitsu-will-stick-unix-keep-ibm-in-check-exec-says-227476?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/fujitsu-will-stick-unix-keep-ibm-in-check-exec-says-227476",
		"http://akamai.infoworld.com/t/hacking/security-researcher-claims-good-intentions-in-hacking-apple-dev-center-223205?source=rss_application_development": "http://akamai.infoworld.com/t/hacking/security-researcher-claims-good-intentions-in-hacking-apple-dev-center-223205",
		"http://akamai.infoworld.com/t/technology-business/breaking-ballmer-out-nasdaq-down-out-googles-258-million-uber-tab-nginxs-first-commercial-server-amazon?source=rss_business_intelligence": "http://akamai.infoworld.com/t/technology-business/breaking-ballmer-out-nasdaq-down-out-googles-258-million-uber-tab-nginxs-first-commercial-server-amazon",
		"http://akamai.infoworld.com/d/microsoft-windows/windows-server-2012-r2-and-azure-pack-work-better-together-226050?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/microsoft-windows/windows-server-2012-r2-and-azure-pack-work-better-together-226050",
		"http://akamai.infoworld.com/t/microsoft-windows/microsoft-surface-and-the-multibillion-dollar-boondoggle-223776?source=rss_microsoft_windows": "http://akamai.infoworld.com/t/microsoft-windows/microsoft-surface-and-the-multibillion-dollar-boondoggle-223776",
		"http://akamai.infoworld.com/d/computer-hardware/google-intel-cement-ties-chrome-os-could-weaken-wintel-226691?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/computer-hardware/google-intel-cement-ties-chrome-os-could-weaken-wintel-226691",
		"http://akamai.infoworld.com/d/mobile-technology/review-lenovo-thinkpad-helix-flips-ultrabook-expectations-225079?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/mobile-technology/review-lenovo-thinkpad-helix-flips-ultrabook-expectations-225079",
		"http://akamai.infoworld.com/d/the-industry-standard/ibm-says-sec-investigating-how-it-reports-cloud-revenues-223843?source=rss_cloud_computing": "http://akamai.infoworld.com/d/the-industry-standard/ibm-says-sec-investigating-how-it-reports-cloud-revenues-223843",
		"http://akamai.infoworld.com/slideshow/112963/your-it-project-toast-11-early-indicators-watch-224329?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/slideshow/112963/your-it-project-toast-11-early-indicators-watch-224329",
		"http://akamai.infoworld.com/t/technology-business/no-1-lenovo-sells-more-smartphones-tablets-pcs-ibms-1b-win-another-uncle-sam-cloud-apple-tastes-china-m?source=rss_business_intelligence": "http://akamai.infoworld.com/t/technology-business/no-1-lenovo-sells-more-smartphones-tablets-pcs-ibms-1b-win-another-uncle-sam-cloud-apple-tastes-china-m",
		"http://akamai.infoworld.com/d/application-development/beginners-guide-r-syntax-quirks-youll-want-know-225361?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/beginners-guide-r-syntax-quirks-youll-want-know-225361",
		"http://akamai.infoworld.com/d/computer-hardware/fujitsu-will-stick-unix-keep-ibm-in-check-exec-says-227476?source=rss_open_source_software": "http://akamai.infoworld.com/d/computer-hardware/fujitsu-will-stick-unix-keep-ibm-in-check-exec-says-227476",
		"http://akamai.infoworld.com/d/storage/enterprise-flash-arrays-pack-in-more-storage-denser-media-224764?source=rss_storage": "http://akamai.infoworld.com/d/storage/enterprise-flash-arrays-pack-in-more-storage-denser-media-224764",
		"http://akamai.infoworld.com/d/the-industry-standard/us-vetoes-import-ban-att-iphone-4-3g-ipad-2-224084?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/us-vetoes-import-ban-att-iphone-4-3g-ipad-2-224084",
		"http://akamai.infoworld.com/d/applications/apple-issues-final-non-security-update-os-x-mountain-lion-226786?source=rss_applications": "http://akamai.infoworld.com/d/applications/apple-issues-final-non-security-update-os-x-mountain-lion-226786",
		"http://akamai.infoworld.com/d/microsoft-windows/windows-server-2012-r2-and-azure-pack-work-better-together-226050?source=rss_data_center": "http://akamai.infoworld.com/d/microsoft-windows/windows-server-2012-r2-and-azure-pack-work-better-together-226050",
		"http://akamai.infoworld.com/d/virtualization/review-new-parallels-fusion-virtual-desktops-os-x-fail-the-smell-test-226160?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/virtualization/review-new-parallels-fusion-virtual-desktops-os-x-fail-the-smell-test-226160",
		"http://akamai.infoworld.com/t/microsoft-windows/leaked-windows-81-build-9471-surprises-disappoints-224715?source=rss_microsoft_windows": "http://akamai.infoworld.com/t/microsoft-windows/leaked-windows-81-build-9471-surprises-disappoints-224715",
		"http://akamai.infoworld.com/t/smartphones/the-ubuntu-edge-good-fit-the-enterprise-223552?source=rss_open_source_software": "http://akamai.infoworld.com/t/smartphones/the-ubuntu-edge-good-fit-the-enterprise-223552",
		"http://akamai.infoworld.com/d/cloud-computing/cloud-adoption-suffers-in-the-wake-of-nsa-snooping-223606?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/cloud-adoption-suffers-in-the-wake-of-nsa-snooping-223606",
		"http://akamai.infoworld.com/d/networking/weighing-the-it-implications-of-implementing-sdns-227726?source=rss_networking": "http://akamai.infoworld.com/d/networking/weighing-the-it-implications-of-implementing-sdns-227726",
		"http://akamai.infoworld.com/node/224084?source=rss_the_industry_standard": "http://akamai.infoworld.com/node/224084",
		"http://akamai.infoworld.com/d/application-development/how-my-company-went-100-percent-cloud-222927?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/how-my-company-went-100-percent-cloud-222927",
		"http://akamai.infoworld.com/d/cloud-computing/serious-action-needed-undo-nsas-damage-us-cloud-providers-224667?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/serious-action-needed-undo-nsas-damage-us-cloud-providers-224667",
		"http://akamai.infoworld.com/d/computer-hardware/intel-ceo-gives-peek-laptop-future-broadwell-chip-226533?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/intel-ceo-gives-peek-laptop-future-broadwell-chip-226533",
		"http://akamai.infoworld.com/d/consumerization-of-it/wishful-thinking-wont-reverse-microsofts-misfortune-224877?source=rss_computer_hardware": "http://akamai.infoworld.com/d/consumerization-of-it/wishful-thinking-wont-reverse-microsofts-misfortune-224877",
		"http://akamai.infoworld.com/d/open-source-software/review-5-free-linux-text-editors-developer-could-love-223848?source=rss_applications": "http://akamai.infoworld.com/d/open-source-software/review-5-free-linux-text-editors-developer-could-love-223848",
		"http://akamai.infoworld.com/t/mobile-technology/the-problem-smart-watches-theyre-watches-226382?source=rss_computer_hardware": "http://akamai.infoworld.com/t/mobile-technology/the-problem-smart-watches-theyre-watches-226382",
		"http://akamai.infoworld.com/t/technology-business/sinofsky-joins-box-take-down-office-microsoft-courting-foursquare-facebook-user-pix-facial-recognition-?source=rss_business_intelligence": "http://akamai.infoworld.com/t/technology-business/sinofsky-joins-box-take-down-office-microsoft-courting-foursquare-facebook-user-pix-facial-recognition-",
		"http://akamai.infoworld.com/d/computer-hardware/google-intel-cement-ties-chrome-os-could-weaken-wintel-226691?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/google-intel-cement-ties-chrome-os-could-weaken-wintel-226691",
		"http://akamai.infoworld.com/d/computer-hardware/ibms-new-power8-doubles-performance-of-watson-chip-225664?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/ibms-new-power8-doubles-performance-of-watson-chip-225664",
		"http://akamai.infoworld.com/d/computer-hardware/the-7-key-lessons-of-idf-226792?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/the-7-key-lessons-of-idf-226792",
		"http://akamai.infoworld.com/d/data-center/the-moment-of-truth-when-new-eyes-meet-old-code-227658?source=rss_data_center": "http://akamai.infoworld.com/d/data-center/the-moment-of-truth-when-new-eyes-meet-old-code-227658",
		"http://akamai.infoworld.com/d/networking/cisco-reveals-its-internet-of-everything-router-227440?source=rss_networking": "http://akamai.infoworld.com/d/networking/cisco-reveals-its-internet-of-everything-router-227440",
		"http://akamai.infoworld.com/t/application-development/good-advice-bad-code-happens-so-be-prepared-225450?source=rss_application_development": "http://akamai.infoworld.com/t/application-development/good-advice-bad-code-happens-so-be-prepared-225450",
		"http://akamai.infoworld.com/d/applications/speech-recognition-gimmick-or-good-enough-225421?source=rss_applications": "http://akamai.infoworld.com/d/applications/speech-recognition-gimmick-or-good-enough-225421",
		"http://akamai.infoworld.com/d/cloud-computing/when-it-makes-sense-become-cloud-provider-225895?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/when-it-makes-sense-become-cloud-provider-225895",
		"http://akamai.infoworld.com/d/storage/seagate-hybrid-drive-promises-speed-boost-below-the-cost-of-flash-223337?source=rss_storage": "http://akamai.infoworld.com/d/storage/seagate-hybrid-drive-promises-speed-boost-below-the-cost-of-flash-223337",
		"http://akamai.infoworld.com/t/cringely/its-never-too-early-plan-sysadmin-day-2014-223625?source=rss_data_center": "http://akamai.infoworld.com/t/cringely/its-never-too-early-plan-sysadmin-day-2014-223625",
		"http://akamai.infoworld.com/t/open-source-software/open-source-races-the-top-223569?source=rss_application_development": "http://akamai.infoworld.com/t/open-source-software/open-source-races-the-top-223569",
		"http://akamai.infoworld.com/d/cloud-computing/clouds-are-backing-clouds-more-choices-tap-224212?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/clouds-are-backing-clouds-more-choices-tap-224212",
		"http://akamai.infoworld.com/d/data-management/mysql-face-mysql-or-mariadb-224665?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/data-management/mysql-face-mysql-or-mariadb-224665",
		"http://akamai.infoworld.com/d/microsoft-windows/your-hypervisor-still-matters-so-choose-wisely-224232?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/microsoft-windows/your-hypervisor-still-matters-so-choose-wisely-224232",
		"http://akamai.infoworld.com/node/224132?source=rss_cloud_computing": "http://akamai.infoworld.com/node/224132",
		"http://akamai.infoworld.com/d/business-intelligence/software-ag-acquires-jackbe-mashup-tooling-real-time-analytics-225419?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/business-intelligence/software-ag-acquires-jackbe-mashup-tooling-real-time-analytics-225419",
		"http://akamai.infoworld.com/d/open-source-software/why-ubuntu-edge-deserves-your-support-223967?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/why-ubuntu-edge-deserves-your-support-223967",
		"http://akamai.infoworld.com/d/the-industry-standard/apple-supplier-pegatron-slammed-alleged-labor-abuses-in-china-223580?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/apple-supplier-pegatron-slammed-alleged-labor-abuses-in-china-223580",
		"http://akamai.infoworld.com/d/the-industry-standard/cisco-ceo-we-will-become-the-no-1-it-company-223210?source=rss_data_center": "http://akamai.infoworld.com/d/the-industry-standard/cisco-ceo-we-will-become-the-no-1-it-company-223210",
		"http://akamai.infoworld.com/t/technology-consulting/win-81-rtms-andreessen-gelsinger-brawl-vmworld-ftc-investigating-google-waze-tie-nsa-hits-corporate-b?source=rss_business_intelligence": "http://akamai.infoworld.com/t/technology-consulting/win-81-rtms-andreessen-gelsinger-brawl-vmworld-ftc-investigating-google-waze-tie-nsa-hits-corporate-b",
		"http://akamai.infoworld.com/d/consumerization-of-it/it-no-show-when-it-comes-mobile-apps-223926?source=rss_html5": "http://akamai.infoworld.com/d/consumerization-of-it/it-no-show-when-it-comes-mobile-apps-223926",
		"http://akamai.infoworld.com/d/application-development/the-bare-bones-cloud-why-bother-226172?source=rss_cloud_computing": "http://akamai.infoworld.com/d/application-development/the-bare-bones-cloud-why-bother-226172",
		"http://akamai.infoworld.com/d/computer-hardware/canonical-looking-team-dell-chinese-version-of-ubuntu-os-225754?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/canonical-looking-team-dell-chinese-version-of-ubuntu-os-225754",
		"http://akamai.infoworld.com/d/computer-hardware/new-3d-printing-drm-copies-netflixs-moves-blockade-physical-pirates-225788?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/new-3d-printing-drm-copies-netflixs-moves-blockade-physical-pirates-225788",
		"http://akamai.infoworld.com/d/computer-hardware/nvidia-drops-tegra-revenue-forecast-windows-rt-woes-loom-224570?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/nvidia-drops-tegra-revenue-forecast-windows-rt-woes-loom-224570",
		"http://akamai.infoworld.com/d/open-source-software/facebook-open-source-cache-squeezes-more-flash-disks-228503?source=rss_storage": "http://akamai.infoworld.com/d/open-source-software/facebook-open-source-cache-squeezes-more-flash-disks-228503",
		"http://akamai.infoworld.com/d/security/unisys-going-offense-in-server-and-security-markets-225586?source=rss_data_center": "http://akamai.infoworld.com/d/security/unisys-going-offense-in-server-and-security-markets-225586",
		"http://akamai.infoworld.com/d/application-development/beginners-guide-r-get-your-data-r-225369?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/application-development/beginners-guide-r-get-your-data-r-225369",
		"http://akamai.infoworld.com/d/data-center/beware-of-backups-come-back-bite-you-226118?source=rss_data_center": "http://akamai.infoworld.com/d/data-center/beware-of-backups-come-back-bite-you-226118",
		"http://akamai.infoworld.com/d/data-center/move-over-cisco-ios-dawn-of-the-industry-standard-switch-221178?source=rss_networking": "http://akamai.infoworld.com/d/data-center/move-over-cisco-ios-dawn-of-the-industry-standard-switch-221178",
		"http://akamai.infoworld.com/d/security/microsoft-moves-block-md5-certificates-and-improve-rdp-authentication-224893?source=rss_security": "http://akamai.infoworld.com/d/security/microsoft-moves-block-md5-certificates-and-improve-rdp-authentication-224893",
		"http://akamai.infoworld.com/t/data-security/how-defend-your-web-apps-against-the-new-breach-attack-224281?source=rss_security": "http://akamai.infoworld.com/t/data-security/how-defend-your-web-apps-against-the-new-breach-attack-224281",
		"http://akamai.infoworld.com/t/html5/sencha-ceo-treat-html5-apps-programming-platform-not-web-page-217436?source=rss_html5": "http://akamai.infoworld.com/t/html5/sencha-ceo-treat-html5-apps-programming-platform-not-web-page-217436",
		"http://akamai.infoworld.com/d/html5/how-ensure-privacy-in-the-age-of-html5-221446?source=rss_html5": "http://akamai.infoworld.com/d/html5/how-ensure-privacy-in-the-age-of-html5-221446",
		"http://akamai.infoworld.com/d/open-source-software/bossies-2012-the-best-of-open-source-software-awards-202465?source=rss_html5": "http://akamai.infoworld.com/d/open-source-software/bossies-2012-the-best-of-open-source-software-awards-202465",
		"http://akamai.infoworld.com/d/the-industry-standard/ibm-acquire-endpoint-security-company-trusteer-224984?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/ibm-acquire-endpoint-security-company-trusteer-224984",
		"http://akamai.infoworld.com/node/224662?source=rss_security": "http://akamai.infoworld.com/node/224662",
		"http://akamai.infoworld.com/d/application-development/beginners-guide-r-get-your-data-r-225369?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/beginners-guide-r-get-your-data-r-225369",
		"http://akamai.infoworld.com/d/computer-hardware/google-rekindles-motorola-legacy-mobile-x8-chipset-223975?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/computer-hardware/google-rekindles-motorola-legacy-mobile-x8-chipset-223975",
		"http://akamai.infoworld.com/d/data-explosion/vmware-vsan-inside-the-revolutionary-new-approach-storage-225962?source=rss_storage": "http://akamai.infoworld.com/d/data-explosion/vmware-vsan-inside-the-revolutionary-new-approach-storage-225962",
		"http://akamai.infoworld.com/t/applications/if-you-think-phones-tablets-and-computers-are-smart-now-just-wait-225885?source=rss_cloud_computing": "http://akamai.infoworld.com/t/applications/if-you-think-phones-tablets-and-computers-are-smart-now-just-wait-225885",
		"http://akamai.infoworld.com/t/java-programming/java-tops-c-most-popular-language-in-developer-index-224781?source=rss_application_development": "http://akamai.infoworld.com/t/java-programming/java-tops-c-most-popular-language-in-developer-index-224781",
		"http://akamai.infoworld.com/d/application-development/build-windows-8-app-get-prize-microsoft-224608?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/build-windows-8-app-get-prize-microsoft-224608",
		"http://akamai.infoworld.com/d/security/enterprises-still-running-old-java-and-flash-software-websense-finds-226448?source=rss_application_development": "http://akamai.infoworld.com/d/security/enterprises-still-running-old-java-and-flash-software-websense-finds-226448",
		"http://akamai.infoworld.com/t/sdn/hps-open-ecosystem-sdn-isnt-just-about-sdn-227789?source=rss_data_center": "http://akamai.infoworld.com/t/sdn/hps-open-ecosystem-sdn-isnt-just-about-sdn-227789",
		"http://akamai.infoworld.com/d/cloud-computing/3-common-mistakes-in-cloud-migrations-and-how-avoid-them-224666?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/3-common-mistakes-in-cloud-migrations-and-how-avoid-them-224666",
		"http://akamai.infoworld.com/d/data-center/no-google-fiber-doesnt-violate-net-neutrality-223828?source=rss_networking": "http://akamai.infoworld.com/d/data-center/no-google-fiber-doesnt-violate-net-neutrality-223828",
		"http://akamai.infoworld.com/t/it-strategy/dont-believe-the-drumbeat-against-it-213425?source=rss_enterprise_architecture": "http://akamai.infoworld.com/t/it-strategy/dont-believe-the-drumbeat-against-it-213425",
		"http://akamai.infoworld.com/d/networking/juniper-ships-sdn-controller-dismisses-opendaylight-technology-226996?source=rss_networking": "http://akamai.infoworld.com/d/networking/juniper-ships-sdn-controller-dismisses-opendaylight-technology-226996",
		"http://akamai.infoworld.com/d/security/new-security-scheme-tracks-text-spammers-in-hours-224487?source=rss_security": "http://akamai.infoworld.com/d/security/new-security-scheme-tracks-text-spammers-in-hours-224487",
		"http://akamai.infoworld.com/d/the-industry-standard/whose-self-driving-car-will-you-trust-google-or-the-automakers-225799?source=rss_computer_hardware": "http://akamai.infoworld.com/d/the-industry-standard/whose-self-driving-car-will-you-trust-google-or-the-automakers-225799",
		"http://akamai.infoworld.com/t/iphone/microsoft-and-apple-dueling-disappointments-226732?source=rss_microsoft_windows": "http://akamai.infoworld.com/t/iphone/microsoft-and-apple-dueling-disappointments-226732",
		"http://akamai.infoworld.com/d/application-development/zuckerberg-facebook-wants-take-the-pain-out-of-building-apps-226240?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/zuckerberg-facebook-wants-take-the-pain-out-of-building-apps-226240",
		"http://akamai.infoworld.com/d/applications/mozilla-ship-metro-ized-firefox-dec-10-225067?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/applications/mozilla-ship-metro-ized-firefox-dec-10-225067",
		"http://akamai.infoworld.com/t/cloud-computing/software-defined-infrastructure-cloud-services-do-sdn-one-better-227999?source=rss_networking": "http://akamai.infoworld.com/t/cloud-computing/software-defined-infrastructure-cloud-services-do-sdn-one-better-227999",
		"http://akamai.infoworld.com/d/storage/review-qnap-nas-meets-xbmc-media-center-222966?source=rss_storage": "http://akamai.infoworld.com/d/storage/review-qnap-nas-meets-xbmc-media-center-222966",
		"http://akamai.infoworld.com/t/microsoft-windows/microsoft-botches-still-more-patches-in-latest-automatic-update-226594?source=rss_microsoft_windows": "http://akamai.infoworld.com/t/microsoft-windows/microsoft-botches-still-more-patches-in-latest-automatic-update-226594",
		"http://akamai.infoworld.com/d/computer-hardware/intel-pushes-speed-reliability-claims-new-mxc-cable-226170?source=rss_networking": "http://akamai.infoworld.com/d/computer-hardware/intel-pushes-speed-reliability-claims-new-mxc-cable-226170",
		"http://akamai.infoworld.com/d/mobile-technology/dell-drops-299-windows-rt-tablet-cheapest-offer-now-479-225114?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/mobile-technology/dell-drops-299-windows-rt-tablet-cheapest-offer-now-479-225114",
		"http://akamai.infoworld.com/d/open-source-software/review-5-free-linux-text-editors-developer-could-love-223848?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/review-5-free-linux-text-editors-developer-could-love-223848",
		"http://akamai.infoworld.com/d/security/privacy-groups-criticize-proposed-85-million-google-settlement-225472?source=rss_applications": "http://akamai.infoworld.com/d/security/privacy-groups-criticize-proposed-85-million-google-settlement-225472",
		"http://akamai.infoworld.com/d/security/cisco-patches-vulnerabilities-in-some-security-appliances-switches-and-routers-228551?source=rss_networking": "http://akamai.infoworld.com/d/security/cisco-patches-vulnerabilities-in-some-security-appliances-switches-and-routers-228551",
		"http://akamai.infoworld.com/d/storage/flash-breakthrough-promises-faster-storage-terabytes-of-memory-223670?source=rss_computer_hardware": "http://akamai.infoworld.com/d/storage/flash-breakthrough-promises-faster-storage-terabytes-of-memory-223670",
		"http://akamai.infoworld.com/node/224212?source=rss_security": "http://akamai.infoworld.com/node/224212",
		"http://akamai.infoworld.com/t/cloud-computing/vmware-takes-another-whack-the-cloud-224579?source=rss_cloud_computing": "http://akamai.infoworld.com/t/cloud-computing/vmware-takes-another-whack-the-cloud-224579",
		"http://akamai.infoworld.com/d/applications/firefox-chrome-strengthen-in-browser-debugging-224333?source=rss_application_development": "http://akamai.infoworld.com/d/applications/firefox-chrome-strengthen-in-browser-debugging-224333",
		"http://akamai.infoworld.com/t/byod/the-realists-guide-byod-and-why-its-long-term-trend-210801?source=rss_enterprise_architecture": "http://akamai.infoworld.com/t/byod/the-realists-guide-byod-and-why-its-long-term-trend-210801",
		"http://akamai.infoworld.com/d/the-industry-standard/sinofsky-captivated-andreessen-horowitz-becomes-board-partner-225469?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/the-industry-standard/sinofsky-captivated-andreessen-horowitz-becomes-board-partner-225469",
		"http://akamai.infoworld.com/node/224333?source=rss_application_development": "http://akamai.infoworld.com/node/224333",
		"http://akamai.infoworld.com/t/application-development/dan-bricklin-javascript-beats-native-code-mobile-226537?source=rss_application_development": "http://akamai.infoworld.com/t/application-development/dan-bricklin-javascript-beats-native-code-mobile-226537",
		"http://akamai.infoworld.com/t/microsoft-windows/microsoft-pulls-botched-kb-2871630-while-many-office-patch-problems-remain-226690?source=rss_microsoft_windows": "http://akamai.infoworld.com/t/microsoft-windows/microsoft-pulls-botched-kb-2871630-while-many-office-patch-problems-remain-226690",
		"http://akamai.infoworld.com/d/mobile-technology/the-8-mobile-os-upstarts-want-topple-ios-and-android-213427?source=rss_html5": "http://akamai.infoworld.com/d/mobile-technology/the-8-mobile-os-upstarts-want-topple-ios-and-android-213427",
		"http://akamai.infoworld.com/d/application-development/apache-struts-security-update-disables-vulnerable-feature-227313?source=rss_open_source_software": "http://akamai.infoworld.com/d/application-development/apache-struts-security-update-disables-vulnerable-feature-227313",
		"http://akamai.infoworld.com/d/consumerization-of-it/giving-kids-ipads-wont-solve-the-education-challenge-224485?source=rss_computer_hardware": "http://akamai.infoworld.com/d/consumerization-of-it/giving-kids-ipads-wont-solve-the-education-challenge-224485",
		"http://akamai.infoworld.com/d/mobile-technology/review-lenovo-ideapad-yoga-11s-has-some-odd-moves-224027?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/mobile-technology/review-lenovo-ideapad-yoga-11s-has-some-odd-moves-224027",
		"http://akamai.infoworld.com/d/applications/chrome-will-block-npapi-plug-ins-over-stability-security-concerns-227428?source=rss_applications": "http://akamai.infoworld.com/d/applications/chrome-will-block-npapi-plug-ins-over-stability-security-concerns-227428",
		"http://akamai.infoworld.com/d/applications/review-apache-openoffice-4-vs-libreoffice-41-224280?source=rss_open_source_software": "http://akamai.infoworld.com/d/applications/review-apache-openoffice-4-vs-libreoffice-41-224280",
		"http://akamai.infoworld.com/d/microsoft-windows/microsoft-names-oct-18-windows-81-launch-224913?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/microsoft-windows/microsoft-names-oct-18-windows-81-launch-224913",
		"http://akamai.infoworld.com/t/search-engines/googles-new-hummingbird-algorithm-about-queries-not-just-seo-227732?source=rss_applications": "http://akamai.infoworld.com/t/search-engines/googles-new-hummingbird-algorithm-about-queries-not-just-seo-227732",
		"http://akamai.infoworld.com/d/application-development/why-microsoft-net-failed-225817?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/why-microsoft-net-failed-225817",
		"http://akamai.infoworld.com/d/open-source-software/jeff-hawkins-where-open-source-and-machine-learning-meet-big-data-224069?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/jeff-hawkins-where-open-source-and-machine-learning-meet-big-data-224069",
		"http://akamai.infoworld.com/d/open-source-software/vmware-brings-suse-linux-newly-launched-cloud-service-225734?source=rss_virtualization": "http://akamai.infoworld.com/d/open-source-software/vmware-brings-suse-linux-newly-launched-cloud-service-225734",
		"http://akamai.infoworld.com/d/storage/vm-based-storage-platform-scales-out-multiple-sites-228406?source=rss_storage": "http://akamai.infoworld.com/d/storage/vm-based-storage-platform-scales-out-multiple-sites-228406",
		"http://akamai.infoworld.com/d/virtualization/review-new-parallels-fusion-virtual-desktops-os-x-fail-the-smell-test-226160?source=rss_applications": "http://akamai.infoworld.com/d/virtualization/review-new-parallels-fusion-virtual-desktops-os-x-fail-the-smell-test-226160",
		"http://akamai.infoworld.com/d/applications/mozilla-plug-n-hack-project-aims-tighter-security-tool-integration-225464?source=rss_applications": "http://akamai.infoworld.com/d/applications/mozilla-plug-n-hack-project-aims-tighter-security-tool-integration-225464",
		"http://akamai.infoworld.com/d/security/zero-day-attacks-how-fight-back-224718?source=rss_security": "http://akamai.infoworld.com/d/security/zero-day-attacks-how-fight-back-224718",
		"http://akamai.infoworld.com/t/misadventures/the-best-of-the-worst-the-dirty-it-jobs-hall-of-shame-224567?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/t/misadventures/the-best-of-the-worst-the-dirty-it-jobs-hall-of-shame-224567",
		"http://akamai.infoworld.com/d/cloud-computing/update-salesforcecom-impose-massive-fee-hike-app-store-security-review-224587?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/update-salesforcecom-impose-massive-fee-hike-app-store-security-review-224587",
		"http://akamai.infoworld.com/t/cringely/no-one-said-it-would-be-easy-disrupt-amazon-226390?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/t/cringely/no-one-said-it-would-be-easy-disrupt-amazon-226390",
		"http://akamai.infoworld.com/d/microsoft-windows/microsoft-will-craft-xp-patches-after-april-14-not-you-225677?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/microsoft-windows/microsoft-will-craft-xp-patches-after-april-14-not-you-225677",
		"http://akamai.infoworld.com/d/mobile-technology/review-new-nexus-7-takes-ipad-mini-and-kindle-fire-hd-224483?source=rss_computer_hardware": "http://akamai.infoworld.com/d/mobile-technology/review-new-nexus-7-takes-ipad-mini-and-kindle-fire-hd-224483",
		"http://akamai.infoworld.com/d/the-industry-standard/high-pc-prices-hindering-industry-recovery-analysts-say-224647?source=rss_computer_hardware": "http://akamai.infoworld.com/d/the-industry-standard/high-pc-prices-hindering-industry-recovery-analysts-say-224647",
		"http://akamai.infoworld.com/d/security/microsoft-moves-block-md5-certificates-and-improve-rdp-authentication-224893?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/security/microsoft-moves-block-md5-certificates-and-improve-rdp-authentication-224893",
		"http://akamai.infoworld.com/t/microsoft-windows/microsoft-needs-your-help-fix-botched-patch-kb-2859537-225314?source=rss_microsoft_windows": "http://akamai.infoworld.com/t/microsoft-windows/microsoft-needs-your-help-fix-botched-patch-kb-2859537-225314",
		"http://akamai.infoworld.com/d/the-industry-standard/why-apple-has-thrived-while-dell-may-die-223402?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/the-industry-standard/why-apple-has-thrived-while-dell-may-die-223402",
		"http://akamai.infoworld.com/d/cloud-computing/google-encrypt-cloud-storage-data-default-225042?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/google-encrypt-cloud-storage-data-default-225042",
		"http://akamai.infoworld.com/d/computer-hardware/larry-ellison-skips-openworld-keynote-watch-americas-cup-227478?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/larry-ellison-skips-openworld-keynote-watch-americas-cup-227478",
		"http://akamai.infoworld.com/d/mobile-technology/facebook-buys-speech-translation-software-company-224795?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/mobile-technology/facebook-buys-speech-translation-software-company-224795",
		"http://akamai.infoworld.com/d/the-industry-standard/sinofsky-captivated-andreessen-horowitz-becomes-board-partner-225469?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/sinofsky-captivated-andreessen-horowitz-becomes-board-partner-225469",
		"http://akamai.infoworld.com/d/mobile-technology/lenovos-yoga-hybrids-strike-lighter-sleeker-pose-226189?source=rss_computer_hardware": "http://akamai.infoworld.com/d/mobile-technology/lenovos-yoga-hybrids-strike-lighter-sleeker-pose-226189",
		"http://akamai.infoworld.com/d/the-industry-standard/dance-of-the-zombies-why-going-private-wont-save-dell-or-blackberry-227556?source=rss_computer_hardware": "http://akamai.infoworld.com/d/the-industry-standard/dance-of-the-zombies-why-going-private-wont-save-dell-or-blackberry-227556",
		"http://akamai.infoworld.com/t/mobile-technology/the-problem-smart-watches-theyre-watches-226382?source=rss_mobile_technology": "http://akamai.infoworld.com/t/mobile-technology/the-problem-smart-watches-theyre-watches-226382",
		"http://akamai.infoworld.com/t/windows-phone/trying-the-apple-strategy-microsoft-buys-nokias-mobile-business-226008?source=rss_consumerization_of_it": "http://akamai.infoworld.com/t/windows-phone/trying-the-apple-strategy-microsoft-buys-nokias-mobile-business-226008",
		"http://akamai.infoworld.com/d/mobile-technology/the-apple-newton-messagepad-revisited-warts-wins-and-all-225184?source=rss_computer_hardware": "http://akamai.infoworld.com/d/mobile-technology/the-apple-newton-messagepad-revisited-warts-wins-and-all-225184",
		"http://akamai.infoworld.com/d/open-source-software/vmware-brings-suse-linux-newly-launched-cloud-service-225734?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/vmware-brings-suse-linux-newly-launched-cloud-service-225734",
		"http://akamai.infoworld.com/d/virtualization/rackspace-hosts-vmware-management-new-dedicated-server-225255?source=rss_virtualization": "http://akamai.infoworld.com/d/virtualization/rackspace-hosts-vmware-management-new-dedicated-server-225255",
		"http://akamai.infoworld.com/t/intellectual-property/trolling-effects-site-aims-fight-patent-trolls-crowdsourcing-223853?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/t/intellectual-property/trolling-effects-site-aims-fight-patent-trolls-crowdsourcing-223853",
		"http://akamai.infoworld.com/d/application-development/what-are-graph-databases-good-heres-killer-app-223729?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/what-are-graph-databases-good-heres-killer-app-223729",
		"http://akamai.infoworld.com/d/computer-hardware/intels-new-quark-chips-target-wearable-computing-226529?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/intels-new-quark-chips-target-wearable-computing-226529",
		"http://akamai.infoworld.com/d/mobile-technology/windows-tablets-capture-more-share-surface-suffers-224171?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/mobile-technology/windows-tablets-capture-more-share-surface-suffers-224171",
		"http://akamai.infoworld.com/d/security/red-hat-enterprise-linux-gets-cozy-mongodb-223696?source=rss_open_source_software": "http://akamai.infoworld.com/d/security/red-hat-enterprise-linux-gets-cozy-mongodb-223696",
		"http://akamai.infoworld.com/d/security/dangerous-linux-trojan-could-be-sign-of-things-come-224649?source=rss_security": "http://akamai.infoworld.com/d/security/dangerous-linux-trojan-could-be-sign-of-things-come-224649",
		"http://akamai.infoworld.com/t/applications/processmaker-25-open-source-workflow-made-faster-simpler-225159?source=rss_open_source_software": "http://akamai.infoworld.com/t/applications/processmaker-25-open-source-workflow-made-faster-simpler-225159",
		"http://akamai.infoworld.com/t/data-security/tor-browser-bundle-windows-users-susceptible-info-stealing-attack-224157?source=rss_security": "http://akamai.infoworld.com/t/data-security/tor-browser-bundle-windows-users-susceptible-info-stealing-attack-224157",
		"http://akamai.infoworld.com/t/mobile-development/native-mobile-app-dev-vs-html5-why-not-both-206167?source=rss_html5": "http://akamai.infoworld.com/t/mobile-development/native-mobile-app-dev-vs-html5-why-not-both-206167",
		"http://akamai.infoworld.com/t/nosql/datastax-primps-cassandra-developers-223222?source=rss_data_center": "http://akamai.infoworld.com/t/nosql/datastax-primps-cassandra-developers-223222",
		"http://akamai.infoworld.com/d/open-source-software/bossies-2013-the-best-of-open-source-software-awards-226971?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/bossies-2013-the-best-of-open-source-software-awards-226971",
		"http://akamai.infoworld.com/d/application-development/sap-creates-lava-design-language-heat-analytics-225089?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/sap-creates-lava-design-language-heat-analytics-225089",
		"http://akamai.infoworld.com/d/computer-hardware/lapsing-of-moores-law-opens-opportunity-in-chip-design-225722?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/lapsing-of-moores-law-opens-opportunity-in-chip-design-225722",
		"http://akamai.infoworld.com/d/computer-hardware/nvidia-drops-tegra-revenue-forecast-windows-rt-woes-loom-224570?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/computer-hardware/nvidia-drops-tegra-revenue-forecast-windows-rt-woes-loom-224570",
		"http://akamai.infoworld.com/d/data-explosion/in-cloud-world-developers-and-admins-cant-ignore-each-other-226862?source=rss_data_center": "http://akamai.infoworld.com/d/data-explosion/in-cloud-world-developers-and-admins-cant-ignore-each-other-226862",
		"http://akamai.infoworld.com/d/networking/tracking-services-monitor-your-every-move-228415?source=rss_networking": "http://akamai.infoworld.com/d/networking/tracking-services-monitor-your-every-move-228415",
		"http://akamai.infoworld.com/d/the-industry-standard/update-hp-replaces-enterprise-chief-posts-q3-sales-drop-225378?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/update-hp-replaces-enterprise-chief-posts-q3-sales-drop-225378",
		"http://akamai.infoworld.com/slideshow/114429/ifttt-nodejs-bakers-dozon-of-tech-tutorials-224569?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/slideshow/114429/ifttt-nodejs-bakers-dozon-of-tech-tutorials-224569",
		"http://akamai.infoworld.com/d/application-development/java-faces-tough-climb-catch-net-224372?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/java-faces-tough-climb-catch-net-224372",
		"http://akamai.infoworld.com/d/mobile-technology/moto-x-motorolas-chance-break-free-of-the-middle-223325?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/mobile-technology/moto-x-motorolas-chance-break-free-of-the-middle-223325",
		"http://akamai.infoworld.com/d/cloud-computing/cloud-kudos-only-grow-does-recognition-of-its-true-value-226044?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/cloud-kudos-only-grow-does-recognition-of-its-true-value-226044",
		"http://akamai.infoworld.com/d/computer-hardware/google-intel-cement-ties-chrome-os-could-weaken-wintel-226691?source=rss_mobile_technology": "http://akamai.infoworld.com/d/computer-hardware/google-intel-cement-ties-chrome-os-could-weaken-wintel-226691",
		"http://akamai.infoworld.com/d/data-center/restore-the-right-privacy-self-signed-certificates-226725?source=rss_networking": "http://akamai.infoworld.com/d/data-center/restore-the-right-privacy-self-signed-certificates-226725",
		"http://akamai.infoworld.com/d/microsoft-windows/do-devs-and-it-pros-get-windows-81-early-not-even-microsoft-knows-225029?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/microsoft-windows/do-devs-and-it-pros-get-windows-81-early-not-even-microsoft-knows-225029",
		"http://akamai.infoworld.com/d/virtualization/review-vmware-workstation-10-turns-tablets-226573?source=rss_application_development": "http://akamai.infoworld.com/d/virtualization/review-vmware-workstation-10-turns-tablets-226573",
		"http://akamai.infoworld.com/t/open-source-software/github-ceo-backs-mit-open-source-license-223505?source=rss_open_source_software": "http://akamai.infoworld.com/t/open-source-software/github-ceo-backs-mit-open-source-license-223505",
		"http://akamai.infoworld.com/d/application-development/oracle-and-arm-tweak-java-223191?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/oracle-and-arm-tweak-java-223191",
		"http://akamai.infoworld.com/d/data-center/nine-traits-of-the-veteran-network-admin-222513?source=rss_data_center": "http://akamai.infoworld.com/d/data-center/nine-traits-of-the-veteran-network-admin-222513",
		"http://akamai.infoworld.com/d/data-center/why-openflow-the-next-big-thing-221692?source=rss_networking": "http://akamai.infoworld.com/d/data-center/why-openflow-the-next-big-thing-221692",
		"http://akamai.infoworld.com/d/mobile-technology/how-apple-could-make-truly-cheap-iphone-5c-223637?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/mobile-technology/how-apple-could-make-truly-cheap-iphone-5c-223637",
		"http://akamai.infoworld.com/d/open-source-software/vmware-brings-suse-linux-newly-launched-cloud-service-225734?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/open-source-software/vmware-brings-suse-linux-newly-launched-cloud-service-225734",
		"http://akamai.infoworld.com/t/application-development/c-jumps-back-top-of-language-popularity-index-226731?source=rss_application_development": "http://akamai.infoworld.com/t/application-development/c-jumps-back-top-of-language-popularity-index-226731",
		"http://akamai.infoworld.com/t/application-development/dan-bricklin-javascript-beats-native-code-mobile-226537?source=rss_mobile_technology": "http://akamai.infoworld.com/t/application-development/dan-bricklin-javascript-beats-native-code-mobile-226537",
		"http://akamai.infoworld.com/d/applications/google-turns-15-and-celebrates-smartening-search-227661?source=rss_applications": "http://akamai.infoworld.com/d/applications/google-turns-15-and-celebrates-smartening-search-227661",
		"http://akamai.infoworld.com/t/hacking/video-watch-what-happens-when-prius-gets-hacked-224270?source=rss_security": "http://akamai.infoworld.com/t/hacking/video-watch-what-happens-when-prius-gets-hacked-224270",
		"http://akamai.infoworld.com/t/java-programming/oracle-hitches-java-internet-of-things-223214?source=rss_application_development": "http://akamai.infoworld.com/t/java-programming/oracle-hitches-java-internet-of-things-223214",
		"http://akamai.infoworld.com/d/cloud-computing/dimension-data-plans-cloud-backup-its-computing-services-224353?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/dimension-data-plans-cloud-backup-its-computing-services-224353",
		"http://akamai.infoworld.com/d/mobile-technology/parallels-access-shows-why-ipad-poor-pc-or-mac-225833?source=rss_applications": "http://akamai.infoworld.com/d/mobile-technology/parallels-access-shows-why-ipad-poor-pc-or-mac-225833",
		"http://akamai.infoworld.com/d/virtualization/first-look-windows-server-2012-r2-hyper-v-shines-223301?source=rss_data_center": "http://akamai.infoworld.com/d/virtualization/first-look-windows-server-2012-r2-hyper-v-shines-223301",
		"http://akamai.infoworld.com/d/open-source-software/bye-bye-ballmer-hello-open-source-microsofts-upcoming-options-225891?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/bye-bye-ballmer-hello-open-source-microsofts-upcoming-options-225891",
		"http://akamai.infoworld.com/d/virtualization/vmware-ceo-talks-software-defined-data-centers-openstack-and-dueling-amazon-224937?source=rss_virtualization": "http://akamai.infoworld.com/d/virtualization/vmware-ceo-talks-software-defined-data-centers-openstack-and-dueling-amazon-224937",
		"http://akamai.infoworld.com/t/internet-privacy/censor-busting-piratebrowser-works-within-limits-224886?source=rss_applications": "http://akamai.infoworld.com/t/internet-privacy/censor-busting-piratebrowser-works-within-limits-224886",
		"http://akamai.infoworld.com/t/linux/apache-and-linux-tale-of-two-open-source-projects-225873?source=rss_open_source_software": "http://akamai.infoworld.com/t/linux/apache-and-linux-tale-of-two-open-source-projects-225873",
		"http://akamai.infoworld.com/d/applications/facebook-launches-graph-search-acknowledges-privacy-concerns-224449?source=rss_applications": "http://akamai.infoworld.com/d/applications/facebook-launches-graph-search-acknowledges-privacy-concerns-224449",
		"http://akamai.infoworld.com/d/applications/microsoft-trades-reticence-transparency-and-discloses-office-365-uptime-data-224488?source=rss_cloud_computing": "http://akamai.infoworld.com/d/applications/microsoft-trades-reticence-transparency-and-discloses-office-365-uptime-data-224488",
		"http://akamai.infoworld.com/d/cloud-computing/what-the-cloud-will-look-in-3-years-224170?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/cloud-computing/what-the-cloud-will-look-in-3-years-224170",
		"http://akamai.infoworld.com/d/security/how-roll-your-own-vpn-223650?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/security/how-roll-your-own-vpn-223650",
		"http://akamai.infoworld.com/d/applications/move-over-android-the-future-will-be-chrome-223630?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/applications/move-over-android-the-future-will-be-chrome-223630",
		"http://akamai.infoworld.com/d/computer-hardware/bring-the-20gbps-speeds-asus-announces-worlds-first-thunderbolt-2-motherboard-225326?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/bring-the-20gbps-speeds-asus-announces-worlds-first-thunderbolt-2-motherboard-225326",
		"http://akamai.infoworld.com/d/computer-hardware/qualcomm-calls-out-eight-core-processors-dumb-223984?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/qualcomm-calls-out-eight-core-processors-dumb-223984",
		"http://akamai.infoworld.com/d/consumerization-of-it/giving-kids-ipads-wont-solve-the-education-challenge-224485?source=rss_applications": "http://akamai.infoworld.com/d/consumerization-of-it/giving-kids-ipads-wont-solve-the-education-challenge-224485",
		"http://akamai.infoworld.com/d/microsoft-windows/windows-81-review-new-version-same-mess-226510?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/microsoft-windows/windows-81-review-new-version-same-mess-226510",
		"http://akamai.infoworld.com/d/application-development/sap-expands-partner-program-application-development-223623?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/sap-expands-partner-program-application-development-223623",
		"http://akamai.infoworld.com/d/applications/sap-erp-customers-gain-options-improved-ui-224383?source=rss_applications": "http://akamai.infoworld.com/d/applications/sap-erp-customers-gain-options-improved-ui-224383",
		"http://akamai.infoworld.com/d/computer-hardware/windows-8-comes-open-source-pcs-gizmosphere-board-225010?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/windows-8-comes-open-source-pcs-gizmosphere-board-225010",
		"http://akamai.infoworld.com/d/open-source-software/bye-bye-ballmer-hello-open-source-microsofts-upcoming-options-225891?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/open-source-software/bye-bye-ballmer-hello-open-source-microsofts-upcoming-options-225891",
		"http://akamai.infoworld.com/d/the-industry-standard/apple-drops-exec-bob-mansfield-companys-leadership-team-223583?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/apple-drops-exec-bob-mansfield-companys-leadership-team-223583",
		"http://akamai.infoworld.com/d/data-center/review-chef-cooks-configuration-management-224178?source=rss_data_center": "http://akamai.infoworld.com/d/data-center/review-chef-cooks-configuration-management-224178",
		"http://akamai.infoworld.com/t/java-programming/java-8-developer-preview-ready-testing-226417?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/t/java-programming/java-8-developer-preview-ready-testing-226417",
		"http://akamai.infoworld.com/d/storage/review-qnap-nas-meets-xbmc-media-center-222966?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/storage/review-qnap-nas-meets-xbmc-media-center-222966",
		"http://akamai.infoworld.com/t/cloud-computing/how-it-will-be-blown-bits-208216?source=rss_enterprise_architecture": "http://akamai.infoworld.com/t/cloud-computing/how-it-will-be-blown-bits-208216",
		"http://akamai.infoworld.com/t/it-management/the-big-shift-in-business-technology-222038?source=rss_enterprise_architecture": "http://akamai.infoworld.com/t/it-management/the-big-shift-in-business-technology-222038",
		"http://akamai.infoworld.com/d/computer-hardware/4-things-love-about-googles-chromebook-pixel-and-4-things-hate-224990?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/4-things-love-about-googles-chromebook-pixel-and-4-things-hate-224990",
		"http://akamai.infoworld.com/d/data-explosion/the-welcome-rise-of-the-cloud-middleman-227361?source=rss_data_center": "http://akamai.infoworld.com/d/data-explosion/the-welcome-rise-of-the-cloud-middleman-227361",
		"http://akamai.infoworld.com/d/open-source-software/new-red-hat-enterprise-linux-licensing-aims-unify-cloud-physical-environments-228005?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/new-red-hat-enterprise-linux-licensing-aims-unify-cloud-physical-environments-228005",
		"http://akamai.infoworld.com/d/security/microsoft-patch-tuesday-the-ping-of-death-returns-ipv6-style-224867?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/security/microsoft-patch-tuesday-the-ping-of-death-returns-ipv6-style-224867",
		"http://akamai.infoworld.com/node/224132?source=rss_security": "http://akamai.infoworld.com/node/224132",
		"http://akamai.infoworld.com/d/the-industry-standard/developers-ios-down-html5-203393?source=rss_html5": "http://akamai.infoworld.com/d/the-industry-standard/developers-ios-down-html5-203393",
		"http://akamai.infoworld.com/d/application-development/beginners-guide-r-painless-data-visualization-225370?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/beginners-guide-r-painless-data-visualization-225370",
		"http://akamai.infoworld.com/d/security/dangerous-linux-trojan-could-be-sign-of-things-come-224649?source=rss_open_source_software": "http://akamai.infoworld.com/d/security/dangerous-linux-trojan-could-be-sign-of-things-come-224649",
		"http://akamai.infoworld.com/d/the-industry-standard/dell-profit-slides-72-percent-privatization-battle-drags-225048?source=rss_computer_hardware": "http://akamai.infoworld.com/d/the-industry-standard/dell-profit-slides-72-percent-privatization-battle-drags-225048",
		"http://akamai.infoworld.com/d/computer-hardware/dells-project-ophelia-could-be-more-bad-news-pcs-223649?source=rss_storage": "http://akamai.infoworld.com/d/computer-hardware/dells-project-ophelia-could-be-more-bad-news-pcs-223649",
		"http://akamai.infoworld.com/d/consumerization-of-it/the-wireless-revolutions-forgotten-victim-the-phone-itself-225797?source=rss_computer_hardware": "http://akamai.infoworld.com/d/consumerization-of-it/the-wireless-revolutions-forgotten-victim-the-phone-itself-225797",
		"http://akamai.infoworld.com/d/storage/disk-giants-raise-the-hard-drive-banner-flash-storage-powwow-224842?source=rss_storage": "http://akamai.infoworld.com/d/storage/disk-giants-raise-the-hard-drive-banner-flash-storage-powwow-224842",
		"http://akamai.infoworld.com/d/application-development/in-defense-of-apache-225555?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/in-defense-of-apache-225555",
		"http://akamai.infoworld.com/d/cloud-computing/programmer-exploits-windows-vulnerability-in-cloud-based-services-226728?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/programmer-exploits-windows-vulnerability-in-cloud-based-services-226728",
		"http://akamai.infoworld.com/d/the-industry-standard/microsoft-who-sinofsky-adds-another-scene-his-second-act-signs-box-225888?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/microsoft-who-sinofsky-adds-another-scene-his-second-act-signs-box-225888",
		"http://akamai.infoworld.com/d/virtualization/commvault-announces-vm-archiving-eliminate-vm-sprawl-225551?source=rss_virtualization": "http://akamai.infoworld.com/d/virtualization/commvault-announces-vm-archiving-eliminate-vm-sprawl-225551",
		"http://akamai.infoworld.com/d/business-intelligence/big-data-without-good-analytics-can-lead-bad-decisions-225608?source=rss_business_intelligence": "http://akamai.infoworld.com/d/business-intelligence/big-data-without-good-analytics-can-lead-bad-decisions-225608",
		"http://akamai.infoworld.com/d/security/cisco-ios-updates-fix-10-denial-of-service-vulnerabilities-227715?source=rss_networking": "http://akamai.infoworld.com/d/security/cisco-ios-updates-fix-10-denial-of-service-vulnerabilities-227715",
		"http://akamai.infoworld.com/d/virtualization/vmware-sets-its-sights-network-virtualization-225647?source=rss_virtualization": "http://akamai.infoworld.com/d/virtualization/vmware-sets-its-sights-network-virtualization-225647",
		"http://akamai.infoworld.com/d/virtualization/vmwares-virtualization-quest-could-help-shake-storage-too-225792?source=rss_storage": "http://akamai.infoworld.com/d/virtualization/vmwares-virtualization-quest-could-help-shake-storage-too-225792",
		"http://akamai.infoworld.com/d/mobile-technology/update-blackberry-starts-looking-buyer-or-partner-new-os-struggles-224683?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/mobile-technology/update-blackberry-starts-looking-buyer-or-partner-new-os-struggles-224683",
		"http://akamai.infoworld.com/d/security/public-release-of-ie-exploit-could-spark-widespread-attacks-227950?source=rss_applications": "http://akamai.infoworld.com/d/security/public-release-of-ie-exploit-could-spark-widespread-attacks-227950",
		"http://akamai.infoworld.com/d/applications/codependent-no-more-onenote-ipad-liberated-desktop-app-226304?source=rss_applications": "http://akamai.infoworld.com/d/applications/codependent-no-more-onenote-ipad-liberated-desktop-app-226304",
		"http://akamai.infoworld.com/d/applications/the-blink-tag-finally-dead-killed-firefox-23-224363?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/applications/the-blink-tag-finally-dead-killed-firefox-23-224363",
		"http://akamai.infoworld.com/d/data-explosion/two-key-reasons-deploying-the-cloud-different-223619?source=rss_cloud_computing": "http://akamai.infoworld.com/d/data-explosion/two-key-reasons-deploying-the-cloud-different-223619",
		"http://akamai.infoworld.com/d/open-source-software/bossies-2013-the-best-of-open-source-software-awards-226971?source=rss_data_center": "http://akamai.infoworld.com/d/open-source-software/bossies-2013-the-best-of-open-source-software-awards-226971",
		"http://akamai.infoworld.com/t/mobile-technology/the-problem-smart-watches-theyre-watches-226382?source=rss_consumerization_of_it": "http://akamai.infoworld.com/t/mobile-technology/the-problem-smart-watches-theyre-watches-226382",
		"http://akamai.infoworld.com/d/microsoft-windows/dell-sticks-windows-8-business-tablets-226346?source=rss_mobile_technology": "http://akamai.infoworld.com/d/microsoft-windows/dell-sticks-windows-8-business-tablets-226346",
		"http://akamai.infoworld.com/d/open-source-software/red-hat-unveils-new-offerings-cloud-certification-vmworld-225642?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/red-hat-unveils-new-offerings-cloud-certification-vmworld-225642",
		"http://akamai.infoworld.com/d/the-industry-standard/high-pc-prices-hindering-industry-recovery-analysts-say-224647?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/high-pc-prices-hindering-industry-recovery-analysts-say-224647",
		"http://akamai.infoworld.com/t/cringely/meet-the-new-hackers-johnny-law-224156?source=rss_security": "http://akamai.infoworld.com/t/cringely/meet-the-new-hackers-johnny-law-224156",
		"http://akamai.infoworld.com/t/cringely/the-myth-of-do-not-track-and-the-tragedy-of-internet-privacy-223827?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/t/cringely/the-myth-of-do-not-track-and-the-tragedy-of-internet-privacy-223827",
		"http://akamai.infoworld.com/t/data-center/the-best-hardware-software-and-cloud-services-of-the-year-210362?source=rss_html5": "http://akamai.infoworld.com/t/data-center/the-best-hardware-software-and-cloud-services-of-the-year-210362",
		"http://akamai.infoworld.com/t/development-tools/salesforce-touts-new-mobile-tools-developers-223661?source=rss_cloud_computing": "http://akamai.infoworld.com/t/development-tools/salesforce-touts-new-mobile-tools-developers-223661",
		"http://akamai.infoworld.com/d/security/anonymous-not-anonymous-224783?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/security/anonymous-not-anonymous-224783",
		"http://akamai.infoworld.com/t/cringely/windows-rt-more-windows-wtf-224950?source=rss_microsoft_windows": "http://akamai.infoworld.com/t/cringely/windows-rt-more-windows-wtf-224950",
		"http://akamai.infoworld.com/d/the-industry-standard/facebook-and-infosys-working-hard-perpetuate-h-1b-hypocrisy-224422?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/the-industry-standard/facebook-and-infosys-working-hard-perpetuate-h-1b-hypocrisy-224422",
		"http://akamai.infoworld.com/t/microsoft-windows/first-jaundiced-look-windows-81-rtm-225925?source=rss_microsoft_windows": "http://akamai.infoworld.com/t/microsoft-windows/first-jaundiced-look-windows-81-rtm-225925",
		"http://akamai.infoworld.com/d/computer-hardware/new-haswell-chromebooks-expected-week-idf-226428?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/new-haswell-chromebooks-expected-week-idf-226428",
		"http://akamai.infoworld.com/d/data-center/review-ansible-orchestration-veteran-unix-admins-dream-228509?source=rss_data_center": "http://akamai.infoworld.com/d/data-center/review-ansible-orchestration-veteran-unix-admins-dream-228509",
		"http://akamai.infoworld.com/t/applications/if-you-think-phones-tablets-and-computers-are-smart-now-just-wait-225885?source=rss_applications": "http://akamai.infoworld.com/t/applications/if-you-think-phones-tablets-and-computers-are-smart-now-just-wait-225885",
		"http://akamai.infoworld.com/d/applications/hp-consolidates-record-management-applications-224359?source=rss_applications": "http://akamai.infoworld.com/d/applications/hp-consolidates-record-management-applications-224359",
		"http://akamai.infoworld.com/d/open-source-software/in-their-own-words-unix-pioneers-remember-the-good-times-225113?source=rss_applications": "http://akamai.infoworld.com/d/open-source-software/in-their-own-words-unix-pioneers-remember-the-good-times-225113",
		"http://akamai.infoworld.com/slideshow/114906/beyond-google-glass-the-wearable-tech-will-revolutionize-business-224958?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/slideshow/114906/beyond-google-glass-the-wearable-tech-will-revolutionize-business-224958",
		"http://akamai.infoworld.com/t/technology-business/iphone-5s-5c-release-rumor-outbreak-%E2%80%94-leaked-next-windows-81-build-%E2%80%98privacy-leaching%E2%80%99-%E2%80%94-blackberry-trad?source=rss_the_industry_standard": "http://akamai.infoworld.com/t/technology-business/iphone-5s-5c-release-rumor-outbreak-%E2%80%94-leaked-next-windows-81-build-%E2%80%98privacy-leaching%E2%80%99-%E2%80%94-blackberry-trad",
		"http://akamai.infoworld.com/d/computer-hardware/review-samsung-ativ-book-6-goes-big-gamers-business-users-too-227262?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/review-samsung-ativ-book-6-goes-big-gamers-business-users-too-227262",
		"http://akamai.infoworld.com/d/mobile-technology/lawyers-sue-microsoft-over-surface-rt-unmitigated-disaster-224890?source=rss_mobile_technology": "http://akamai.infoworld.com/d/mobile-technology/lawyers-sue-microsoft-over-surface-rt-unmitigated-disaster-224890",
		"http://akamai.infoworld.com/d/business-intelligence/workday-rolls-out-big-data-analytics-module-226440?source=rss_cloud_computing": "http://akamai.infoworld.com/d/business-intelligence/workday-rolls-out-big-data-analytics-module-226440",
		"http://akamai.infoworld.com/d/consumerization-of-it/wishful-thinking-wont-reverse-microsofts-misfortune-224877?source=rss_mobile_technology": "http://akamai.infoworld.com/d/consumerization-of-it/wishful-thinking-wont-reverse-microsofts-misfortune-224877",
		"http://akamai.infoworld.com/node/224396?source=rss_security": "http://akamai.infoworld.com/node/224396",
		"http://akamai.infoworld.com/t/printers/coming-business-near-you-3d-printing-227214?source=rss_computer_hardware": "http://akamai.infoworld.com/t/printers/coming-business-near-you-3d-printing-227214",
		"http://akamai.infoworld.com/d/mobile-technology/review-lenovo-ideapad-yoga-11s-has-some-odd-moves-224027?source=rss_computer_hardware": "http://akamai.infoworld.com/d/mobile-technology/review-lenovo-ideapad-yoga-11s-has-some-odd-moves-224027",
		"http://akamai.infoworld.com/d/networking/sdn-pioneers-share-their-secrets-228278?source=rss_networking": "http://akamai.infoworld.com/d/networking/sdn-pioneers-share-their-secrets-228278",
		"http://akamai.infoworld.com/t/data-security/lavabit-shutdown-marks-another-costly-blemish-us-tech-companies-224582?source=rss_security": "http://akamai.infoworld.com/t/data-security/lavabit-shutdown-marks-another-costly-blemish-us-tech-companies-224582",
		"http://akamai.infoworld.com/d/application-development/the-bare-bones-cloud-why-bother-226172?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/the-bare-bones-cloud-why-bother-226172",
		"http://akamai.infoworld.com/d/mobile-technology/apple-sneaks-in-changes-applecare-226602?source=rss_mobile_technology": "http://akamai.infoworld.com/d/mobile-technology/apple-sneaks-in-changes-applecare-226602",
		"http://akamai.infoworld.com/d/mobile-technology/finally-mobile-management-both-it-and-users-can-get-behind-225449?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/mobile-technology/finally-mobile-management-both-it-and-users-can-get-behind-225449",
		"http://akamai.infoworld.com/t/java-programming/microsoft-azul-put-open-source-java-azure-cloud-223377?source=rss_open_source_software": "http://akamai.infoworld.com/t/java-programming/microsoft-azul-put-open-source-java-azure-cloud-223377",
		"http://akamai.infoworld.com/t/outsourcing/outsourced-software-project-6000-pages-of-specs-ends-badly-224777?source=rss_application_development": "http://akamai.infoworld.com/t/outsourcing/outsourced-software-project-6000-pages-of-specs-ends-badly-224777",
		"http://akamai.infoworld.com/d/data-center/sap-seeks-edge-nsa-surveillance-worries-227944?source=rss_data_center": "http://akamai.infoworld.com/d/data-center/sap-seeks-edge-nsa-surveillance-worries-227944",
		"http://akamai.infoworld.com/t/data-center/understanding-the-software-defined-data-center-225652?source=rss_virtualization": "http://akamai.infoworld.com/t/data-center/understanding-the-software-defined-data-center-225652",
		"http://akamai.infoworld.com/d/applications/outlookcom-and-skype-integration-starts-roll-out-225208?source=rss_applications": "http://akamai.infoworld.com/d/applications/outlookcom-and-skype-integration-starts-roll-out-225208",
		"http://akamai.infoworld.com/d/computer-hardware/samsung-starts-mass-production-of-ddr4-memories-225928?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/samsung-starts-mass-production-of-ddr4-memories-225928",
		"http://akamai.infoworld.com/d/data-center/build-your-production-system-first-tearing-it-down-224481?source=rss_data_center": "http://akamai.infoworld.com/d/data-center/build-your-production-system-first-tearing-it-down-224481",
		"http://akamai.infoworld.com/d/mobile-technology/review-acer-iconia-w3-810-too-little-too-lame-225819?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/mobile-technology/review-acer-iconia-w3-810-too-little-too-lame-225819",
		"http://akamai.infoworld.com/d/computer-hardware/samsung-mass-produces-industrys-first-3d-nand-flash-chips-224190?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/samsung-mass-produces-industrys-first-3d-nand-flash-chips-224190",
		"http://akamai.infoworld.com/d/microsoft-windows/dell-sticks-windows-8-business-tablets-226346?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/microsoft-windows/dell-sticks-windows-8-business-tablets-226346",
		"http://akamai.infoworld.com/d/mobile-technology/android-mobile-worlds-equivalent-of-windows-hackers-225057?source=rss_mobile_technology": "http://akamai.infoworld.com/d/mobile-technology/android-mobile-worlds-equivalent-of-windows-hackers-225057",
		"http://akamai.infoworld.com/t/consumerization-of-it/the-futility-of-the-single-device-solution-224850?source=rss_consumerization_of_it": "http://akamai.infoworld.com/t/consumerization-of-it/the-futility-of-the-single-device-solution-224850",
		"http://akamai.infoworld.com/d/data-center/why-you-should-be-using-rsync-225814?source=rss_data_center": "http://akamai.infoworld.com/d/data-center/why-you-should-be-using-rsync-225814",
		"http://akamai.infoworld.com/d/the-industry-standard/blackberrys-bleak-options-will-anyone-really-want-buy-it-224782?source=rss_mobile_technology": "http://akamai.infoworld.com/d/the-industry-standard/blackberrys-bleak-options-will-anyone-really-want-buy-it-224782",
		"http://akamai.infoworld.com/t/consumerization-of-it/your-key-technology-decisions-2013-208803?source=rss_enterprise_architecture": "http://akamai.infoworld.com/t/consumerization-of-it/your-key-technology-decisions-2013-208803",
		"http://akamai.infoworld.com/d/the-industry-standard/sprint-reports-16b-net-loss-it-shuts-down-nextel-platform-223675?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/sprint-reports-16b-net-loss-it-shuts-down-nextel-platform-223675",
		"http://akamai.infoworld.com/t/intellectual-property/trolling-effects-site-aims-fight-patent-trolls-crowdsourcing-223853?source=rss_the_industry_standard": "http://akamai.infoworld.com/t/intellectual-property/trolling-effects-site-aims-fight-patent-trolls-crowdsourcing-223853",
		"http://akamai.infoworld.com/d/applications/microsofts-office-365-add-ons-muddy-licensing-and-make-customers-pay-twice-224766?source=rss_applications": "http://akamai.infoworld.com/d/applications/microsofts-office-365-add-ons-muddy-licensing-and-make-customers-pay-twice-224766",
		"http://akamai.infoworld.com/d/computer-hardware/google-rekindles-motorola-legacy-mobile-x8-chipset-223975?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/google-rekindles-motorola-legacy-mobile-x8-chipset-223975",
		"http://akamai.infoworld.com/d/consumerization-of-it/go-free-chat-disruptive-services-outrun-big-brother-225282?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/consumerization-of-it/go-free-chat-disruptive-services-outrun-big-brother-225282",
		"http://akamai.infoworld.com/d/consumerization-of-it/giving-kids-ipads-wont-solve-the-education-challenge-224485?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/consumerization-of-it/giving-kids-ipads-wont-solve-the-education-challenge-224485",
		"http://akamai.infoworld.com/d/consumerization-of-it/lenovos-thinkpad-t440-packs-dual-batteries-runs-17-hours-226009?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/consumerization-of-it/lenovos-thinkpad-t440-packs-dual-batteries-runs-17-hours-226009",
		"http://akamai.infoworld.com/d/the-industry-standard/dell-profit-slides-72-percent-privatization-battle-drags-225048?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/dell-profit-slides-72-percent-privatization-battle-drags-225048",
		"http://akamai.infoworld.com/t/mobile-technology/the-problem-smart-watches-theyre-watches-226382?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/t/mobile-technology/the-problem-smart-watches-theyre-watches-226382",
		"http://akamai.infoworld.com/d/applications/google-takes-second-browser-spot-the-back-of-mobile-226014?source=rss_applications": "http://akamai.infoworld.com/d/applications/google-takes-second-browser-spot-the-back-of-mobile-226014",
		"http://akamai.infoworld.com/d/cloud-computing/microsoft-continues-cloud-erp-push-dynamics-nav-update-226140?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/microsoft-continues-cloud-erp-push-dynamics-nav-update-226140",
		"http://akamai.infoworld.com/d/data-management/mysql-face-mysql-or-mariadb-224665?source=rss_open_source_software": "http://akamai.infoworld.com/d/data-management/mysql-face-mysql-or-mariadb-224665",
		"http://akamai.infoworld.com/d/security/bitcoin-wallets-upgraded-after-android-cryptography-problem-224887?source=rss_security": "http://akamai.infoworld.com/d/security/bitcoin-wallets-upgraded-after-android-cryptography-problem-224887",
		"http://akamai.infoworld.com/d/the-industry-standard/the-surface-fiasco-fallout-ballmer-youre-fired-223821?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/the-surface-fiasco-fallout-ballmer-youre-fired-223821",
		"http://akamai.infoworld.com/d/data-center/review-puppet-enterprise-30-pulls-more-strings-222737?source=rss_data_center": "http://akamai.infoworld.com/d/data-center/review-puppet-enterprise-30-pulls-more-strings-222737",
		"http://akamai.infoworld.com/d/data-explosion/vmware-vsan-inside-the-revolutionary-new-approach-storage-225962?source=rss_virtualization": "http://akamai.infoworld.com/d/data-explosion/vmware-vsan-inside-the-revolutionary-new-approach-storage-225962",
		"http://akamai.infoworld.com/t/java-programming/javafx-evangelism-why-developers-should-have-faith-197443?source=rss_html5": "http://akamai.infoworld.com/t/java-programming/javafx-evangelism-why-developers-should-have-faith-197443",
		"http://akamai.infoworld.com/d/application-development/amazon-lets-developers-make-money-selling-physical-goods-android-apps-225707?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/amazon-lets-developers-make-money-selling-physical-goods-android-apps-225707",
		"http://akamai.infoworld.com/d/microsoft-windows/xps-retirement-will-be-hacker-heaven-224796?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/microsoft-windows/xps-retirement-will-be-hacker-heaven-224796",
		"http://akamai.infoworld.com/d/open-source-software/the-last-days-of-unix-225112?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/the-last-days-of-unix-225112",
		"http://akamai.infoworld.com/d/storage/flash-breakthrough-promises-faster-storage-terabytes-of-memory-223670?source=rss_storage": "http://akamai.infoworld.com/d/storage/flash-breakthrough-promises-faster-storage-terabytes-of-memory-223670",
		"http://akamai.infoworld.com/t/application-development/now-the-developer-king-221850?source=rss_enterprise_architecture": "http://akamai.infoworld.com/t/application-development/now-the-developer-king-221850",
		"http://akamai.infoworld.com/t/java-programming/java-security-will-be-in-the-spotlight-javaone-225920?source=rss_application_development": "http://akamai.infoworld.com/t/java-programming/java-security-will-be-in-the-spotlight-javaone-225920",
		"http://akamai.infoworld.com/t/microsoft-windows/could-microsofts-rebranding-extend-far-beyond-skydrive-224095?source=rss_the_industry_standard": "http://akamai.infoworld.com/t/microsoft-windows/could-microsofts-rebranding-extend-far-beyond-skydrive-224095",
		"http://akamai.infoworld.com/t/startups/are-we-in-enterprise-startup-bubble-223138?source=rss_consumerization_of_it": "http://akamai.infoworld.com/t/startups/are-we-in-enterprise-startup-bubble-223138",
		"http://akamai.infoworld.com/d/security/open-source-project-crypton-seeks-make-encryption-easier-223509?source=rss_open_source_software": "http://akamai.infoworld.com/d/security/open-source-project-crypton-seeks-make-encryption-easier-223509",
		"http://akamai.infoworld.com/t/cloud-computing/protect-yourself-the-coming-cloud-crack-218872?source=rss_enterprise_architecture": "http://akamai.infoworld.com/t/cloud-computing/protect-yourself-the-coming-cloud-crack-218872",
		"http://akamai.infoworld.com/t/cringely/watch-the-throne-the-cruelest-hack-of-all-224391?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/t/cringely/watch-the-throne-the-cruelest-hack-of-all-224391",
		"http://akamai.infoworld.com/t/technology-business/beyond-the-iphone-what-pundits-dont-get-about-apple-226640?source=rss_computer_hardware": "http://akamai.infoworld.com/t/technology-business/beyond-the-iphone-what-pundits-dont-get-about-apple-226640",
		"http://akamai.infoworld.com/d/application-development/love-and-hate-java-8-223200?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/love-and-hate-java-8-223200",
		"http://akamai.infoworld.com/d/cloud-computing/the-clouds-next-big-federal-spying-threat-224086?source=rss_security": "http://akamai.infoworld.com/d/cloud-computing/the-clouds-next-big-federal-spying-threat-224086",
		"http://akamai.infoworld.com/d/open-source-software/red-hat-unveils-new-offerings-cloud-certification-vmworld-225642?source=rss_virtualization": "http://akamai.infoworld.com/d/open-source-software/red-hat-unveils-new-offerings-cloud-certification-vmworld-225642",
		"http://akamai.infoworld.com/d/virtualization/hytrust-enforces-two-person-approval-vmware-security-225567?source=rss_virtualization": "http://akamai.infoworld.com/d/virtualization/hytrust-enforces-two-person-approval-vmware-security-225567",
		"http://akamai.infoworld.com/d/virtualization/inside-look-what-expect-vmworld-2013-225106?source=rss_virtualization": "http://akamai.infoworld.com/d/virtualization/inside-look-what-expect-vmworld-2013-225106",
		"http://akamai.infoworld.com/t/microsoft-windows/windows-81-rtms-developers-wont-get-it-until-october-225693?source=rss_microsoft_windows": "http://akamai.infoworld.com/t/microsoft-windows/windows-81-rtms-developers-wont-get-it-until-october-225693",
		"http://akamai.infoworld.com/t/web-development/microsofts-new-web-scanning-tool-finds-companys-own-sites-lacking-212000?source=rss_html5": "http://akamai.infoworld.com/t/web-development/microsofts-new-web-scanning-tool-finds-companys-own-sites-lacking-212000",
		"http://akamai.infoworld.com/d/applications/microsoft-trades-reticence-transparency-and-discloses-office-365-uptime-data-224488?source=rss_applications": "http://akamai.infoworld.com/d/applications/microsoft-trades-reticence-transparency-and-discloses-office-365-uptime-data-224488",
		"http://akamai.infoworld.com/d/consumerization-of-it/battle-of-the-media-ecosystems-amazon-apple-google-and-microsoft-223998?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/consumerization-of-it/battle-of-the-media-ecosystems-amazon-apple-google-and-microsoft-223998",
		"http://akamai.infoworld.com/d/open-source-software/review-ubuntu-comes-out-ahead-among-5-linux-enterprise-servers-226416?source=rss_computer_hardware": "http://akamai.infoworld.com/d/open-source-software/review-ubuntu-comes-out-ahead-among-5-linux-enterprise-servers-226416",
		"http://akamai.infoworld.com/d/applications/facebook-widens-graph-search-include-posts-status-updates-227888?source=rss_applications": "http://akamai.infoworld.com/d/applications/facebook-widens-graph-search-include-posts-status-updates-227888",
		"http://akamai.infoworld.com/d/data-center/beware-of-backups-come-back-bite-you-226118?source=rss_storage": "http://akamai.infoworld.com/d/data-center/beware-of-backups-come-back-bite-you-226118",
		"http://akamai.infoworld.com/d/mobile-technology/apple-announces-take-back-program-iphone-power-adapters-224230?source=rss_computer_hardware": "http://akamai.infoworld.com/d/mobile-technology/apple-announces-take-back-program-iphone-power-adapters-224230",
		"http://akamai.infoworld.com/d/mobile-technology/microsoft-sticks-guns-will-unveil-refreshed-surface-tablets-sept-23-226441?source=rss_mobile_technology": "http://akamai.infoworld.com/d/mobile-technology/microsoft-sticks-guns-will-unveil-refreshed-surface-tablets-sept-23-226441",
		"http://akamai.infoworld.com/t/networking/making-broadband-business-ready-228436?source=rss_networking": "http://akamai.infoworld.com/t/networking/making-broadband-business-ready-228436",
		"http://akamai.infoworld.com/d/cloud-computing/gartner-amazon-still-public-cloud-leader-long-shot-225324?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/gartner-amazon-still-public-cloud-leader-long-shot-225324",
		"http://akamai.infoworld.com/d/networking/will-software-defined-networking-kill-network-engineers-beloved-cli-225968?source=rss_networking": "http://akamai.infoworld.com/d/networking/will-software-defined-networking-kill-network-engineers-beloved-cli-225968",
		"http://akamai.infoworld.com/d/the-industry-standard/ibm-says-sec-investigating-how-it-reports-cloud-revenues-223843?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/ibm-says-sec-investigating-how-it-reports-cloud-revenues-223843",
		"http://akamai.infoworld.com/d/application-development/who-nailed-the-principles-of-great-ui-design-microsoft-thats-who-217704?source=rss_html5": "http://akamai.infoworld.com/d/application-development/who-nailed-the-principles-of-great-ui-design-microsoft-thats-who-217704",
		"http://akamai.infoworld.com/d/applications/pirate-bay-introduces-web-browser-elude-censorship-224677?source=rss_applications": "http://akamai.infoworld.com/d/applications/pirate-bay-introduces-web-browser-elude-censorship-224677",
		"http://akamai.infoworld.com/d/cloud-computing/forrester-file-sync-and-share-heats-in-the-enterprise-222622?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/cloud-computing/forrester-file-sync-and-share-heats-in-the-enterprise-222622",
		"http://akamai.infoworld.com/t/technology-consulting/new-tweets-second-record-google-downtime-outlook-down-three-days-hadoop-sits-oracle-teradata-upheld-c?source=rss_business_intelligence": "http://akamai.infoworld.com/t/technology-consulting/new-tweets-second-record-google-downtime-outlook-down-three-days-hadoop-sits-oracle-teradata-upheld-c",
		"http://akamai.infoworld.com/d/applications/loud-and-clear-user-requests-prompt-microsoft-add-imap-outlookcom-226764?source=rss_applications": "http://akamai.infoworld.com/d/applications/loud-and-clear-user-requests-prompt-microsoft-add-imap-outlookcom-226764",
		"http://akamai.infoworld.com/d/mobile-technology/t-mobile-usa-sued-over-geolocation-technology-224098?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/mobile-technology/t-mobile-usa-sued-over-geolocation-technology-224098",
		"http://akamai.infoworld.com/d/mobile-technology/what-the-first-64-bit-iphone-chip-means-you-hint-not-much-right-now-226585?source=rss_mobile_technology": "http://akamai.infoworld.com/d/mobile-technology/what-the-first-64-bit-iphone-chip-means-you-hint-not-much-right-now-226585",
		"http://akamai.infoworld.com/d/the-industry-standard/blackberry-reportedly-plans-spin-of-instant-messaging-software-225736?source=rss_applications": "http://akamai.infoworld.com/d/the-industry-standard/blackberry-reportedly-plans-spin-of-instant-messaging-software-225736",
		"http://akamai.infoworld.com/d/the-industry-standard/report-apple-buys-embark-yet-another-mapping-app-225456?source=rss_applications": "http://akamai.infoworld.com/d/the-industry-standard/report-apple-buys-embark-yet-another-mapping-app-225456",
		"http://akamai.infoworld.com/d/mobile-technology/all-you-need-know-about-the-new-iphone-226257?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/mobile-technology/all-you-need-know-about-the-new-iphone-226257",
		"http://akamai.infoworld.com/t/microsoft-windows/microsoft-surface-naming-debacle-about-get-worse-225683?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/t/microsoft-windows/microsoft-surface-naming-debacle-about-get-worse-225683",
		"http://akamai.infoworld.com/d/cloud-computing/microsoft-restores-outlookcom-after-three-day-outage-sort-of-225104?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/microsoft-restores-outlookcom-after-three-day-outage-sort-of-225104",
		"http://akamai.infoworld.com/d/data-center/6-wishes-sysadmin-appreciation-day-223502?source=rss_data_center": "http://akamai.infoworld.com/d/data-center/6-wishes-sysadmin-appreciation-day-223502",
		"http://akamai.infoworld.com/d/open-source-software/facebook-open-source-cache-squeezes-more-flash-disks-228503?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/facebook-open-source-cache-squeezes-more-flash-disks-228503",
		"http://akamai.infoworld.com/d/consumerization-of-it/cisco-shows-how-manage-35000-macs-226305?source=rss_computer_hardware": "http://akamai.infoworld.com/d/consumerization-of-it/cisco-shows-how-manage-35000-macs-226305",
		"http://akamai.infoworld.com/t/hybrid-cloud/microsofts-deal-att-shows-the-new-path-cloud-partnerships-227164?source=rss_networking": "http://akamai.infoworld.com/t/hybrid-cloud/microsofts-deal-att-shows-the-new-path-cloud-partnerships-227164",
		"http://akamai.infoworld.com/t/java-programming/microsoft-azul-put-open-source-java-azure-cloud-223377?source=rss_application_development": "http://akamai.infoworld.com/t/java-programming/microsoft-azul-put-open-source-java-azure-cloud-223377",
		"http://akamai.infoworld.com/d/business-intelligence/oracle-unveils-html5-based-mobile-bi-app-designer-225138?source=rss_application_development": "http://akamai.infoworld.com/d/business-intelligence/oracle-unveils-html5-based-mobile-bi-app-designer-225138",
		"http://akamai.infoworld.com/d/computer-hardware/ultrabook-workstation-not-oxymoron-hp-226666?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/ultrabook-workstation-not-oxymoron-hp-226666",
		"http://akamai.infoworld.com/d/data-center/nine-traits-of-the-veteran-network-admin-222513?source=rss_networking": "http://akamai.infoworld.com/d/data-center/nine-traits-of-the-veteran-network-admin-222513",
		"http://akamai.infoworld.com/d/mobile-technology/how-apple-could-make-truly-cheap-iphone-5c-223637?source=rss_computer_hardware": "http://akamai.infoworld.com/d/mobile-technology/how-apple-could-make-truly-cheap-iphone-5c-223637",
		"http://akamai.infoworld.com/d/data-center/zombie-scripts-can-attack-any-time-225426?source=rss_data_center": "http://akamai.infoworld.com/d/data-center/zombie-scripts-can-attack-any-time-225426",
		"http://akamai.infoworld.com/d/networking/internet-traffic-jams-meet-your-robot-nemesis-223131?source=rss_networking": "http://akamai.infoworld.com/d/networking/internet-traffic-jams-meet-your-robot-nemesis-223131",
		"http://akamai.infoworld.com/t/java-programming/inspired-ruby-rails-grails-go-beyond-web-app-dev-226947?source=rss_open_source_software": "http://akamai.infoworld.com/t/java-programming/inspired-ruby-rails-grails-go-beyond-web-app-dev-226947",
		"http://akamai.infoworld.com/t/data-security/how-defend-your-web-apps-against-the-new-breach-attack-224281?source=rss_applications": "http://akamai.infoworld.com/t/data-security/how-defend-your-web-apps-against-the-new-breach-attack-224281",
		"http://akamai.infoworld.com/d/applications/nsa-resistant-android-app-encrypts-and-erases-sensitive-messages-226093?source=rss_applications": "http://akamai.infoworld.com/d/applications/nsa-resistant-android-app-encrypts-and-erases-sensitive-messages-226093",
		"http://akamai.infoworld.com/d/mobile-technology/6-tips-finding-mobile-app-talent-226147?source=rss_application_development": "http://akamai.infoworld.com/d/mobile-technology/6-tips-finding-mobile-app-talent-226147",
		"http://akamai.infoworld.com/t/microsoft-windows/microsoft-botches-six-windows-patches-in-latest-automatic-update-224988?source=rss_security": "http://akamai.infoworld.com/t/microsoft-windows/microsoft-botches-six-windows-patches-in-latest-automatic-update-224988",
		"http://akamai.infoworld.com/t/sdn/hps-open-ecosystem-sdn-isnt-just-about-sdn-227789?source=rss_networking": "http://akamai.infoworld.com/t/sdn/hps-open-ecosystem-sdn-isnt-just-about-sdn-227789",
		"http://akamai.infoworld.com/d/virtualization/swiftstack-announces-software-defined-storage-openstack-223576?source=rss_networking": "http://akamai.infoworld.com/d/virtualization/swiftstack-announces-software-defined-storage-openstack-223576",
		"http://akamai.infoworld.com/t/technology-business/beyond-the-iphone-what-pundits-dont-get-about-apple-226640?source=rss_mobile_technology": "http://akamai.infoworld.com/t/technology-business/beyond-the-iphone-what-pundits-dont-get-about-apple-226640",
		"http://akamai.infoworld.com/d/mobile-technology/email-spam-campaign-distributes-android-scareware-226494?source=rss_mobile_technology": "http://akamai.infoworld.com/d/mobile-technology/email-spam-campaign-distributes-android-scareware-226494",
		"http://akamai.infoworld.com/d/the-industry-standard/cisco-ceo-we-will-become-the-no-1-it-company-223210?source=rss_storage": "http://akamai.infoworld.com/d/the-industry-standard/cisco-ceo-we-will-become-the-no-1-it-company-223210",
		"http://akamai.infoworld.com/t/information-technology-careers/the-two-guys-most-likely-succeed-steve-ballmer-225493?source=rss_the_industry_standard": "http://akamai.infoworld.com/t/information-technology-careers/the-two-guys-most-likely-succeed-steve-ballmer-225493",
		"http://akamai.infoworld.com/d/applications/salesforcecom-adds-premium-performance-edition-bundle-224759?source=rss_applications": "http://akamai.infoworld.com/d/applications/salesforcecom-adds-premium-performance-edition-bundle-224759",
		"http://akamai.infoworld.com/d/mobile-technology/moto-x-refines-usability-otherwise-just-another-smartphone-223952?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/mobile-technology/moto-x-refines-usability-otherwise-just-another-smartphone-223952",
		"http://akamai.infoworld.com/d/virtualization/swiftstack-announces-software-defined-storage-openstack-223576?source=rss_storage": "http://akamai.infoworld.com/d/virtualization/swiftstack-announces-software-defined-storage-openstack-223576",
		"http://akamai.infoworld.com/d/mobile-technology/all-you-need-know-about-the-new-iphone-226257?source=rss_mobile_technology": "http://akamai.infoworld.com/d/mobile-technology/all-you-need-know-about-the-new-iphone-226257",
		"http://akamai.infoworld.com/t/mampa/the-amazoning-of-news-has-now-begun-224491?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/t/mampa/the-amazoning-of-news-has-now-begun-224491",
		"http://akamai.infoworld.com/t/development-environments/in-the-cloud-code-doesnt-need-developers-223279?source=rss_application_development": "http://akamai.infoworld.com/t/development-environments/in-the-cloud-code-doesnt-need-developers-223279",
		"http://akamai.infoworld.com/d/security/fujitsu-developing-html5-app-platform-enterprise-security-211524?source=rss_html5": "http://akamai.infoworld.com/d/security/fujitsu-developing-html5-app-platform-enterprise-security-211524",
		"http://akamai.infoworld.com/d/security/microsoft-patch-tuesday-the-ping-of-death-returns-ipv6-style-224867?source=rss_security": "http://akamai.infoworld.com/d/security/microsoft-patch-tuesday-the-ping-of-death-returns-ipv6-style-224867",
		"http://akamai.infoworld.com/d/security/researchers-propose-security-adapts-combat-malware-morphs-224921?source=rss_security": "http://akamai.infoworld.com/d/security/researchers-propose-security-adapts-combat-malware-morphs-224921",
		"http://akamai.infoworld.com/t/big-data/joyent-cto-how-big-data-platforms-should-work-224299?source=rss_cloud_computing": "http://akamai.infoworld.com/t/big-data/joyent-cto-how-big-data-platforms-should-work-224299",
		"http://akamai.infoworld.com/t/web-services/duckduckgo-going-straight-226778?source=rss_applications": "http://akamai.infoworld.com/t/web-services/duckduckgo-going-straight-226778",
		"http://akamai.infoworld.com/d/open-source-software/ibm-hopes-power-cloud-analytics-1-billion-linux-investment-227005?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/ibm-hopes-power-cloud-analytics-1-billion-linux-investment-227005",
		"http://akamai.infoworld.com/t/cloud-computing/the-secret-way-edit-your-code-in-microsofts-skydrive-223964?source=rss_microsoft_windows": "http://akamai.infoworld.com/t/cloud-computing/the-secret-way-edit-your-code-in-microsofts-skydrive-223964",
		"http://akamai.infoworld.com/d/cloud-computing/the-clouds-next-big-federal-spying-threat-224086?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/the-clouds-next-big-federal-spying-threat-224086",
		"http://akamai.infoworld.com/d/computer-hardware/dells-project-ophelia-could-be-more-bad-news-pcs-223649?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/dells-project-ophelia-could-be-more-bad-news-pcs-223649",
		"http://akamai.infoworld.com/d/computer-hardware/nand-flash-prices-are-sliding-low-demand-226078?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/nand-flash-prices-are-sliding-low-demand-226078",
		"http://akamai.infoworld.com/d/computer-hardware/windows-81-tablets-64-bit-atom-chips-not-coming-until-q1-226686?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/windows-81-tablets-64-bit-atom-chips-not-coming-until-q1-226686",
		"http://akamai.infoworld.com/d/networking/ciena-test-openflow-sdn-wan-224456?source=rss_networking": "http://akamai.infoworld.com/d/networking/ciena-test-openflow-sdn-wan-224456",
		"http://akamai.infoworld.com/d/open-source-software/has-apache-lost-its-way-225267?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/has-apache-lost-its-way-225267",
		"http://akamai.infoworld.com/d/open-source-software/linux-kernel-luminaries-talk-enterprise-embedded-and-why-theyre-coming-together-227136?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/linux-kernel-luminaries-talk-enterprise-embedded-and-why-theyre-coming-together-227136",
		"http://akamai.infoworld.com/d/the-industry-standard/how-delphis-cio-drives-innovation-change-and-revenue-it-224656?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/how-delphis-cio-drives-innovation-change-and-revenue-it-224656",
		"http://akamai.infoworld.com/t/cloud-computing/software-defined-infrastructure-cloud-services-do-sdn-one-better-227999?source=rss_data_center": "http://akamai.infoworld.com/t/cloud-computing/software-defined-infrastructure-cloud-services-do-sdn-one-better-227999",
		"http://akamai.infoworld.com/d/data-explosion/those-invisible-servers-could-open-your-network-hackers-224019?source=rss_security": "http://akamai.infoworld.com/d/data-explosion/those-invisible-servers-could-open-your-network-hackers-224019",
		"http://akamai.infoworld.com/d/the-industry-standard/report-apple-buys-embark-yet-another-mapping-app-225456?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/report-apple-buys-embark-yet-another-mapping-app-225456",
		"http://akamai.infoworld.com/t/technology-business/bust-msft-sold-only-200k-surface-pros-in-q2-boom-facebooks-sandberg-banks-91m-shares-ellison-short-appl?source=rss_business_intelligence": "http://akamai.infoworld.com/t/technology-business/bust-msft-sold-only-200k-surface-pros-in-q2-boom-facebooks-sandberg-banks-91m-shares-ellison-short-appl",
		"http://akamai.infoworld.com/d/cloud-computing/google-nsa-youll-have-take-our-data-the-hard-way-226407?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/google-nsa-youll-have-take-our-data-the-hard-way-226407",
		"http://akamai.infoworld.com/d/security/how-roll-your-own-vpn-223650?source=rss_open_source_software": "http://akamai.infoworld.com/d/security/how-roll-your-own-vpn-223650",
		"http://akamai.infoworld.com/d/application-development/amazon-lets-developers-make-money-selling-physical-goods-android-apps-225707?source=rss_applications": "http://akamai.infoworld.com/d/application-development/amazon-lets-developers-make-money-selling-physical-goods-android-apps-225707",
		"http://akamai.infoworld.com/d/the-industry-standard/lenovos-smartphone-tablets-outsell-pcs-in-first-quarter-224981?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/lenovos-smartphone-tablets-outsell-pcs-in-first-quarter-224981",
		"http://akamai.infoworld.com/node/224353?source=rss_cloud_computing": "http://akamai.infoworld.com/node/224353",
		"http://akamai.infoworld.com/t/iphone/how-apple-makes-the-iphone-5s-the-same-price-the-iphone-5-227559?source=rss_computer_hardware": "http://akamai.infoworld.com/t/iphone/how-apple-makes-the-iphone-5s-the-same-price-the-iphone-5-227559",
		"http://akamai.infoworld.com/t/microsoft-windows/windows-81-rtms-developers-wont-get-it-until-october-225693?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/t/microsoft-windows/windows-81-rtms-developers-wont-get-it-until-october-225693",
		"http://akamai.infoworld.com/t/technology-consulting/islamist-hacker-hits-twitter-feds-attempt-deeper-bitcoin-control-groklaw-shuts-self-down-outlookcom-n?source=rss_business_intelligence": "http://akamai.infoworld.com/t/technology-consulting/islamist-hacker-hits-twitter-feds-attempt-deeper-bitcoin-control-groklaw-shuts-self-down-outlookcom-n",
		"http://akamai.infoworld.com/d/mobile-technology/wtf-microsofts-senseless-outlook-app-ipads-and-iphones-222943?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/mobile-technology/wtf-microsofts-senseless-outlook-app-ipads-and-iphones-222943",
		"http://akamai.infoworld.com/d/security/microsoft-patch-dangerous-outlook-hack-preview-bug-next-week-226251?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/security/microsoft-patch-dangerous-outlook-hack-preview-bug-next-week-226251",
		"http://akamai.infoworld.com/t/it-jobs/in-case-of-it-emergency-break-out-the-chocolate-225720?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/t/it-jobs/in-case-of-it-emergency-break-out-the-chocolate-225720",
		"http://akamai.infoworld.com/d/cloud-computing/when-it-makes-sense-become-cloud-provider-225895?source=rss_data_center": "http://akamai.infoworld.com/d/cloud-computing/when-it-makes-sense-become-cloud-provider-225895",
		"http://akamai.infoworld.com/d/open-source-software/review-ubuntu-comes-out-ahead-among-5-linux-enterprise-servers-226416?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/review-ubuntu-comes-out-ahead-among-5-linux-enterprise-servers-226416",
		"http://akamai.infoworld.com/d/the-industry-standard/lenovos-smartphone-tablets-outsell-pcs-in-first-quarter-224981?source=rss_computer_hardware": "http://akamai.infoworld.com/d/the-industry-standard/lenovos-smartphone-tablets-outsell-pcs-in-first-quarter-224981",
		"http://akamai.infoworld.com/d/cloud-computing/amazon-website-mobile-apps-down-in-hourlong-outage-225230?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/amazon-website-mobile-apps-down-in-hourlong-outage-225230",
		"http://akamai.infoworld.com/d/cloud-computing/cloud-review-8-public-cloud-services-put-the-test-214403?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/cloud-computing/cloud-review-8-public-cloud-services-put-the-test-214403",
		"http://akamai.infoworld.com/t/hacking/security-researcher-claims-good-intentions-in-hacking-apple-dev-center-223205?source=rss_storage": "http://akamai.infoworld.com/t/hacking/security-researcher-claims-good-intentions-in-hacking-apple-dev-center-223205",
		"http://akamai.infoworld.com/d/computer-hardware/intels-avoton-server-chip-comes-in-13-varieties-226166?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/intels-avoton-server-chip-comes-in-13-varieties-226166",
		"http://akamai.infoworld.com/d/mobile-technology/google-acknowledges-nexus-7-tablet-problems-gps-multitouch-224892?source=rss_mobile_technology": "http://akamai.infoworld.com/d/mobile-technology/google-acknowledges-nexus-7-tablet-problems-gps-multitouch-224892",
		"http://akamai.infoworld.com/d/networking/wireless-usb-get-high-speed-jolt-wigig-226352?source=rss_networking": "http://akamai.infoworld.com/d/networking/wireless-usb-get-high-speed-jolt-wigig-226352",
		"http://akamai.infoworld.com/t/cringely/hacker-i-pwned-zuckerberg-least-give-me-stupid-t-shirt-225135?source=rss_applications": "http://akamai.infoworld.com/t/cringely/hacker-i-pwned-zuckerberg-least-give-me-stupid-t-shirt-225135",
		"http://akamai.infoworld.com/d/computer-hardware/amd-ship-64-bit-arm-chips-server-makers-next-year-226056?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/amd-ship-64-bit-arm-chips-server-makers-next-year-226056",
		"http://akamai.infoworld.com/d/security/attackers-turning-legit-cloud-services-firms-plant-malware-224046?source=rss_security": "http://akamai.infoworld.com/d/security/attackers-turning-legit-cloud-services-firms-plant-malware-224046",
		"http://akamai.infoworld.com/t/hybrid-cloud/microsofts-deal-att-shows-the-new-path-cloud-partnerships-227164?source=rss_data_center": "http://akamai.infoworld.com/t/hybrid-cloud/microsofts-deal-att-shows-the-new-path-cloud-partnerships-227164",
		"http://akamai.infoworld.com/d/applications/salesforcecom-adds-premium-performance-edition-bundle-224759?source=rss_cloud_computing": "http://akamai.infoworld.com/d/applications/salesforcecom-adds-premium-performance-edition-bundle-224759",
		"http://akamai.infoworld.com/d/cloud-computing/lenovos-reach-cloud-service-aims-replace-local-apps-224776?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/lenovos-reach-cloud-service-aims-replace-local-apps-224776",
		"http://akamai.infoworld.com/d/computer-hardware/intel-pushes-speed-reliability-claims-new-mxc-cable-226170?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/intel-pushes-speed-reliability-claims-new-mxc-cable-226170",
		"http://akamai.infoworld.com/d/microsoft-windows/xps-retirement-will-be-hacker-heaven-224796?source=rss_security": "http://akamai.infoworld.com/d/microsoft-windows/xps-retirement-will-be-hacker-heaven-224796",
		"http://akamai.infoworld.com/t/smartphones/canonical-lands-first-enterprise-backer-ubuntu-edge-just-49-go-224498?source=rss_open_source_software": "http://akamai.infoworld.com/t/smartphones/canonical-lands-first-enterprise-backer-ubuntu-edge-just-49-go-224498",
		"http://akamai.infoworld.com/d/big-data/the-internet-of-things-will-mean-really-really-big-data-223314?source=rss_networking": "http://akamai.infoworld.com/d/big-data/the-internet-of-things-will-mean-really-really-big-data-223314",
		"http://akamai.infoworld.com/d/computer-hardware/imagination-battle-arm-mips-server-chips-225923?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/imagination-battle-arm-mips-server-chips-225923",
		"http://akamai.infoworld.com/d/computer-hardware/windows-81-wont-rescue-pc-market-year-idc-says-225910?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/computer-hardware/windows-81-wont-rescue-pc-market-year-idc-says-225910",
		"http://akamai.infoworld.com/t/open-source-software/ubuntu-phone-not-moment-too-soon-210074-0?source=rss_html5": "http://akamai.infoworld.com/t/open-source-software/ubuntu-phone-not-moment-too-soon-210074-0",
		"http://akamai.infoworld.com/t/it-management/gartner-the-top-10-it-altering-predictions-2014-228419?source=rss_networking": "http://akamai.infoworld.com/t/it-management/gartner-the-top-10-it-altering-predictions-2014-228419",
		"http://akamai.infoworld.com/d/computer-hardware/apple-launches-new-imac-227415?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/apple-launches-new-imac-227415",
		"http://akamai.infoworld.com/d/networking/8-key-considerations-making-the-leap-sdn-221989?source=rss_networking": "http://akamai.infoworld.com/d/networking/8-key-considerations-making-the-leap-sdn-221989",
		"http://akamai.infoworld.com/d/microsoft-windows/wanna-keep-your-it-job-master-automation-223293?source=rss_data_center": "http://akamai.infoworld.com/d/microsoft-windows/wanna-keep-your-it-job-master-automation-223293",
		"http://akamai.infoworld.com/d/applications/facebook-offers-real-time-feed-of-user-data-online-and-tv-news-226351?source=rss_applications": "http://akamai.infoworld.com/d/applications/facebook-offers-real-time-feed-of-user-data-online-and-tv-news-226351",
		"http://akamai.infoworld.com/d/applications/google-gives-chrome-29-mulligan-button-225327?source=rss_applications": "http://akamai.infoworld.com/d/applications/google-gives-chrome-29-mulligan-button-225327",
		"http://akamai.infoworld.com/t/sdn/infoblox-shows-the-promise-of-openflow-227486?source=rss_open_source_software": "http://akamai.infoworld.com/t/sdn/infoblox-shows-the-promise-of-openflow-227486",
		"http://akamai.infoworld.com/t/virtualization/vmworld-2013-networking-and-storage-take-center-stage-225563?source=rss_networking": "http://akamai.infoworld.com/t/virtualization/vmworld-2013-networking-and-storage-take-center-stage-225563",
		"http://akamai.infoworld.com/d/cloud-computing/microsoft-plans-changes-office-365-targeted-sharepoint-online-users-226267?source=rss_applications": "http://akamai.infoworld.com/d/cloud-computing/microsoft-plans-changes-office-365-targeted-sharepoint-online-users-226267",
		"http://akamai.infoworld.com/t/consumerization-of-it/the-futility-of-the-single-device-solution-224850?source=rss_mobile_technology": "http://akamai.infoworld.com/t/consumerization-of-it/the-futility-of-the-single-device-solution-224850",
		"http://akamai.infoworld.com/t/it-jobs/look-out-below-young-techie-coming-through-224258?source=rss_networking": "http://akamai.infoworld.com/t/it-jobs/look-out-below-young-techie-coming-through-224258",
		"http://akamai.infoworld.com/d/security/us-and-germany-enter-no-spying-agreement-in-wake-of-nsa-leaks-224912?source=rss_security": "http://akamai.infoworld.com/d/security/us-and-germany-enter-no-spying-agreement-in-wake-of-nsa-leaks-224912",
		"http://akamai.infoworld.com/d/virtualization/swiftstack-announces-software-defined-storage-openstack-223576?source=rss_open_source_software": "http://akamai.infoworld.com/d/virtualization/swiftstack-announces-software-defined-storage-openstack-223576",
		"http://akamai.infoworld.com/d/computer-hardware/the-best-laptops-convertibles-and-ultrabooks-windows-8-226575?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/the-best-laptops-convertibles-and-ultrabooks-windows-8-226575",
		"http://akamai.infoworld.com/d/business-intelligence/facebooks-graph-search-puts-apache-giraph-the-map-224955?source=rss_business_intelligence": "http://akamai.infoworld.com/d/business-intelligence/facebooks-graph-search-puts-apache-giraph-the-map-224955",
		"http://akamai.infoworld.com/d/the-industry-standard/facebook-and-infosys-working-hard-perpetuate-h-1b-hypocrisy-224422?source=rss_the_industry_standard": "http://akamai.infoworld.com/d/the-industry-standard/facebook-and-infosys-working-hard-perpetuate-h-1b-hypocrisy-224422",
		"http://akamai.infoworld.com/d/virtualization/hp-juniper-help-vmware-take-networks-nsx-225666?source=rss_virtualization": "http://akamai.infoworld.com/d/virtualization/hp-juniper-help-vmware-take-networks-nsx-225666",
		"http://akamai.infoworld.com/d/applications/microsoft-fixes-skydrive-problem-issues-persist-outlookcom-224987?source=rss_applications": "http://akamai.infoworld.com/d/applications/microsoft-fixes-skydrive-problem-issues-persist-outlookcom-224987",
		"http://akamai.infoworld.com/d/security/cyber-security-pros-in-high-demand-highly-paid-and-highly-selective-224572?source=rss_security": "http://akamai.infoworld.com/d/security/cyber-security-pros-in-high-demand-highly-paid-and-highly-selective-224572",
		"http://akamai.infoworld.com/d/security/startup-defensenet-debuts-anti-ddos-service-224221?source=rss_security": "http://akamai.infoworld.com/d/security/startup-defensenet-debuts-anti-ddos-service-224221",
		"http://akamai.infoworld.com/t/technology-business/beyond-the-iphone-what-pundits-dont-get-about-apple-226640?source=rss_consumerization_of_it": "http://akamai.infoworld.com/t/technology-business/beyond-the-iphone-what-pundits-dont-get-about-apple-226640",
		"http://akamai.infoworld.com/d/applications/yahoo-makes-mail-beautiful-woo-gmail-users-228398?source=rss_applications": "http://akamai.infoworld.com/d/applications/yahoo-makes-mail-beautiful-woo-gmail-users-228398",
		"http://akamai.infoworld.com/t/microsoft-windows/microsoft-botches-six-windows-patches-in-latest-automatic-update-224988?source=rss_microsoft_windows": "http://akamai.infoworld.com/t/microsoft-windows/microsoft-botches-six-windows-patches-in-latest-automatic-update-224988",
		"http://akamai.infoworld.com/d/microsoft-windows/meet-windows-servers-byod-features-224112?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/microsoft-windows/meet-windows-servers-byod-features-224112",
		"http://akamai.infoworld.com/t/microsoft-windows/could-microsofts-rebranding-extend-far-beyond-skydrive-224095?source=rss_microsoft_windows": "http://akamai.infoworld.com/t/microsoft-windows/could-microsofts-rebranding-extend-far-beyond-skydrive-224095",
		"http://akamai.infoworld.com/d/computer-hardware/apples-80211ac-wi-fi-problems-theyre-real-221649?source=rss_networking": "http://akamai.infoworld.com/d/computer-hardware/apples-80211ac-wi-fi-problems-theyre-real-221649",
		"http://akamai.infoworld.com/d/microsoft-windows/windows-server-2012-r2-kicks-hyper-v-another-notch-225288?source=rss_microsoft_windows": "http://akamai.infoworld.com/d/microsoft-windows/windows-server-2012-r2-kicks-hyper-v-another-notch-225288",
		"http://akamai.infoworld.com/d/open-source-software/suse-drops-libreoffice-and-collabora-picks-it-226133?source=rss_open_source_software": "http://akamai.infoworld.com/d/open-source-software/suse-drops-libreoffice-and-collabora-picks-it-226133",
		"http://akamai.infoworld.com/d/applications/move-over-android-the-future-will-be-chrome-223630?source=rss_html5": "http://akamai.infoworld.com/d/applications/move-over-android-the-future-will-be-chrome-223630",
		"http://akamai.infoworld.com/d/computer-hardware/mit-develops-110-core-processor-more-power-efficient-computing-225748?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/mit-develops-110-core-processor-more-power-efficient-computing-225748",
		"http://akamai.infoworld.com/d/consumerization-of-it/the-latest-mobile-security-darlings-wont-work-either-222744?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/consumerization-of-it/the-latest-mobile-security-darlings-wont-work-either-222744",
		"http://akamai.infoworld.com/d/the-industry-standard/cisco-ceo-we-will-become-the-no-1-it-company-223210?source=rss_enterprise_architecture": "http://akamai.infoworld.com/d/the-industry-standard/cisco-ceo-we-will-become-the-no-1-it-company-223210",
		"http://akamai.infoworld.com/d/virtualization/startup-pernixdata-virtualizes-server-based-flash-224094?source=rss_storage": "http://akamai.infoworld.com/d/virtualization/startup-pernixdata-virtualizes-server-based-flash-224094",
		"http://akamai.infoworld.com/t/iaas/apache-cloudstack-42-easier-upgrades-faster-installation-better-scaling-227913?source=rss_open_source_software": "http://akamai.infoworld.com/t/iaas/apache-cloudstack-42-easier-upgrades-faster-installation-better-scaling-227913",
		"http://akamai.infoworld.com/d/data-center/why-you-should-be-using-rsync-225814?source=rss_open_source_software": "http://akamai.infoworld.com/d/data-center/why-you-should-be-using-rsync-225814",
		"http://akamai.infoworld.com/t/microsoft-windows/acer-latest-tablet-maker-moving-away-the-windows-fold-224592?source=rss_microsoft_windows": "http://akamai.infoworld.com/t/microsoft-windows/acer-latest-tablet-maker-moving-away-the-windows-fold-224592",
		"http://akamai.infoworld.com/d/cloud-computing/3-common-mistakes-in-cloud-migrations-and-how-avoid-them-224666?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/cloud-computing/3-common-mistakes-in-cloud-migrations-and-how-avoid-them-224666",
		"http://akamai.infoworld.com/d/data-center/why-talent-tech-different-skill-223484?source=rss_data_center": "http://akamai.infoworld.com/d/data-center/why-talent-tech-different-skill-223484",
		"http://akamai.infoworld.com/d/mobile-technology/review-firefox-os-sputters-the-zte-open-225794?source=rss_open_source_software": "http://akamai.infoworld.com/d/mobile-technology/review-firefox-os-sputters-the-zte-open-225794",
		"http://akamai.infoworld.com/d/mobile-technology/what-look-in-smart-watch-222729?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/mobile-technology/what-look-in-smart-watch-222729",
		"http://akamai.infoworld.com/d/open-source-software/suse-drops-libreoffice-and-collabora-picks-it-226133?source=rss_applications": "http://akamai.infoworld.com/d/open-source-software/suse-drops-libreoffice-and-collabora-picks-it-226133",
		"http://akamai.infoworld.com/t/html5/intel-throws-its-weight-behind-html5-225008?source=rss_application_development": "http://akamai.infoworld.com/t/html5/intel-throws-its-weight-behind-html5-225008",
		"http://akamai.infoworld.com/d/cloud-computing/why-you-should-care-about-multicloud-222173?source=rss_enterprise_architecture": "http://akamai.infoworld.com/d/cloud-computing/why-you-should-care-about-multicloud-222173",
		"http://akamai.infoworld.com/d/open-source-software/review-ubuntu-comes-out-ahead-among-5-linux-enterprise-servers-226416?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/open-source-software/review-ubuntu-comes-out-ahead-among-5-linux-enterprise-servers-226416",
		"http://akamai.infoworld.com/d/the-industry-standard/google-backs-project-cut-internet-costs-5-percent-of-users-income-228352?source=rss_networking": "http://akamai.infoworld.com/d/the-industry-standard/google-backs-project-cut-internet-costs-5-percent-of-users-income-228352",
		"http://akamai.infoworld.com/d/consumerization-of-it/its-vacation-time-leave-the-work-safely-behind-223413?source=rss_consumerization_of_it": "http://akamai.infoworld.com/d/consumerization-of-it/its-vacation-time-leave-the-work-safely-behind-223413",
		"http://akamai.infoworld.com/t/cringely/stick-fork-in-apple-its-done-226187?source=rss_computer_hardware": "http://akamai.infoworld.com/t/cringely/stick-fork-in-apple-its-done-226187",
		"http://akamai.infoworld.com/d/computer-hardware/windows-81-tablets-64-bit-atom-chips-not-coming-until-q1-226686?source=rss_mobile_technology": "http://akamai.infoworld.com/d/computer-hardware/windows-81-tablets-64-bit-atom-chips-not-coming-until-q1-226686",
		"http://akamai.infoworld.com/d/data-center/download-the-software-defined-data-center-digital-spotlight-221420?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/data-center/download-the-software-defined-data-center-digital-spotlight-221420",
		"http://akamai.infoworld.com/t/applications/can-infor-upset-the-oracle-sap-duopoly-224087?source=rss_applications": "http://akamai.infoworld.com/t/applications/can-infor-upset-the-oracle-sap-duopoly-224087",
		"http://akamai.infoworld.com/t/cringely/the-tor-teardown-brought-you-goats-giraffes-and-thors-hammer-228244?source=rss_networking": "http://akamai.infoworld.com/t/cringely/the-tor-teardown-brought-you-goats-giraffes-and-thors-hammer-228244",
		"http://akamai.infoworld.com/t/information-technology-careers/the-open-source-job-market-booming-223463?source=rss_open_source_software": "http://akamai.infoworld.com/t/information-technology-careers/the-open-source-job-market-booming-223463",
		"http://akamai.infoworld.com/d/applications/google-seeks-marry-desktop-and-cloud-new-chrome-apps-226223?source=rss_applications": "http://akamai.infoworld.com/d/applications/google-seeks-marry-desktop-and-cloud-new-chrome-apps-226223",
		"http://akamai.infoworld.com/d/applications/outlookcom-and-skype-integration-starts-roll-out-225208?source=rss_networking": "http://akamai.infoworld.com/d/applications/outlookcom-and-skype-integration-starts-roll-out-225208",
		"http://akamai.infoworld.com/d/data-explosion/vmware-vsan-inside-the-revolutionary-new-approach-storage-225962?source=rss_data_center": "http://akamai.infoworld.com/d/data-explosion/vmware-vsan-inside-the-revolutionary-new-approach-storage-225962",
		"http://akamai.infoworld.com/d/microsoft-windows/active-directory-heads-the-cloud-what-it-does-and-doesnt-do-222847?source=rss_data_center": "http://akamai.infoworld.com/d/microsoft-windows/active-directory-heads-the-cloud-what-it-does-and-doesnt-do-222847",
		"http://akamai.infoworld.com/d/mobile-technology/blackberry-turns-7-os-social-networking-features-new-9720-smartphone-224797?source=rss_mobile_technology": "http://akamai.infoworld.com/d/mobile-technology/blackberry-turns-7-os-social-networking-features-new-9720-smartphone-224797",
		"http://akamai.infoworld.com/node/224088?source=rss_security": "http://akamai.infoworld.com/node/224088",
		"http://akamai.infoworld.com/t/data-center/understanding-the-software-defined-data-center-225652?source=rss_data_center": "http://akamai.infoworld.com/t/data-center/understanding-the-software-defined-data-center-225652",
		"http://akamai.infoworld.com/t/microsoft-windows/microsoft-botches-six-windows-patches-in-latest-automatic-update-224988?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/t/microsoft-windows/microsoft-botches-six-windows-patches-in-latest-automatic-update-224988",
		"http://akamai.infoworld.com/d/mobile-technology/go-go-gadget-hands-samsungs-galaxy-gear-smartwatch-226185?source=rss_computer_hardware": "http://akamai.infoworld.com/d/mobile-technology/go-go-gadget-hands-samsungs-galaxy-gear-smartwatch-226185",
		"http://akamai.infoworld.com/d/applications/google-talk-bug-sent-ims-wrong-recipients-227621?source=rss_applications": "http://akamai.infoworld.com/d/applications/google-talk-bug-sent-ims-wrong-recipients-227621",
		"http://akamai.infoworld.com/d/mobile-technology/review-new-nexus-7-takes-ipad-mini-and-kindle-fire-hd-224483?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/d/mobile-technology/review-new-nexus-7-takes-ipad-mini-and-kindle-fire-hd-224483",
		"http://akamai.infoworld.com/d/security/most-enterprise-networks-riddled-vulnerable-java-installations-report-says-222983?source=rss_application_development": "http://akamai.infoworld.com/d/security/most-enterprise-networks-riddled-vulnerable-java-installations-report-says-222983",
		"http://akamai.infoworld.com/d/virtualization/dell-foglight-vanquishes-zombie-vms-225235?source=rss_virtualization": "http://akamai.infoworld.com/d/virtualization/dell-foglight-vanquishes-zombie-vms-225235",
		"http://akamai.infoworld.com/t/cringely/personal-email-and-private-clouds-fall-in-war-privacy-224603?source=rss_cloud_computing": "http://akamai.infoworld.com/t/cringely/personal-email-and-private-clouds-fall-in-war-privacy-224603",
		"http://akamai.infoworld.com/t/cringely/personal-email-and-private-clouds-fall-in-war-privacy-224603?source=rss_security": "http://akamai.infoworld.com/t/cringely/personal-email-and-private-clouds-fall-in-war-privacy-224603",
		"http://akamai.infoworld.com/d/html5/7-apps-making-the-most-of-html5-205047?source=rss_html5": "http://akamai.infoworld.com/d/html5/7-apps-making-the-most-of-html5-205047",
		"http://akamai.infoworld.com/d/html5/the-html5-iq-test-207088?source=rss_html5": "http://akamai.infoworld.com/d/html5/the-html5-iq-test-207088",
		"http://akamai.infoworld.com/d/networking/proposed-changes-whois-system-called-extremely-disquieting-227019?source=rss_networking": "http://akamai.infoworld.com/d/networking/proposed-changes-whois-system-called-extremely-disquieting-227019",
		"http://akamai.infoworld.com/d/application-development/khronos-group-releases-updates-graphics-parallel-programming-tools-223194?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/khronos-group-releases-updates-graphics-parallel-programming-tools-223194",
		"http://akamai.infoworld.com/d/big-data/oracle-makes-its-big-data-push-even-bigger-227363?source=rss_computer_hardware": "http://akamai.infoworld.com/d/big-data/oracle-makes-its-big-data-push-even-bigger-227363",
		"http://akamai.infoworld.com/d/cloud-computing/nirvanix-shutdown-has-cloud-users-wondering-whos-next-227364?source=rss_storage": "http://akamai.infoworld.com/d/cloud-computing/nirvanix-shutdown-has-cloud-users-wondering-whos-next-227364",
		"http://akamai.infoworld.com/d/computer-hardware/ibm-license-power-chip-design-google-others-225570?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/ibm-license-power-chip-design-google-others-225570",
		"http://akamai.infoworld.com/d/computer-hardware/ibm-opens-power-microprocessor-design-partners-google-224309?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/ibm-opens-power-microprocessor-design-partners-google-224309",
		"http://akamai.infoworld.com/d/computer-hardware/oracle-software-will-run-faster-new-sparc-m6-chip-225752?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/oracle-software-will-run-faster-new-sparc-m6-chip-225752",
		"http://akamai.infoworld.com/d/mobile-technology/mobile-first-mobile-only-what-it-really-means-go-mobile-220360?source=rss_html5": "http://akamai.infoworld.com/d/mobile-technology/mobile-first-mobile-only-what-it-really-means-go-mobile-220360",
		"http://akamai.infoworld.com/t/data-security/lavabit-shutdown-marks-another-costly-blemish-us-tech-companies-224582?source=rss_infoworld_top_stories_": "http://akamai.infoworld.com/t/data-security/lavabit-shutdown-marks-another-costly-blemish-us-tech-companies-224582",
		"http://akamai.infoworld.com/t/enterprise-application-integration/zagile-ceo-why-you-should-consider-model-driven-integration-225304?source=rss_cloud_computing": "http://akamai.infoworld.com/t/enterprise-application-integration/zagile-ceo-why-you-should-consider-model-driven-integration-225304",
		"http://akamai.infoworld.com/t/java-programming/java-8-developer-preview-ready-testing-226417?source=rss_application_development": "http://akamai.infoworld.com/t/java-programming/java-8-developer-preview-ready-testing-226417",
		"http://akamai.infoworld.com/d/cloud-computing/happy-birthday-openstack-dont-get-too-comfortable-223212?source=rss_data_center": "http://akamai.infoworld.com/d/cloud-computing/happy-birthday-openstack-dont-get-too-comfortable-223212",
		"http://akamai.infoworld.com/d/computer-hardware/dram-shortage-hynix-fire-hit-pcs-hardest-226847?source=rss_computer_hardware": "http://akamai.infoworld.com/d/computer-hardware/dram-shortage-hynix-fire-hit-pcs-hardest-226847",
		"http://akamai.infoworld.com/t/java-programming/wanted-java-developers-be-226250?source=rss_application_development": "http://akamai.infoworld.com/t/java-programming/wanted-java-developers-be-226250",
		"http://akamai.infoworld.com/t/microsoft-windows/surface-2-leaked-details-paint-lackluster-picture-226125?source=rss_microsoft_windows": "http://akamai.infoworld.com/t/microsoft-windows/surface-2-leaked-details-paint-lackluster-picture-226125",
		"http://akamai.infoworld.com/d/application-development/beginners-guide-r-easy-ways-do-basic-data-analysis-225363?source=rss_application_development": "http://akamai.infoworld.com/d/application-development/beginners-guide-r-easy-ways-do-basic-data-analysis-225363",
		"http://akamai.infoworld.com/d/applications/forrester-survey-data-dispels-3-myths-about-enterprise-software-224405?source=rss_applications": "http://akamai.infoworld.com/d/applications/forrester-survey-data-dispels-3-myths-about-enterprise-software-224405",
		"http://akamai.infoworld.com/d/cloud-computing/googles-cloud-encryption-good-pr-and-users-too-225179?source=rss_cloud_computing": "http://akamai.infoworld.com/d/cloud-computing/googles-cloud-encryption-good-pr-and-users-too-225179",
		"http://akamai.infoworld.com/d/mobile-technology/facebook-buys-speech-translation-software-company-224795?source=rss_mobile_technology": "http://akamai.infoworld.com/d/mobile-technology/facebook-buys-speech-translation-software-company-224795",
	}
	testURLs(t, urls)
}
func Test_www_americanbanker_com(t *testing.T) {
	urls := map[string]string{
		"http://www.americanbanker.com/bankthink/fed-rule-violation-general-electric-exits-retail-lending-1061711-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/fed-rule-violation-general-electric-exits-retail-lending-1061711-1.html",
		"http://www.americanbanker.com/bankthink/hints-at-a-deal-in-congress-but-fiscal-fallout-drags-on-1062739-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/hints-at-a-deal-in-congress-but-fiscal-fallout-drags-on-1062739-1.html",
		"http://www.americanbanker.com/bankthink/how-to-keep-c-and-i-lending-profitable-as-margins-narrow-1060950-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/how-to-keep-c-and-i-lending-profitable-as-margins-narrow-1060950-1.html",
		"http://www.americanbanker.com/bankthink/new-ruling-on-swipe-fee-cap-same-tired-arguments-from-banks-1061146-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/new-ruling-on-swipe-fee-cap-same-tired-arguments-from-banks-1061146-1.html",
		"http://www.americanbanker.com/bankthink/regulation-crisis-starter-or-crisis-suppressor-the-future-of-tbtf-1062466-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/regulation-crisis-starter-or-crisis-suppressor-the-future-of-tbtf-1062466-1.html",
		"http://www.americanbanker.com/bankthink/bank-ceos-visit-washington-is-black-market-bust-good-or-bad-for-bitcoin-1062577-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/bank-ceos-visit-washington-is-black-market-bust-good-or-bad-for-bitcoin-1062577-1.html",
		"http://www.americanbanker.com/bankthink/heres-one-more-third-party-compliance-risk-for-banks-to-worry-about-1061121-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/heres-one-more-third-party-compliance-risk-for-banks-to-worry-about-1061121-1.html",
		"http://www.americanbanker.com/bankthink/keeping-deal-information-confidential-in-a-digital-world-1061170-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/keeping-deal-information-confidential-in-a-digital-world-1061170-1.html",
		"http://www.americanbanker.com/bankthink/mortgage-markets-will-pay-price-for-contradictory-policies-of-cfpb-1061389-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/mortgage-markets-will-pay-price-for-contradictory-policies-of-cfpb-1061389-1.html",
		"http://www.americanbanker.com/bankthink/regulators-release-softened-qrm-proposal-bank-of-england-to-keep-rates-low-1061668-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/regulators-release-softened-qrm-proposal-bank-of-england-to-keep-rates-low-1061668-1.html",
		"http://www.americanbanker.com/bankthink/global-banks-are-undercapitalized-is-that-so-wrong-1061779-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/global-banks-are-undercapitalized-is-that-so-wrong-1061779-1.html",
		"http://www.americanbanker.com/bankthink/preventing-next-mortgage-crisis-job-one-for-gse-reform-1061855-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/preventing-next-mortgage-crisis-job-one-for-gse-reform-1061855-1.html",
		"http://www.americanbanker.com/bankthink/talk-of-ticker-symbols-shows-how-far-bitcoin-has-come-1061489-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/talk-of-ticker-symbols-shows-how-far-bitcoin-has-come-1061489-1.html",
		"http://www.americanbanker.com/bankthink/the-silly-romantic-side-of-fabulous-fab-1060900-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/the-silly-romantic-side-of-fabulous-fab-1060900-1.html",
		"http://www.americanbanker.com/bankthink/why-former-investors-despair-of-returning-to-mortgages-1061962-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/why-former-investors-despair-of-returning-to-mortgages-1061962-1.html",
		"http://www.americanbanker.com/bankthink/digital-currency-firms-must-act-fast-to-tame-laundering-risk-1062559-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/digital-currency-firms-must-act-fast-to-tame-laundering-risk-1062559-1.html",
		"http://www.americanbanker.com/bankthink/how-online-home-price-estimators-distort-the-market-1062480-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/how-online-home-price-estimators-distort-the-market-1062480-1.html",
		"http://www.americanbanker.com/bankthink/how-to-perfect-your-banks-website-1061209-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/how-to-perfect-your-banks-website-1061209-1.html",
		"http://www.americanbanker.com/bankthink/one-cheer-for-bank-regulators-1061442-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/one-cheer-for-bank-regulators-1061442-1.html",
		"http://www.americanbanker.com/bankthink/why-most-bank-m-and-a-deals-are-duds-1061192-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/why-most-bank-m-and-a-deals-are-duds-1061192-1.html",
		"http://www.americanbanker.com/bankthink/basel-has-an-eye-on-shadow-banking-1061445-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/basel-has-an-eye-on-shadow-banking-1061445-1.html",
		"http://www.americanbanker.com/bankthink/big-banks-have-a-get-out-of-jail-free-card-1061848-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/big-banks-have-a-get-out-of-jail-free-card-1061848-1.html",
		"http://www.americanbanker.com/bankthink/five-years-after-lehman-insert-thought-herE-1062042-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/five-years-after-lehman-insert-thought-herE-1062042-1.html",
		"http://www.americanbanker.com/bankthink/take-a-serious-look-at-hurley-plan-to-end-tbtf-1061014-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/take-a-serious-look-at-hurley-plan-to-end-tbtf-1061014-1.html",
		"http://www.americanbanker.com/bankthink/ditch-the-word-underbanked-it-is-confusing-and-misleading-1061471-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/ditch-the-word-underbanked-it-is-confusing-and-misleading-1061471-1.html",
		"http://www.americanbanker.com/bankthink/jpm-weighs-admission-in-whale-case-sac-seeks-deal-to-stay-open-1061212-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/jpm-weighs-admission-in-whale-case-sac-seeks-deal-to-stay-open-1061212-1.html",
		"http://www.americanbanker.com/bankthink/nasdaq-tech-woes-moodys-threatens-big-bank-downgrade-jackson-hole-preview-1061535-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/nasdaq-tech-woes-moodys-threatens-big-bank-downgrade-jackson-hole-preview-1061535-1.html",
		"http://www.americanbanker.com/bankthink/wells-settles-with-freddie-occupy-wall-street-creates-prepaid-debit-card-1062509-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/wells-settles-with-freddie-occupy-wall-street-creates-prepaid-debit-card-1062509-1.html",
		"http://www.americanbanker.com/bankthink/yellens-lesson-for-women-in-banking-1062735-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/yellens-lesson-for-women-in-banking-1062735-1.html",
		"http://www.americanbanker.com/bankthink/in-talent-war-wall-street-sets-a-fine-example-1060946-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/in-talent-war-wall-street-sets-a-fine-example-1060946-1.html",
		"http://www.americanbanker.com/bankthink/payday-loan-pugilism-recruiting-tomorrows-bankers-pandits-unsung-idea-1061416-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/payday-loan-pugilism-recruiting-tomorrows-bankers-pandits-unsung-idea-1061416-1.html",
		"http://www.americanbanker.com/bankthink/people-not-prices-win-business-1060979-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/people-not-prices-win-business-1060979-1.html",
		"http://www.americanbanker.com/bankthink/ripe-for-radical-change-banks-payments-infrastructure-1060947-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/ripe-for-radical-change-banks-payments-infrastructure-1060947-1.html",
		"http://www.americanbanker.com/bankthink/too-many-banks-still-treat-mobile-banking-as-an-afterthought-1061023-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/too-many-banks-still-treat-mobile-banking-as-an-afterthought-1061023-1.html",
		"http://www.americanbanker.com/bankthink/why-payday-loans-are-good-for-millions-of-people-1061280-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/why-payday-loans-are-good-for-millions-of-people-1061280-1.html",
		"http://www.americanbanker.com/bankthink/debit-interchange-a-service-worth-paying-for-1061898-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/debit-interchange-a-service-worth-paying-for-1061898-1.html",
		"http://www.americanbanker.com/bankthink/hedge-fund-boss-says-dodd-frank-is-fantastic-for-derivatives-1061954-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/hedge-fund-boss-says-dodd-frank-is-fantastic-for-derivatives-1061954-1.html",
		"http://www.americanbanker.com/bankthink/payment-processors-are-government-allies-against-fraud-1062451-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/payment-processors-are-government-allies-against-fraud-1062451-1.html",
		"http://www.americanbanker.com/bankthink/underbanked-more-like-underwhelmed-1061508-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/underbanked-more-like-underwhelmed-1061508-1.html",
		"http://www.americanbanker.com/bankthink/doj-sec-enforcement-palooza-jpm-update-rogue-computer-foils-goldman-1061476-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/doj-sec-enforcement-palooza-jpm-update-rogue-computer-foils-goldman-1061476-1.html",
		"http://www.americanbanker.com/bankthink/stress-testing-the-imf-way-1061308-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/stress-testing-the-imf-way-1061308-1.html",
		"http://www.americanbanker.com/bankthink/try-to-remember-the-kind-of-september-when-lehman-failed-markets-panicked-1062022-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/try-to-remember-the-kind-of-september-when-lehman-failed-markets-panicked-1062022-1.html",
		"http://www.americanbanker.com/bankthink/why-bank-m-and-a-is-good-for-buyers-sellers-and-the-economy-1061229-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/why-bank-m-and-a-is-good-for-buyers-sellers-and-the-economy-1061229-1.html",
		"http://www.americanbanker.com/bankthink/worries-mount-over-state-of-chinas-banking-system-1061386-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/worries-mount-over-state-of-chinas-banking-system-1061386-1.html",
		"http://www.americanbanker.com/bankthink/ferc-accuses-jpm-virtual-currencies-self-regulation-tourre-trial-nears-end-1060958-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/ferc-accuses-jpm-virtual-currencies-self-regulation-tourre-trial-nears-end-1060958-1.html",
		"http://www.americanbanker.com/bankthink/how-to-improve-the-corker-warner-gse-bill-1061116-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/how-to-improve-the-corker-warner-gse-bill-1061116-1.html",
		"http://www.americanbanker.com/bankthink/london-whale-loomed-large-in-trading-probe-but-escaped-charges-1061361-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/london-whale-loomed-large-in-trading-probe-but-escaped-charges-1061361-1.html",
		"http://www.americanbanker.com/bankthink/nyc-elections-jpmorgan-chase-angle-how-strong-its-new-board-members-are-1061914-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/nyc-elections-jpmorgan-chase-angle-how-strong-its-new-board-members-are-1061914-1.html",
		"http://www.americanbanker.com/bankthink/share-your-star-performers-strategies-with-the-rest-of-the-staff-1062504-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/share-your-star-performers-strategies-with-the-rest-of-the-staff-1062504-1.html",
		"http://www.americanbanker.com/bankthink/the-death-of-the-traditional-community-bank-1061363-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/the-death-of-the-traditional-community-bank-1061363-1.html",
		"http://www.americanbanker.com/bankthink/basel-needs-help-combating-money-laundering-1061663-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/basel-needs-help-combating-money-laundering-1061663-1.html",
		"http://www.americanbanker.com/bankthink/dodd-frank-rules-provide-limited-protection-for-mortgage-investors-1061815-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/dodd-frank-rules-provide-limited-protection-for-mortgage-investors-1061815-1.html",
		"http://www.americanbanker.com/bankthink/holdout-banks-cling-to-debt-trap-loans-1061352-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/holdout-banks-cling-to-debt-trap-loans-1061352-1.html",
		"http://www.americanbanker.com/bankthink/merchants-score-a-win-in-swipe-fee-war-rbs-picks-new-ceo-1061026-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/merchants-score-a-win-in-swipe-fee-war-rbs-picks-new-ceo-1061026-1.html",
		"http://www.americanbanker.com/bankthink/counterargument-the-case-for-slowing-dodd-frank-1062518-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/counterargument-the-case-for-slowing-dodd-frank-1062518-1.html",
		"http://www.americanbanker.com/bankthink/thats-rich-fannie-freddie-finance-luxury-rentals-1061921-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/thats-rich-fannie-freddie-finance-luxury-rentals-1061921-1.html",
		"http://www.americanbanker.com/bankthink/fed-chair-fight-continues-charges-planned-in-whale-case-1061316-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/fed-chair-fight-continues-charges-planned-in-whale-case-1061316-1.html",
		"http://www.americanbanker.com/bankthink/the-future-model-of-banking-part-two-gse-reform-part-infinity-1060886-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/the-future-model-of-banking-part-two-gse-reform-part-infinity-1060886-1.html",
		"http://www.americanbanker.com/bankthink/the-merchant-and-the-king-a-payments-parable-1061048-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/the-merchant-and-the-king-a-payments-parable-1061048-1.html",
		"http://www.americanbanker.com/bankthink/wells-stumpf-community-banks-are-vital-to-our-way-of-life-1061639-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/wells-stumpf-community-banks-are-vital-to-our-way-of-life-1061639-1.html",
		"http://www.americanbanker.com/bankthink/banks-and-regulators-should-be-allies-not-enemies-1062500-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/banks-and-regulators-should-be-allies-not-enemies-1062500-1.html",
		"http://www.americanbanker.com/bankthink/todays-mortgage-reform-could-become-tomorrows-redlining-1061777-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/todays-mortgage-reform-could-become-tomorrows-redlining-1061777-1.html",
		"http://www.americanbanker.com/bankthink/united-states-isolating-itself-from-global-payments-system-1062744-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/united-states-isolating-itself-from-global-payments-system-1062744-1.html",
		"http://www.americanbanker.com/bankthink/access-to-credit-is--1062699-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/access-to-credit-is--1062699-1.html",
		"http://www.americanbanker.com/bankthink/getting-real-about-diversity-1062536-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/getting-real-about-diversity-1062536-1.html",
		"http://www.americanbanker.com/bankthink/jpm-probed-for-possibly-obstructing-probe-nasdaq-malfunctions-again-1061797-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/jpm-probed-for-possibly-obstructing-probe-nasdaq-malfunctions-again-1061797-1.html",
		"http://www.americanbanker.com/bankthink/more-bank-execs-should-be-on-twitter-1060825-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/more-bank-execs-should-be-on-twitter-1060825-1.html",
		"http://www.americanbanker.com/bankthink/regulators-gang-up-on-banks-and-third-party-payment-processors-1061533-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/regulators-gang-up-on-banks-and-third-party-payment-processors-1061533-1.html",
		"http://www.americanbanker.com/bankthink/tax-reform-proposal-backs-credit-unions-into-a-corner-1061492-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/tax-reform-proposal-backs-credit-unions-into-a-corner-1061492-1.html",
		"http://www.americanbanker.com/bankthink/schneiderman-again-poised-to-sue-wells-wall-st-infiltrates-p-to-p-lending-1062543-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/schneiderman-again-poised-to-sue-wells-wall-st-infiltrates-p-to-p-lending-1062543-1.html",
		"http://www.americanbanker.com/bankthink/back-down-bankers-credit-union-tax-exemption-has-merit-1061649-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/back-down-bankers-credit-union-tax-exemption-has-merit-1061649-1.html",
		"http://www.americanbanker.com/bankthink/mortgage-demand-weakens-europe-approves-new-regulator-1061989-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/mortgage-demand-weakens-europe-approves-new-regulator-1061989-1.html",
		"http://www.americanbanker.com/bankthink/yellens-fed-nomination-may-hit-washington-gridlock-1062706-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/yellens-fed-nomination-may-hit-washington-gridlock-1062706-1.html",
		"http://www.americanbanker.com/bankthink/banking-is-still-a-great-career-choice-1061286-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/banking-is-still-a-great-career-choice-1061286-1.html",
		"http://www.americanbanker.com/bankthink/free-market-alternative-modern-banking-1060861-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/free-market-alternative-modern-banking-1060861-1.html",
		"http://www.americanbanker.com/bankthink/jpm-faces-probe-over-hiring-in-china-merrill-to-dissolve-into-b-of-a-1061419-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/jpm-faces-probe-over-hiring-in-china-merrill-to-dissolve-into-b-of-a-1061419-1.html",
		"http://www.americanbanker.com/bankthink/jpm-ferc-update-home-rental-payment-backed-securities-geithner-fed-chair-1060994-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/jpm-ferc-update-home-rental-payment-backed-securities-geithner-fed-chair-1060994-1.html",
		"http://www.americanbanker.com/bankthink/only-congress-thinks-main-street-banks-are-tbtf-1061104-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/only-congress-thinks-main-street-banks-are-tbtf-1061104-1.html",
		"http://www.americanbanker.com/bankthink/stress-tests-for-midsize-banks-are-unnecessarily-stringent-1062544-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/stress-tests-for-midsize-banks-are-unnecessarily-stringent-1062544-1.html",
		"http://www.americanbanker.com/bankthink/dc-jitters-go-global-wrongdoer-faces-music-1062674-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/dc-jitters-go-global-wrongdoer-faces-music-1062674-1.html",
		"http://www.americanbanker.com/bankthink/losers-in-debit-interchange-ruling-consumers-1061311-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/losers-in-debit-interchange-ruling-consumers-1061311-1.html",
		"http://www.americanbanker.com/bankthink/opportunities-for-banks-remain-in-mortgage-market-1062677-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/opportunities-for-banks-remain-in-mortgage-market-1062677-1.html",
		"http://www.americanbanker.com/bankthink/where-in-the-world-are-the-london-whale-traders-1061253-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/where-in-the-world-are-the-london-whale-traders-1061253-1.html",
		"http://www.americanbanker.com/bankthink/a-simpler-gentler-basel-1061243-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/a-simpler-gentler-basel-1061243-1.html",
		"http://www.americanbanker.com/bankthink/basels-new-guidance-on-derivatives-counterparties-fixes-shortcomings-1061015-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/basels-new-guidance-on-derivatives-counterparties-fixes-shortcomings-1061015-1.html",
		"http://www.americanbanker.com/bankthink/fear-of-boomerang-mortgages-still-hinders-the-market-1061190-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/fear-of-boomerang-mortgages-still-hinders-the-market-1061190-1.html",
		"http://www.americanbanker.com/bankthink/fine-spare-the-bank-jail-the-banker-1062016-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/fine-spare-the-bank-jail-the-banker-1062016-1.html",
		"http://www.americanbanker.com/bankthink/summers-yellen-and-the-signals-for-women-1061662-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/summers-yellen-and-the-signals-for-women-1061662-1.html",
		"http://www.americanbanker.com/bankthink/how-dodd-frank-makes-m-and-a-more-difficult-1061478-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/how-dodd-frank-makes-m-and-a-more-difficult-1061478-1.html",
		"http://www.americanbanker.com/bankthink/join-us-for-a-tweet-chat-on-the-future-model-of-banking-1060882-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/join-us-for-a-tweet-chat-on-the-future-model-of-banking-1060882-1.html",
		"http://www.americanbanker.com/bankthink/regulators-made-questionable-call-on-qrm-rule-1061715-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/regulators-made-questionable-call-on-qrm-rule-1061715-1.html",
		"http://www.americanbanker.com/bankthink/wells-stumpf-on-community-banks-the-evolving-housing-market-1061724-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/wells-stumpf-on-community-banks-the-evolving-housing-market-1061724-1.html",
		"http://www.americanbanker.com/bankthink/why-jpmorgans-regulatory-fixes-may-fall-short-1061267-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/why-jpmorgans-regulatory-fixes-may-fall-short-1061267-1.html",
		"http://www.americanbanker.com/bankthink/a-better-way-to-address-disparate-impact-1061621-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/a-better-way-to-address-disparate-impact-1061621-1.html",
		"http://www.americanbanker.com/bankthink/do-not-let-bitcoin-morph-into-govcoin-1060955-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/do-not-let-bitcoin-morph-into-govcoin-1060955-1.html",
		"http://www.americanbanker.com/bankthink/fed-insiders-bolster-new-film-slamming-easy-money-policies-1061984-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/fed-insiders-bolster-new-film-slamming-easy-money-policies-1061984-1.html",
		"http://www.americanbanker.com/bankthink/forget-semantics-focus-on-improving-consumers-financial-health-1061560-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/forget-semantics-focus-on-improving-consumers-financial-health-1061560-1.html",
		"http://www.americanbanker.com/bankthink/the-missed-opportunities-of-dodd-frank-1061830-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/the-missed-opportunities-of-dodd-frank-1061830-1.html",
		"http://www.americanbanker.com/bankthink/twenty-thousand-pages-of-new-rules-yet-to-come-1062030-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/twenty-thousand-pages-of-new-rules-yet-to-come-1062030-1.html",
		"http://www.americanbanker.com/bankthink/all-eyes-on-congress-as-government-shutdown-looms-clos-rising-1062481-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/all-eyes-on-congress-as-government-shutdown-looms-clos-rising-1062481-1.html",
		"http://www.americanbanker.com/bankthink/as-goldman-turns-commodity-drought-sen-brown-does-banking-1061086-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/as-goldman-turns-commodity-drought-sen-brown-does-banking-1061086-1.html",
		"http://www.americanbanker.com/bankthink/b-of-a-gets-sued-and-ubs-settles-1061153-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/b-of-a-gets-sued-and-ubs-settles-1061153-1.html",
		"http://www.americanbanker.com/bankthink/fdic-guidance-still-leaves-banks-processors-at-examiners-mercy-1062697-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/fdic-guidance-still-leaves-banks-processors-at-examiners-mercy-1062697-1.html",
		"http://www.americanbanker.com/bankthink/some-sobering-lessons-from-freddie-mac-risk-sharing-deal-1061077-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/some-sobering-lessons-from-freddie-mac-risk-sharing-deal-1061077-1.html",
		"http://www.americanbanker.com/bankthink/banks-should-make-it-harder-to-withdraw-cds-early-1061929-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/banks-should-make-it-harder-to-withdraw-cds-early-1061929-1.html",
		"http://www.americanbanker.com/bankthink/big-changes-loom-for-bank-boards-1061025-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/big-changes-loom-for-bank-boards-1061025-1.html",
		"http://www.americanbanker.com/bankthink/bofa-intern-stories-show-just-how-far-banks-have-sunk-1061501-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/bofa-intern-stories-show-just-how-far-banks-have-sunk-1061501-1.html",
		"http://www.americanbanker.com/bankthink/jpm-exits-student-lending-summers-could-face-key-senate-opposition-1061826-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/jpm-exits-student-lending-summers-could-face-key-senate-opposition-1061826-1.html",
		"http://www.americanbanker.com/bankthink/nys-victory-over-tribal-lenders-may-be-short-lived-1062641-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/nys-victory-over-tribal-lenders-may-be-short-lived-1062641-1.html",
		"http://www.americanbanker.com/bankthink/rwa-beats-leverage-in-international-debate-1061580-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/rwa-beats-leverage-in-international-debate-1061580-1.html",
		"http://www.americanbanker.com/bankthink/since-lehman-the-financial-sector-has-changed-for-the-better-1061992-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/since-lehman-the-financial-sector-has-changed-for-the-better-1061992-1.html",
		"http://www.americanbanker.com/bankthink/a-u-s-default-is-the-ultimate-systemic-risk-1062768-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/a-u-s-default-is-the-ultimate-systemic-risk-1062768-1.html",
		"http://www.americanbanker.com/bankthink/cftc-rushes-bungles-swap-market-reform-industry-plays-along-1062734-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/cftc-rushes-bungles-swap-market-reform-industry-plays-along-1062734-1.html",
		"http://www.americanbanker.com/bankthink/jpm-discloses-criminal-probe-grameen-bank-faces-nationalization-1061186-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/jpm-discloses-criminal-probe-grameen-bank-faces-nationalization-1061186-1.html",
		"http://www.americanbanker.com/bankthink/regulatory-capital-road-test-as-economic-capital-actual-driving-1061908-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/regulatory-capital-road-test-as-economic-capital-actual-driving-1061908-1.html",
		"http://www.americanbanker.com/bankthink/sobering-lessons-from-freddie-mac-risk-sharing-deal-1061077-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/sobering-lessons-from-freddie-mac-risk-sharing-deal-1061077-1.html",
		"http://www.americanbanker.com/bankthink/summers-right-experience-for-fed-chair-1062033-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/summers-right-experience-for-fed-chair-1062033-1.html",
		"http://www.americanbanker.com/bankthink/do-not-undermine-liquidity-for-the-sake-of-capital-1062763-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/do-not-undermine-liquidity-for-the-sake-of-capital-1062763-1.html",
		"http://www.americanbanker.com/bankthink/the-intriguing-implications-of-the-fed-chair-battle-1061350-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/the-intriguing-implications-of-the-fed-chair-battle-1061350-1.html",
		"http://www.americanbanker.com/bankthink/why-roger-ferguson-may-be-the-next-fed-chair-1061473-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/why-roger-ferguson-may-be-the-next-fed-chair-1061473-1.html",
		"http://www.americanbanker.com/bankthink/a-new-wave-of-fair-lending-activism-1061317-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/a-new-wave-of-fair-lending-activism-1061317-1.html",
		"http://www.americanbanker.com/bankthink/fabulous-fab-found-liable-rbs-names-ceo-more-b-of-a-mortgage-woes-1061056-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/fabulous-fab-found-liable-rbs-names-ceo-more-b-of-a-mortgage-woes-1061056-1.html",
		"http://www.americanbanker.com/bankthink/improving-customer-relationships-closing-out-future-model-of-banking-1061063-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/improving-customer-relationships-closing-out-future-model-of-banking-1061063-1.html",
		"http://www.americanbanker.com/bankthink/seizing-underwater-mortgages-an-idea-that-is-all-wet-1061357-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/seizing-underwater-mortgages-an-idea-that-is-all-wet-1061357-1.html",
		"http://www.americanbanker.com/bankthink/tougher-enforcement-actions-are-coming-1061930-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/tougher-enforcement-actions-are-coming-1061930-1.html",
		"http://www.americanbanker.com/bankthink/whos-to-blame-for-feds-poor-morale-1061703-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/whos-to-blame-for-feds-poor-morale-1061703-1.html",
		"http://www.americanbanker.com/bankthink/basel-simplification-to-get-airing-in-austria-1061338-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/basel-simplification-to-get-airing-in-austria-1061338-1.html",
		"http://www.americanbanker.com/bankthink/lets-embrace-basels-higher-capital-buffers-for-big-banks-1061524-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/lets-embrace-basels-higher-capital-buffers-for-big-banks-1061524-1.html",
		"http://www.americanbanker.com/bankthink/mr-dimon-goes-to-washington-the-feds-stein-speaks-out-1062452-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/mr-dimon-goes-to-washington-the-feds-stein-speaks-out-1062452-1.html",
		"http://www.americanbanker.com/bankthink/jpmorgan-gives-everyone-deja-vu-hedge-fund-manager-admits-wrongdoing-1061448-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/jpmorgan-gives-everyone-deja-vu-hedge-fund-manager-admits-wrongdoing-1061448-1.html",
		"http://www.americanbanker.com/bankthink/the-meltdown-five-years-later-brainard-considered-for-fed-seat-1061856-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/the-meltdown-five-years-later-brainard-considered-for-fed-seat-1061856-1.html",
		"http://www.americanbanker.com/bankthink/weekly-wrap-the-limitations-of-dodd-frank-regulating-rating-agencies-1061845-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/weekly-wrap-the-limitations-of-dodd-frank-regulating-rating-agencies-1061845-1.html",
		"http://www.americanbanker.com/bankthink/what-engagement-banking-needs-is-less-engagement-1062004-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/what-engagement-banking-needs-is-less-engagement-1062004-1.html",
		"http://www.americanbanker.com/bankthink/derivative-clearing-houses-should-not-be-tbtf-either-1061283-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/derivative-clearing-houses-should-not-be-tbtf-either-1061283-1.html",
		"http://www.americanbanker.com/bankthink/mobile-chat-has-a-place-in-every-banking-app-1061065-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/mobile-chat-has-a-place-in-every-banking-app-1061065-1.html",
		"http://www.americanbanker.com/bankthink/the-real-reason-corker-warner-has-bipartisan-backing-1061681-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/the-real-reason-corker-warner-has-bipartisan-backing-1061681-1.html",
		"http://www.americanbanker.com/bankthink/the-return-of-bank-m-and-a-deals-that-actually-add-value-1061823-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/the-return-of-bank-m-and-a-deals-that-actually-add-value-1061823-1.html",
		"http://www.americanbanker.com/bankthink/when-screening-for-bad-guys-matching-names-no-longer-enough-1062513-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/when-screening-for-bad-guys-matching-names-no-longer-enough-1062513-1.html",
		"http://www.americanbanker.com/bankthink/how-community-banks-can-come-back-strong-in-mortgages-1061168-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/how-community-banks-can-come-back-strong-in-mortgages-1061168-1.html",
		"http://www.americanbanker.com/bankthink/what-work-of-ronald-coase-can-teach-about-banking-1061958-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/what-work-of-ronald-coase-can-teach-about-banking-1061958-1.html",
		"http://www.americanbanker.com/bankthink/a-beautiful-branch-only-depreciates-in-value-1062643-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/a-beautiful-branch-only-depreciates-in-value-1062643-1.html",
		"http://www.americanbanker.com/bankthink/barclays-to-unveil-capital-plans-fed-doves-best-hawks-on-forecasts-1060926-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/barclays-to-unveil-capital-plans-fed-doves-best-hawks-on-forecasts-1060926-1.html",
		"http://www.americanbanker.com/bankthink/commodities-arms-still-draw-attention-n-y-sues-payday-lender-1061284-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/commodities-arms-still-draw-attention-n-y-sues-payday-lender-1061284-1.html",
		"http://www.americanbanker.com/bankthink/earnings-season-default-fears-loom-fed-examiner-who-dared-criticize-goldman-1062770-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/earnings-season-default-fears-loom-fed-examiner-who-dared-criticize-goldman-1062770-1.html",
		"http://www.americanbanker.com/bankthink/swipe-fee-battle-rages-on-regulation-vs-innovation-do-bank-mergers-work-1061245-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/swipe-fee-battle-rages-on-regulation-vs-innovation-do-bank-mergers-work-1061245-1.html",
		"http://www.americanbanker.com/bankthink/swipe-fees-and-free-markets-how-durbin-can-help-payments-1061176-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/swipe-fees-and-free-markets-how-durbin-can-help-payments-1061176-1.html",
		"http://www.americanbanker.com/bankthink/yellen-knows-what-it-takes-to-fix-the-financial-system-1062715-1.html?CMP=OTC-RSS": "http://www.americanbanker.com/bankthink/yellen-knows-what-it-takes-to-fix-the-financial-system-1062715-1.html",
	}
	testURLs(t, urls)
}
func Test_articles_bestlawfirms_usnews_com(t *testing.T) {
	urls := map[string]string{
		"http://articles.bestlawfirms.usnews.com/law/blogs/law-firm-insider/2013/07/31/law-firm-insider-07312013?s_cid=rss%25253Alaw-firm-insider%25253Alaw-firm-insider-07312013": "http://articles.bestlawfirms.usnews.com/law/blogs/law-firm-insider/2013/07/31/law-firm-insider-07312013",
		"http://articles.bestlawfirms.usnews.com/law/blogs/law-firm-insider/2013/07/31/law-firm-insider-07312013?s_cid=rss%253Alaw-firm-insider%253Alaw-firm-insider-07312013": "http://articles.bestlawfirms.usnews.com/law/blogs/law-firm-insider/2013/07/31/law-firm-insider-07312013",
	}
	testURLs(t, urls)
}
func Test_accounts_google_com(t *testing.T) {
	urls := map[string]string{
		"https://accounts.google.com/ServiceLogin?continue=http%3A%2F%2Fwww.youtube.com%2Fsignin%3Faction_handle_signin%3Dtrue%26feature%3Dredirect_login%26hl%3Den_US%26next%3D%252Fedit%253Fns%253D1%2526video_id%253DEknoznBttvs%26nomobiletemp%3D1&hl=en_US&passive=true&service=youtube&uilel=3": "https://accounts.google.com/ServiceLogin?continue=http%3A%2F%2Fwww.youtube.com%2Fsignin%3Faction_handle_signin%3Dtrue%26feature%3Dredirect_login%26hl%3Den_US%26next%3D%252Fedit%253Fns%253D1%2526video_id%253DEknoznBttvs%26nomobiletemp%3D1&hl=en_US&passive=true&service=youtube&uilel=3",
	}
	testURLs(t, urls)
}
func Test_www_ateam_oracle_com(t *testing.T) {
	urls := map[string]string{
		"http://www.ateam-oracle.com/a-convenience-method-for-closing-multiple-resources/?fb=": "http://www.ateam-oracle.com/a-convenience-method-for-closing-multiple-resources/",
		"http://www.ateam-oracle.com/autolearning-and-oaam-patterns-logic/?fb=": "http://www.ateam-oracle.com/autolearning-and-oaam-patterns-logic/",
		"http://www.ateam-oracle.com/case-management-in-depth-cases-case-activities-part-1-acivity-scope/?fb=": "http://www.ateam-oracle.com/case-management-in-depth-cases-case-activities-part-1-acivity-scope/",
		"http://www.ateam-oracle.com/creating-a-custom-ovd-plugin/?fb=": "http://www.ateam-oracle.com/creating-a-custom-ovd-plugin/",
		"http://www.ateam-oracle.com/oracle-bam-adapter-batching-deep-dive/?fb=": "http://www.ateam-oracle.com/oracle-bam-adapter-batching-deep-dive/",
		"http://www.ateam-oracle.com/solaris-on-exalogic-using-netgroup-with-nis/?gplus=": "http://www.ateam-oracle.com/solaris-on-exalogic-using-netgroup-with-nis/",
		"http://www.ateam-oracle.com/webcenter-11-1-1-8-performance-analysis-feature/?fb=": "http://www.ateam-oracle.com/webcenter-11-1-1-8-performance-analysis-feature/",
		"http://www.ateam-oracle.com/why-do-we-need-to-change-or-whats-wrong-with-how-we-do-it-now/?fb=": "http://www.ateam-oracle.com/why-do-we-need-to-change-or-whats-wrong-with-how-we-do-it-now/",
	}
	testURLs(t, urls)
}
func Test_www_auntminnie_com(t *testing.T) {
	urls := map[string]string{
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104201%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104201%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104204%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104204%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104235%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104235%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104440%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104440%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104449%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104449%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104181%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104181%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104234%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104234%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104398%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104398%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104188%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104188%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dimc%26pag%3Ddis%26ItemID%3D105039%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dimc%26pag%3Ddis%26ItemID%3D105039%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104252%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104252%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104267%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104267%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104419%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104419%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dimc%26pag%3Ddis%26ItemID%3D105070%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dimc%26pag%3Ddis%26ItemID%3D105070%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dmri%26pag%3Ddis%26ItemID%3D105009%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dmri%26pag%3Ddis%26ItemID%3D105009%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104239%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104239%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104329%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104329%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104436%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104436%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dwom%26pag%3Ddis%26ItemID%3D105021%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dwom%26pag%3Ddis%26ItemID%3D105021%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104155%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104155%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104198%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104198%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104394%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104394%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104182%26pag%3Ddis%26sec%3Dsup%26sub%3Dres%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104182%26pag%3Ddis%26sec%3Dsup%26sub%3Dres%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104226%26pag%3Ddis%26sec%3Dsup%26sub%3Dxra%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104226%26pag%3Ddis%26sec%3Dsup%26sub%3Dxra%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104386%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104386%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104124%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104124%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104219%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104219%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104325%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104325%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104428%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104428%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104184%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104184%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104330%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104330%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dris%26pag%3Ddis%26ItemID%3D105086%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dris%26pag%3Ddis%26ItemID%3D105086%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104119%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104119%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104176%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104176%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104187%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104187%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104241%26pag%3Ddis%26sec%3Dsup%26sub%3Dres%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104241%26pag%3Ddis%26sec%3Dsup%26sub%3Dres%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104336%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104336%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dult%26pag%3Ddis%26ItemID%3D105083%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dult%26pag%3Ddis%26ItemID%3D105083%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104407%26pag%3Ddis%26sec%3Dsup%26sub%3Dxra%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104407%26pag%3Ddis%26sec%3Dsup%26sub%3Dxra%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dimc%26pag%3Ddis%26ItemID%3D105071%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dimc%26pag%3Ddis%26ItemID%3D105071%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D103795%26pag%3Ddis%26sec%3Dsup%26sub%3Dres%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D103795%26pag%3Ddis%26sec%3Dsup%26sub%3Dres%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104162%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104162%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104104%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104104%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104450%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104450%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104134%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104134%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104139%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104139%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104189%26pag%3Ddis%26sec%3Dsup%26sub%3Dxra%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104189%26pag%3Ddis%26sec%3Dsup%26sub%3Dxra%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104281%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104281%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104421%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104421%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dimc%26pag%3Ddis%26ItemID%3D105049%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dimc%26pag%3Ddis%26ItemID%3D105049%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104149%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104149%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104123%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104123%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104144%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104144%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104159%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104159%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104218%26pag%3Ddis%26sec%3Dsup%26sub%3Dxra%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104218%26pag%3Ddis%26sec%3Dsup%26sub%3Dxra%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104412%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104412%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dres%26pag%3Ddis%26ItemID%3D105082%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dres%26pag%3Ddis%26ItemID%3D105082%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104245%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104245%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dxra%26pag%3Ddis%26ItemID%3D105087%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dxra%26pag%3Ddis%26ItemID%3D105087%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104125%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104125%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104238%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104238%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104417%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104417%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dimc%26pag%3Ddis%26ItemID%3D104986%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dimc%26pag%3Ddis%26ItemID%3D104986%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Droc%26pag%3Ddis%26ItemID%3D105008%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Droc%26pag%3Ddis%26ItemID%3D105008%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104068%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104068%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104209%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104209%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104167%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104167%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104387%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104387%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104278%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104278%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dadv%26pag%3Ddis%26ItemID%3D104632%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dadv%26pag%3Ddis%26ItemID%3D104632%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104066%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104066%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104153%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104153%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104171%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104171%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104208%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104208%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104451%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104451%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104138%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104138%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104277%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104277%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dnws%26sub%3Drad%26pag%3Ddis%26ItemID%3D105010%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dnws%26sub%3Drad%26pag%3Ddis%26ItemID%3D105010%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104268%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104268%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104434%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104434%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dmol%26pag%3Ddis%26ItemID%3D105090%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dmol%26pag%3Ddis%26ItemID%3D105090%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104225%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104225%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104280%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104280%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104364%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104364%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104135%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104135%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104269%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104269%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104090%26pag%3Ddis%26sec%3Dsup%26sub%3Dres%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104090%26pag%3Ddis%26sec%3Dsup%26sub%3Dres%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104191%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104191%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104217%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104217%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104265%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104265%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104282%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104282%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104416%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104416%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dadv%26pag%3Ddis%26ItemID%3D105076%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dadv%26pag%3Ddis%26ItemID%3D105076%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104196%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104196%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104255%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104255%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dres%26pag%3Ddis%26ItemID%3D105049%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dres%26pag%3Ddis%26ItemID%3D105049%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104279%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104279%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104430%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104430%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dult%26pag%3Ddis%26ItemID%3D105067%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dult%26pag%3Ddis%26ItemID%3D105067%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104131%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104131%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104166%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104166%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104256%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104256%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104284%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104284%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104326%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104326%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104360%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104360%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104132%26pag%3Ddis%26sec%3Dsup%26sub%3Dres%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104132%26pag%3Ddis%26sec%3Dsup%26sub%3Dres%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104146%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104146%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104227%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104227%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104147%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104147%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104183%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104183%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104236%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104236%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dpac%26pag%3Ddis%26ItemID%3D105015%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dpac%26pag%3Ddis%26ItemID%3D105015%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dpac%26pag%3Ddis%26ItemID%3D105020%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dpac%26pag%3Ddis%26ItemID%3D105020%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104210%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104210%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104257%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104257%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104403%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104403%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104122%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104122%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104232%26pag%3Ddis%26sec%3Dsup%26sub%3Dres%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104232%26pag%3Ddis%26sec%3Dsup%26sub%3Dres%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104263%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104263%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104426%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104426%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dadv%26pag%3Ddis%26ItemID%3D104625%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dadv%26pag%3Ddis%26ItemID%3D104625%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104170%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104170%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104083%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104083%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104185%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104185%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104411%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104411%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104100%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104100%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104246%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104246%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104458%26pag%3Ddis%26sec%3Dsup%26sub%3Dxra%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104458%26pag%3Ddis%26sec%3Dsup%26sub%3Dxra%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104103%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104103%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104154%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104154%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104253%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104253%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104340%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104340%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104121%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104121%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104133%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104133%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104157%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104157%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104212%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104212%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104389%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104389%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104432%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104432%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dmol%26pag%3Ddis%26ItemID%3D105097%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dmol%26pag%3Ddis%26ItemID%3D105097%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104244%26pag%3Ddis%26sec%3Dsup%26sub%3Dxra%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104244%26pag%3Ddis%26sec%3Dsup%26sub%3Dxra%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104339%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104339%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104392%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104392%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dmol%26pag%3Ddis%26ItemID%3D104988%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dmol%26pag%3Ddis%26ItemID%3D104988%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104254%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104254%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104423%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104423%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dres%26pag%3Ddis%26ItemID%3D105089%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dres%26pag%3Ddis%26ItemID%3D105089%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104108%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104108%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104120%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104120%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104199%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104199%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104266%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104266%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104424%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104424%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Droc%26pag%3Ddis%26ItemID%3D104531%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Droc%26pag%3Ddis%26ItemID%3D104531%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104243%26pag%3Ddis%26sec%3Dnws%26sub%3Drad%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104243%26pag%3Ddis%26sec%3Dnws%26sub%3Drad%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104431%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104431%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104037%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104037%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104143%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104143%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104220%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104220%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104221%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104221%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104338%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104338%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dimc%26pag%3Ddis%26ItemID%3D105002%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dimc%26pag%3Ddis%26ItemID%3D105002%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dmri%26pag%3Ddis%26ItemID%3D105019%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dmri%26pag%3Ddis%26ItemID%3D105019%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dpac%26pag%3Ddis%26ItemID%3D105041%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dpac%26pag%3Ddis%26ItemID%3D105041%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104190%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104190%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104448%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104448%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104151%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104151%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104425%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104425%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104438%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104438%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dcto%26pag%3Ddis%26ItemID%3D105096%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dcto%26pag%3Ddis%26ItemID%3D105096%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104136%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104136%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104195%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104195%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104337%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104337%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dimc%26pag%3Ddis%26ItemID%3D105014%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dimc%26pag%3Ddis%26ItemID%3D105014%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104200%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104200%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104437%26pag%3Ddis%26sec%3Dsup%26sub%3Dres%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104437%26pag%3Ddis%26sec%3Dsup%26sub%3Dres%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104444%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104444%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104145%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104145%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104240%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104240%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104323%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104323%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dadv%26pag%3Ddis%26ItemID%3D105018%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dadv%26pag%3Ddis%26ItemID%3D105018%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104175%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104175%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104180%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104180%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104224%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104224%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104422%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104422%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dimc%26pag%3Ddis%26ItemID%3D105088%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dimc%26pag%3Ddis%26ItemID%3D105088%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104094%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104094%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104128%26pag%3Ddis%26sec%3Dnws%26sub%3Drad%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104128%26pag%3Ddis%26sec%3Dnws%26sub%3Drad%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104406%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104406%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104076%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104076%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104168%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104168%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104420%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104420%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104150%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104150%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104341%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104341%26pag%3Ddis%26sec%3Dsup%26sub%3Dris%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104393%26pag%3Ddis%26sec%3Dsup%26sub%3Dres%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104393%26pag%3Ddis%26sec%3Dsup%26sub%3Dres%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104401%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104401%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104435%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104435%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104228%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104228%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104322%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104322%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dult%26pag%3Ddis%26ItemID%3D105070%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dult%26pag%3Ddis%26ItemID%3D105070%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104129%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104129%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104161%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104161%26pag%3Ddis%26sec%3Dsup%26sub%3Droc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104327%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104327%26pag%3Ddis%26sec%3Dsup%26sub%3Dmri%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104137%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104137%26pag%3Ddis%26sec%3Dsup%26sub%3Dadv%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104169%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104169%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104222%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104222%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104242%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104242%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104379%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104379%26pag%3Ddis%26sec%3Dsup%26sub%3Dmol%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104405%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104405%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dwom%26pag%3Ddis%26ItemID%3D105003%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dwom%26pag%3Ddis%26ItemID%3D105003%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104152%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104152%26pag%3Ddis%26sec%3Dsup%26sub%3Dwom%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104203%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104203%26pag%3Ddis%26sec%3Dsup%26sub%3Dpac%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104324%26pag%3Ddis%26sec%3Dsup%26sub%3Dxra%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104324%26pag%3Ddis%26sec%3Dsup%26sub%3Dxra%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dxra%26pag%3Ddis%26ItemID%3D105067%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3Fsec%3Dsup%26sub%3Dxra%26pag%3Ddis%26ItemID%3D105067%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104127%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104127%26pag%3Ddis%26sec%3Dsup%26sub%3Dcto%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104262%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104262%26pag%3Ddis%26sec%3Dsup%26sub%3Dimc%26wf%3D1&sec=log",
		"http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104452%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log": "http://www.auntminnie.com/index.aspx?URL=http%3A%2F%2Fwww.auntminnie.com%2Findex.aspx%3FItemID%3D104452%26pag%3Ddis%26sec%3Dsup%26sub%3Dult%26wf%3D1&sec=log",
	}
	testURLs(t, urls)
}
